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 Functional molecular hybrids based on polyoxometalates: catalytic and biological 
studies 
Ph. D. Thesis by Gloria Modugno, University of Padova, Italy. 
Polyoxometalates (POMs) are molecular and nano-dimensional, multi-metal oxides, which 
have found applications in catalysis, materials science, and nano-medicine. Their general 
formula are: a) [MmOy]
p-
; b) [XxMmOy]
q-
, where M is the main transition metal constituent of 
the POM (M = Mo, V, W), O is the oxygen atom and X can be a non-metal atom, such as P, 
Si, As, Sb, another element of the p block, or a different transition metal. These species are 
characterized by a remarkable variety, since their properties depend on elemental 
composition, structure, and associated counterion. In addition, it is possible to synthesize 
“vacant” POMs derivatives, with surface defects. These last structures feature coordinatively 
unsaturated, terminal oxygen atoms, whose nucleophilicity can be exploited to foster reactions 
with electrophilic organic moieties to give O-X-R bonds, where X = As, P, Si, Sn, and R = 
organic residue. In this way, several organic-inorganic hybrid complexes can be obtained. 
Thus, the merging of organic domains with POM nano-scaffolds can be exploited to design 
new functional molecules and materials. In particular, POM-appended organic/organometallic 
moieties are instrumental for advanced catalytic applications and can direct the 
supramolecular organization of the hybrid molecules towards extended functional 
nanostructures. Among recent examples, the interplay of organic chromophores and POMs by 
covalent linkage and ionic assembly has been proposed for the development of 
photosensitized catalytic processes.  
In this thesis, we report the synthesis of hybrid POM derivatives containing luminescent 
chromophores (dansyl, pyrene and fluorescein), grafted as silane (with general formula 
(nBu4N)4[(R-Si)2O(γ-SiW10O36)]) or chiral phosphonate (with general formula 
(nBu4N)3Na2[(R*PO)2(α-A-PW9O34)]) derivatives, with unique spectroscopic features. The 
use of tetrabutylammonium (nBu4N
+
) as counterion promotes the solubilization of the POM 
in CH3CN. The resulting hybrids have been characterized at the solid state and in solution by 
a combination of techniques (multinuclear NMR, FT-IR, ESI-MS). The characterization 
suggested a bis-substitution: the inorganic POM framework provides a molecular nanosurface 
where two molecules of the same fluorophore are anchored in a tweezer-type arrangement. 
Optical and chiroptical properties of the hybrid derivatives have been investigated. In 
particular, the fluorescence spectroscopy of the fluorophore-tagged POMs has been exploited 
for sensing applications towards metal ions and organic molecules: 
 
 (i) The bis-dansylated complex can selectively coordinate bivalent metal ions (Cu and Pb 
ions), which can be detected in micromolar concentration. In the presence of Cu
2+
, a 
fluorescence quenching has been observed, whereas with Pb
2+
 an increase of luminescence 
has been obtained. 
(ii)  The extended π system of the pyrene derivative has been exploited to bind 
[60]fullerene. The luminescence quenching has highlighted the interaction of the POM 
with fullerene molecules in the micromolar range. 
 
A promising potential for applications in many different fields such as sensing, catalysis, 
nanoelectronics, and photochemical conversion of solar energy is foreseen for these 
luminescent systems. 
Moreover, due to the potential applications of POMs in medicine (many POMs exhibit 
antiviral, antitumoral and antibiotic activity), their association with organic domains may be 
also of interest to improve targeting and delivery strategies. In this scenario, the exploitation 
of hybrid complexes can allow: (i) to enhance stability and biocompatibility; (ii) to increment 
the affinity of derivatives towards carriers and biological targets; (iii) to incorporate imaging 
probes for cellular tracking/trafficking. Luminescent hybrid POMs, in particular, may couple 
the bio-imaging diagnostic potential with innovative therapy protocols. Thus, the assembly 
behavior and the stability of the luminescent hybrid POMs in physiological conditions have 
been investigated by means of dynamic light scattering (DLS), scanning electron microscopy 
(SEM) and transmission electron microscopy (TEM). The analysis showed the formation of 
spherical aggregates with a broad size distribution for these derivatives. The formation of 
such aggregates is expected to be driven by the hindered organic chromophores, bearing 
aromatic residues, whereas the tetrabutylammonium cations may assist the assembly, 
minimizing repulsion between adjacent inorganic polyanions. Moreover, since the 
fluorescence of these compounds is maintained under physiological conditions, they were 
tracked in the cells, showing their localization in different subcellular regions. An 
unprecedented uptake into nucleosomes and mitochondria has been highlighted. The 
cytotoxicity of hybrid POMs has also been determined, showing a reduced toxicity at low 
doses. These results are expected to pave the way to the use of suitable POMs both as drugs 
and as nanodimensional scaffolds for organic drugs.  
Furthermore, since the preparation of hybrid derivatives could be a powerful strategy for the 
introduction of molecular recognition sites and the enhancement of biocompatibility, studies 
 on the interaction between POM and hybrid POMs with important biological macromolecules 
(ferritin and avidin) were explored.  
The binding of two different kind of inorganic POMs ([Ru
IV
4(µ-OH)2(µ-O)4(H2O)4(µ-
SiW10O36)2]
10- 
and
 
[EuW10O36]
9-
) on the ferritin (Ftn) has been indeed higlighted by a 
combined investigation, involving DLS, ζ-potential measurements, ITC (isothermal titration 
calorimetry), fluorimetry, CD (circular dichroism) and TEM. In particular, (i) the shift of Ftn 
ζ-potential towards more negative potentials (by 8-13 mV), in the presence of the POM and 
(ii) the complete quenching of the Trp luminescence (λexc = 290 nm, λem = 327 nm), upon 
addition of >24 eqs of POM, likely due to energy transfer between the two domains, have 
shown that the POM can be successfully attached to the Ftn by means of ionic interactions. In 
addition, the integrity of the protein has been estabilished by DLS and CD analysis. 
Moreover, a biological hybrid POM containing biotin moieties was synthesized and its 
interaction capability with avidin was investigated. Such study allowed to investigate the 
confinement of hybrid POMs in correspondence of specific protein binding sites and to design 
bioconjugated systems with molecular recognition properties, to be exploited in targeting 
therapies. 
A last work, developed during a short scientific mission in Dublin, in collaboration with the 
research group of Prof. Martin Albrecht, is also presented. We have studied a strategy for the 
synthesis of a POM-appended N-heterocyclic carbene (NHC) iridium complex. To this end, 
imidazolium moieties have been successfully grafted on the defect site of a divacant Keggin 
polyanion. The hybrid POM synthesized was tested in catalyzing hydrogen transfer reactions 
(HT). The reduction of benzophenone to diphenyl methanol in iPrOH as solvent and hydrogen 
donor was used as a model reaction for probing the catalytic activity of the iridium(I) 
complex. In particular, full conversion after 120 min has been obtained using tBuOK as base.  
 
 
 
 
 
 
 
 
 
 
 Ibridi molecolari funzionali basati su poliossometallati: studi catalitici e biologici 
Tesi di Dottorato di Gloria Modugno, Università degli Studi di Padova, Italia. 
I poliossometallati (POMs) sono una classe di composti a base di ossidi polianionici discreti 
che presentano potenzialità di utilizzo in campi diversi, quali la catalisi, la scienza dei 
materiali e la medicina. Tali composti possono essere rappresentati da due formule generali:
 
(a) [MmOy]
p-  
isopolianioni; (b)[XxMmOy]
q-  
eteropolianioni,
 
dove M è un metallo delle serie di 
transizione (solitamente V, Mo o W nel più alto stato d’ossidazione (d0)) mentre X può essere 
un non metallo (P, Si, Ge, As, Sb, Te, etc.), o un diverso metallo di transizione (Co, Fe, Mn, 
Cu, etc.). 
 
La diversità strutturale e di composizione che caratterizza i POMs, si riflette in un ampio 
spettro di proprietà, controllabili a livello molecolare, che coinvolgono forma, potenziale 
redox, distribuzione della carica superficiale, acidità e solubilità. In particolare, una delle 
possibili modificazioni della struttura di un poliossometallato consiste nella preparazione di 
un complesso “vacante”. Poichè tali derivati presentano dei difetti strutturali sulla loro 
superficie, caratterizzati dalla presenza di atomi di ossigeno con reattività nucleofila, possono 
essere sfruttati per preparare complessi ibridi organici-inorganici. Infatti, gli atomi di 
ossigeno che si trovano in prossimità della lacuna vengono funzionalizzati mediante reazioni 
con reagenti elettrofili per dare legami O-X-R, dove X = As, P, Si, Sn, e R = residuo organico. 
In questo modo, la funzionalizzazione di POMs con residui organici consente lo sviluppo di 
molecole e materiali ibridi che possono presentare diverse funzionalità. Per esempio, 
l'associazione di residui organici/organometallici ai poliossoanioni ha consentito lo sviluppo 
di aggregati supramolecolari estesi e di sistemi innovativi con applicazioni catalitiche 
bifunzionali e avanzate. Inoltre, l' ancoraggio di cromofori organici è stato recentemente 
proposto per lo sviluppo di processi fotoattivati.  
Sulla base di queste premesse, in questo lavoro di tesi, sono state quindi studiate nuove 
strategie di sintesi, per la preparazione di derivati ibridi luminescenti basati su 
poliossometallati contenenti cromofori, quali dansile, pirene e fluoresceina e legati 
covalentemente al POM come organosilani (con formula generale (nBu4N)4[(R-Si)2O(γ-
SiW10O36)]) o come fosfonati chirali (con formula generale (nBu4N)3Na2[(R*PO)2(α-A-
PW9O34)]). Nella strategia di funzionalizzazione, l’uso di un sale di tetrabutilammonio 
(nBu4NBr) promuove la solubilizzazione del POM in CH3CN. 
I derivati ibridi ottenuti sono stati caratterizzati allo stato solido ed in soluzione utilizzando 
una combinazione di tecniche diverse (NMR multinucleare, FT-IR, ESI-MS). La 
caratterizzazione ha suggerito una bis-funzionalizzazione dello scaffold inorganico: due 
 molecole dello stesso fluoroforo organico sono ancorate sulla superficie del POM secondo un 
arrangiamento a tweezer. Sono state, quindi, studiate le proprietà ottiche e chiroottiche dei 
derivati ibridi luminescenti preparati e, in particolare, mediante indagini di fluorescenza, è 
stato possibile studiare la loro capacità come sensori verso ioni metallici e molecole 
organiche: 
 
(i) Il derivato bis-dansilato coordina selettivamente ioni metallici bivalenti, come il rame e 
il piombo, i quali possono essere, così, rilevati in concentrazione micromolare in soluzione 
organica. In seguito alla presenza di Cu
2+
 e Pb
2+
, in soluzione, sono stato stati osservati, 
rispettivamente, uno spegnimento e un aumento della fluorescenza del derivato. 
(ii) Il sistema esteso π del POM ibrido contenente pirene è stato, invece, sfruttato per 
legare il fullerene. In particolare, misure di luminescenza hanno evidenziato l'interazione 
del POM con molecole di fullerene nell'intervallo micromolare. 
 
I sistemi luminescenti proposti potranno essere utilizzati in diversi ambiti applicativi: 
sensoristica, catalisi, nanoelettronica, e fotochimica. 
Inoltre, considerando il potenziale utilizzo dei POMs in ambito biomedico, che include 
possibile attività antibatterica, antivirale e antitumorale, la loro associazione con domini 
organici e leganti è di interesse anche per disegnare nuove strategie di delivery e di targeting. 
A questo proposito, l' utilizzo di POMs ibridi potrebbe consentire: (i) l'uso di derivati con 
maggiore stabilità e biocompatibilità; (ii) l'incremento dell'affinità dei derivati nei confronti di 
vettori cellulari e di bersagli biologici; (iii) l' associazione di sonde luminescenti per il 
rilevamento di POMs nelle cellule. In particolare, POMs ibridi luminescenti, possono essere 
utilizzati per il bio-imaging, consentendo anche lo sviluppo di protocolli terapeutici 
innovativi. A tale proposito, quindi, sono stati investigati i fenomeni di aggregazione e la 
stabilità dei poliossanioni in soluzione fisiologica mediante indagini di dynamic light 
scattering (DLS), microscopia a scansione elettronica (SEM) e microscopia a trasmissione 
elettronica (TEM). Le analisi hanno permesso di evidenziare, per tali derivati, la formazione 
di aggregati sferici con un' amplia distribuzione delle dimensioni. La formazione di questi 
aggregati è probabilmente dovuta alle interazioni idrofobiche che coinvolgono i residui 
aromatici, mentre i cationi tetrabutilammonio possono minimizzare la repulsione tra gruppi 
polianionici adiacenti. Inoltre, poichè la luminescenza di questi sistemi viene mantenuta anche 
in condizioni fisiologiche, essi sono stati veicolati all'interno delle cellule, e localizzati in 
diverse regioni subcellulari, come nei nucleosomi e nei mitocondri. Studi dell' attività 
 biologica dei POMs ibridi hanno, in seguito, mostrato una ridotta tossicità a basse dosi. Questi 
risultati sono molto promettenti in quanto potrebbero aprire la strada all' utilizzo di POM 
ibridi, come farmaci o supporti biologici per molecole bioattive, in nanomedicina. 
Poichè, inoltre, la preparazione di derivati ibridi potrebbe essere una potente strategia per 
l'introduzione di siti di riconoscimento molecolare e il miglioramento della biocompatibilità 
del derivato stesso, sono stati condotti anche studi di interazione tra POMs e POMs ibridi con 
importanti macromolecole biologiche, come la ferritina e l'avidina. 
Ad esempio, abbiamo studiato l' interazione ionica fra due diversi tipi di POM ([Ru
IV
4 (μ-
OH)2(μ-O)4(H2O)4(μ-SiW10O36)2]
10 -
 e [EuW10O36]
9-
) con la proteina ferritina (Ftn) mediante l' 
ausilio della combinazione di diverse tecniche che hanno incluso: DLS, ζ-potential, ITC 
(calorimetria isotermica di titolazione), fluorimetria, CD (dicroismo circolare) e TEM. In 
particolare, abbiamo osservato (i) lo spostamento del potenziale ζ di Ftn verso valori più 
negativi, in presenza del POM e (ii) il completo quenching della luminescenza di Ftn (Trp: λex 
= 290 nm, λem = 327 nm), in seguito all' aggiunta di > 24 equivalenti di POM, dovuto, 
probabilmente, a trasferimenti energetici tra il POM e la macromolecola. Infine, l'integrità 
della proteina è stata verificata mediante analisi DLS e CD. 
Inoltre, è stato preparato un POM ibrido biologico contenente due molecole di biotina, al fine 
di valutare la sua capacità di interazione con la proteina avidina. In particolare, questo tipo di 
studio ha permesso di investigare la possibilità di confinare POM ibridi in corrispondenza di 
siti specifici di legame delle proteina e di esplorare la progettazione di nuovi sistemi 
bioconiugati con proprietà di riconoscimento molecolare, sfruttabili in terapie di targeting. 
Infine, è stata studiata una strategia di sintesi di un complesso di iridio, contenente come 
legante un poliossoanione ibrido funzionalizzato con un gruppo imidazolico. Questo lavoro è 
stato svolto nel laboratori di ricerca del Prof. Martin Albrecht presso University College of 
Dublin, Dublino, Irlanda. In questo caso, Il POM ibrido, preparato è stato sperimentato nella 
riduzione di gruppi carbonilici, mediante trasferimento di atomi di idrogeno da agenti 
riducenti sacrificali (iPrOH). La riduzione di benzofenone a difenil metanolo in iPrOH è stata, 
quindi, utilizzata come reazione modello per investigare l'attività catalitica del complesso. In 
particolare, è stato possibile ottenere una conversione completa dopo 120 min, utilizzando 
tBuOK come base. 
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1.1 Polyoxometalates: a general presentation 
The history of polyoxometalates (POMs) goes back to early XIX century
1
 when the discovery 
that metals belonging to early transition series, such as niobium, vanadium, tantalum, 
molybdenum, and tungsten in their higher oxidation states (configuration d
0
 or d
1
) can form in 
aqueous solution (at suitable pH, concentration and temperature) discrete polynuclear 
oxoanions with variable dimensions, ranging from few Angstrom and tens of nanometers.
2, 3, 4, 
5,6
 A first classification of these complexes is based on their chemical composition, essentially 
represented by two types of general formula.
2, 3, 4, 5, 6
: 
 
a) [MmOy]
p-
 
b) [XxMmOy]
q- 
 
where M is the main transition metal constituent of the polyoxometalate, O is the oxygen 
atom and X can be a non-metal atom as P, Si, As, Sb, another element of the p block, or a 
different transition metal. In the first case (a), polyoxometalates are called isopolyanions; 
while in the second case (b), they are called heteropolyanions.  
There are many types of polyoxometalate structures (Lindqvist, Keggin, Wells-Dawson, 
Kreb), obtained by a careful tuning of the synthetic parameters: concentration, stoichiometric 
ratio of the reactants, temperature, acidity. Some examples of polyoxometalate structures are 
reported in figure 1.1. 
 
 
 
Figure 1.1 Polyhedral representation of 
polyoxometalates, in which blue 
octahedra are centred on tungsten atoms, 
while the yellow tetrahedra are centered 
on the central hetroatom. 
a) Lindqvist structure [M6O19]
2-
 (M = 
Mo, W); b) α-Keggin structure 
[XW12O40]
n-
 (X = P, Si, B, Al, Ge; M = 
Mo, W); c) α-Well Dawson structure 
[X2M18O82]
n-
; d) Anderson-Evans 
heteropolyanion [XMo6O24]
m-
 (X = P, 
As, Mn); e) Dexter structure X2M12O42
n-.
. 
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The accessibility to such structural and compositional diversity is reflected in a broad range of 
properties that involve shape, redox potential, surface charge, acidity and solubility. 
Noteworthy, isostructural polyoxometalates may also display different properties depending 
on the heteroatom X, whereas the associated countercation is pivotal to foster solubility in 
different solvents. Properties and reactivity of POMs can thus be tuned and controlled at 
molecular level.  
In most cases, the structure of the polyoxometalates is derived from the aggregation of 
octahedral units MO6 with a central metal atom M and the oxygen atoms placed on their 
corners. In such octahedra, oxygen atoms exhibiting simple bonds with the metal allow the 
condensation between two octahedral units, while one oxygen atom- or a maximum of two – 
present a double bond character with the central metal atom and they are not shared with other 
metal atoms within the complex (terminal oxygens, Lipscom' s law
7
). In the following Figure 
1.2, two kinds of octahedra constituting POM structures are represented
2
: the first one is a 
terminal mono-oxo type presenting only one terminal oxygen atom, while the other five 
oxygens are shared with other atoms of the polyoxometalate; the second one is a terminal cis-
di-oxo type and it presents two terminal oxygens, in cis position, while the remaining four 
oxygens are shared by other metals in the whole polyoxometalate structure. 
 
 
 
Figure 1.2 Octahedra constituting the most common structures of the polyoxometalates. 
 
 
Two are the main characteristic features that a metal must possess to originate 
polyoxometalate complexes
2
:  
 
i) dimensions (cationic radius) compatible with a octahedral coordination;  
ii) presence of empty and available d orbitals, to allow the formation of terminal metal–
oxygen double bond.  
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The first feature explains, for example, the absence of a polyoxoanionic chemistry for Cr 
(VI): indeed, its smaller dimensions (ionic radius = 0.58 Å) allow only up to four coordinating 
oxygens. 
The octahedra condensation takes place through shared oxygen atoms, with the formation of μ 
- oxo bridged bonds between two metals ions, by the following three different ways
3,8
: 
 
 
i) corner sharing;  
ii) edge sharing;  
iii) face sharing (less frequent). 
 
These sharing modes are represented in figure 1.3. The presence of terminal oxygen atoms is 
essential for the aggregation to take place in discrete structures and not in an extended 
material (as for most common metal oxides, silicates, germanates, tellurates). Since terminal 
oxygens are less basic, they are not suitable for the condensation with other monomeric units, 
thus providing a barrier towards the linear polymerization and finally favouring discrete 
molecular units.
 2
 
 
 
 
Figure 1.3 Condensation of the octahedral units in polyoxometalates. 
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1.1.1 α-Keggin structure 
One of the most important class of polyoxometalates, is that of Keggin heteropolyanions. 
Their general formula is [XM12O40]
n-
, with M = Mo (VI) or W (VI). Keggin obtained the 
structure of the hexahydrated dodecatungstophosphoric acid for the first time in 1934, by X-
ray investigations
9
. This structure is called α-Keggin and consists of a central PO4 tetrahedron 
surrounded by 12 octahedra WO6 belonging to the mono-oxo terminal type. 
Such octahedra are disposed in four groups (triplets M3O13), each of them constituted by the 
aggregation of three octahedral units by edge-sharing. The four different triplets are 
condensed each other by corner-sharing. 
 
 
Figure 1.4 Two representation of the same α-Keggin structure of the [α-PW12O40]
3-
 heteropolyanion. 
On the left side a ball-and-stick model is represented: the red spheres are oxygen atoms, the blue ones 
are tungsten atoms and the orange one is the central phosphorous atom. On the right side a polyhedral 
model is represented: blue octahedra are centred on tungsten atoms, while the orange tetrahedron is 
centered on the phosphorous atom. 
 
Structure and symmetry of α-Keggin polyanions have also been confirmed in solution by 29Si, 
31
P and 
183
W NMR spectroscopies. 
10, 11, 12,13 NMR characterizations of [-PW12O40]
3-
 and [-
SiW12O40]
4-
 are reported in Table 1.1. The chemical equivalence of the 12 tungsten atoms 
leads to a single signal in both the 
183
W NMR spectra,
10 
while one signal is observed for the 
central atom (Si or P).
11, 12
  
Keggin polyoxometalates can also present structural isomers, which are formally obtained 
from the α structure by 60° rotation of one (β isomer), two (γ isomer), three (δ isomer) or four 
(ε isomer) triplets M3O13.
2,3
 These isomers are characterized by lower symmetry and by a 
decreased thermodynamic stability with respect to the α structure. 
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Table 1.1 Heteronuclear NMR characterizations of heteropolyanions with -
Keggin structure. 
 
 
 
 
 
 
 
 
 
 
1.1.2 Vacant structures 
Heteropolyoxotungstates described above are also called “saturated” structures, due to the 
high symmetry, the low anionic charge and the stability of the structure itself. Starting from 
them, it is also possible to synthesize derivatives with defects in the structure, the so called 
“vacant” (or “lacunary”) polyoxometalates. Such complexes derives from the saturated 
original polyoxometalate, through the formal loss of one or more MO6 tetrahedral units, thus 
affording vacancies on the surface. Synthetic procedures and experimental conditions to yield 
these species are strictly related to the thermodynamic and kinetic stability of the lacunary 
complexes themselves, which can be obtained from the precursors in suitable conditions of 
temperature, concentration and pH. 
As an example, the synthetic procedure and the structure of a monovacant tungsten complex 
[XW11O39]
n-
 (X = Si
IV
, P
V
, …), derived from the α-Keggin structure is reported below.14 
The vacant complex [XW11O39]
n- 
is stable and it can be isolated. Its synthesis can be obtained 
starting from [α-XW12O40]
 (n-4)-
, as well as by mixing stoichiometric amounts of mononuclear 
metal salts and adjusting the pH to a specific acidic value. 
 
 
 
Scheme 1.1 Synthetic procedure of the monovacant -Keggin [XW11O39]
n-
. 
Polyoxoanion 
183
W NMR
a δ, 
ppm 
31
P NMR
b δ, 
ppm 
29
Si NMR
c δ, 
ppm 
[-PW12O40]
3-
 -99.4 -14.9 --- 
[-SiW12O40]
4-
 -103.8 --- -85.3 
a
 ref.: 1 M WO4
2-
 in D2O; 
b
 ref.: 85% H3PO4; 
c
 ref.: Si(CH3)4; 
d
 ref.: H2O. 
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The same considerations applies to di- ([XW10O36]
m-
) and tri-vacant species ([XW9O33]
p-
), 
resulting from the formal loss of two or three octahedra, respectively.
15
 
 
 
 
Figure 1.6 Polyhedral structures of di- (left) and tri-vacant Keggin polyoxotungstates (right). 
 
Since these vacant polyanionic complexes feature reactive terminal, coordinatively 
unsaturated, oxygen atoms around the vacant sites, their nucleophilicity can be exploited to 
prepare the following derivatives: 
 
i) Transition metals-substituted polyoxometalates (TMSPs) complexes  
The reaction between a vacant polyoxometalate with a suitable transition metal precursor 
(M = Cr, Fe, Mn, Co e Ru) allows the incorporation of such metal on the POM structure, 
giving Transition Metals-Substituted Polyoxometalates (TMSPs) complexes (see Figure 
1.7 A). In several cases, a “out-of-pocket” coordination of transition metals yields 
sandwich-like dimeric structures, whereby the metal ions bridge the subunits (Figure 1.7 
B).
16,17
 
Figure 1.5 Ball-and-stick representation 
of the structure of the monovacant -
Keggin [XW11O39]
n-
. The blue spheres are 
tungsten atoms, the white ones are 
oxygens and the green one is the central 
heteroatom X. The red spheres are the 
nucleophilic oxygen atoms bordering the 
vacant site. 
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TMSPs show high stability, since the transition metal becomes an effective constituent of 
the whole polyanion structure. 
 
ii) Organic inorganic hybrid polyoxometalates (hybrid POMs) 
The vacant polyoxometalates can react with electrophilic organic moieties to give O-X-R 
bonds, where X = As, P, Si, Sn, and R = organic residue. In this way organic - inorganic 
hybrid POM complexes are formed (see Figure 1.7 C).
18,19,20  
 
 
Figure 1.7 Examples of derivatives obtained from vacant POMs: A [α-Fe(H2O)SiW11O39]
5-
; B [Fe 4(H2O)10(-
AsW9O33)2]6; C [(HO2CCH2PO)2(γ-SiW10O36)]
4-
. 
 
 
1.1.3 Proprieties of POMs 
Different properties make polyoxometalates very interesting in different scientific fields such 
as catalysis, material science and medicine
4
: 
 
(i) In catalysis, their use as Brönsted acids and homogeneous oxidation catalysts has been 
firmly established since the late 70s and 80s, respectively.
21
 Polyoxometalates in their 
protonated forms are called heteropolyacids (HPAs) and show a very strong Brönsted 
acidity, approaching the superacidic behavior; on the other hand, they are efficient 
oxidants, exhibiting fast reversible multielectron redox transformations under rather mild 
conditions. Furthermore, their acid-base and redox properties can be varied over a wide 
range by changing the chemical composition. On top of that, POMs exhibit a fairly high 
thermal stability in the solid state and they can be easily solubilized in a wide range of 
solvents, by choosing a suitable counterion. Of particular interest is the structural analogy 
between molecular POMs and extended solid oxides, as they may provide soluble models 
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to investigate reactions and surface properties of such related materials.
2,22 
The intriguing 
prospect is to use the well-defined and discrete POM based systems as molecular probes to 
trace new mechanistic pathways at the heterogeneous interface of metal oxide surfaces.
21,23
 
 
(ii) The anchoring of organic substituents on the POMs surface offers the possibility to 
tune the stereoelectronic features of the resulting complexes, and to affect their solubility, 
reactivity, and hydrolytic stability.
19,21,23
 This strategy was successfully employed to obtain 
polymerizable,
24
 dendrimeric
25
, and supramolecular derivatives
26
. Indeed, the merging of 
organic and inorganic domains is a developing field of investigation, mainly focusing on 
the design of new hybrid materials.
27
 The concept of hybrid polyoxometalates will be 
developed in the paragraph 1.2: Hybrid POMs: synthesis and applications. 
 
(iv) More recently, an increasing number of potential medical properties for 
polyoxometalates have been reported in the literature. Several papers deal with their 
bioactivity as antibacterial, antiviral, antitumoral agents or focused on their interactions 
with proteins.
28
 The application of POMs in medicine will be developed in detail in the 
paragraph 1.3: Polyoxometalates in Medicine. 
 
1.2 Hybrid POMs: synthesis and applications 
1.2.1 Synthetic strategies to obtain hybrid POMs 
In relation to the synthetic strategy adopted for their construction, POM hybrids can be 
classified on the basis of of interaction type between their organic and inorganic subunits. In 
particular, Class I is made up of all the species in which only non-covalent interactions (i.e., 
hydrogen bonds, electrostatic, or van der Waals interactions) occur between the two domains, 
while in Class II the organic and inorganic moieties are linked via covalent bonds.
21,23  
 
1.2.1.1 Class I hybrids 
The polyanionic nature of POMs offers a unique advantage in order to generate structural and 
function diversity, simply by counterion exchange.
19c
 Moreover, due to the cooperative effect 
of multiple ionic interactions, polycharged species can be assembled in highly stable 
structures and evolve to persistent nano-architectures. This category includes all POM 
derivatives associated with organic cations (tetraalkylammonium or phosphonium), 
polycationic polymers, dendrimers and dendrons, and organometallic complexes with a 
positive charge. 
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As an example, following this approach, in our research group, a tetraruthenium substituted 
POM complex [Ru4(µ-OH)2(µ-O)4(H2O)4(γ-SiW10O36)2]
10– 
(RuPOM)
 
has been associated to
 
cationic polyaniline (PANI), polydiallyldimethyammonium charged polymers (PDDA) or on 
carbon nanotubes decorated with positively charged dendrons. This POM is known as a 
highly robust and efficient water oxidation catalyst. In particular, the unique mechanistic and 
stability features of RuPOM have been exploited to prepare innovative nano-structured 
oxygen-evolving anodes, upon assembly of the POM cluster on the functionalized 
nanotubes.
29
 
.  
 
 
 
 
 
 
 
 
 
 
 
1.2.1.2 Class II hybrids 
Organic derivatization of polyoxometalates is mainly achieved from lacunary 
heteropolyoxometalates (paragraph 1.1.2), since the nucleophilic vacant oxygen atoms can 
react with electrophilic groups such as organophosponates, organoarsonates, organotin, 
etc.
18,19
 In particular, the variety of electrophilic groups available, combined with the various 
topologies observed in lacunary heteropolyoxometalate realm, explains the recent 
development of such organic/inorganic hybrids. The structure of the vacancy and the 
structural organization of the functionalizing agents are key parameters that need to be 
considered for the synthesis of functionalized heteropolyoxometalates. Furthermore, it has to 
be noticed that, aside from few exceptions, the functionalization of heteropolyoxometalates of 
Keggin and Dawson families is mainly observed with vacant tungsten species. 
In 1978, Klemperer first synthesized a functionalized polyoxometalate from a lacunary 
structure: [PW11O39]
7-
 was reacted with CpTiCl3 in CH2Cl2 to give [PW11O39 (TiCp)] 
4-
.
30
 
This approach was soon extended to the reactions of other hydrolyzable compounds such as 
Figure 1.8 Electrostatic immobilization of 
the RuPOM on the surface of nanotubes 
functionalized with positively charged 
dendrons. 
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RSiCl3, RGeCl3, RAsCl2, RP(O)Cl2 and RSnCl3 with monovacant Keggin and Dawson POM 
structures (Schemes 1.2 and 1.3).
31
 
 
 
Scheme 1.2 Functionalization of monovacant Keggin [α-PW11O39]
7-
 POM with organic moieties to yield hybrid 
POMs.  
 
 
Scheme 1.3 Functionalization of monvacant Dawson [α2-P2W17O61]
10 
POM with organic moieties to yield an 
hybrid POM.  
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In our Research Group, different procedures have been optimized in order to synthesize 
organic–inorganic POM-based hybrid complexes, starting from both organosilyl (SiX3, X = 
Cl, OMe) and organophosphonyl (POX2, X = Cl, OH) compounds as electrophilic reagents. 
The covalent functionalization of different lacunary POMs has been achieved with yields 
ranging from 65 up to 90%.
32
 The use of the bivacant complex [γ-SiW10O36]
8- 
has shown to be 
convenient for these reactions, since it is characterized by a higher hydrolytic stability, than 
other vacant complexes, in the acidic environment required for these reactions. As in the case 
of the monovacant precursor (see Figure 1.5) it presents four equivalent nucleophilic vacant 
oxygen atoms. These features allow to obtain bis-functionalized products with high 
selectivity. The reaction occurs readily in acetonitrile under phase-transfer conditions, by 
addition of nBu4NBr, that guarantee the solubility of the product.
33
 
 
 
 
Scheme 1.4 Functionalization of divacant Keggin [γ-SiW10O36]
8-
 POM
 
with organic moieties to yield hybrid 
POMs. 
Furthermore, to increase the complexity and diversity of these molecular structures, it is 
possible to chemically modify the organic arms grafted onto the polyoxometalate in post-
functionalization reactions. In this respect, for example, in our research group, amino acid 
methyl esters were covalently linked to the phosphonoacetic-substituted POM 
[(HOC(O)CH2PO)2(γ-SiW10O36)]
4–
 by means of classic condensation reactions.
34
 The 
synthetic scheme of the reaction is the following: 
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Scheme 1.5 Functionalization of the phosphonoacetic-substituted POM [(HOC(O)CH2PO)2(γ-SiW10O36)]
4–
 with 
amino acid methyl esters by means of classic condensation reactions.  
EDC=Ethyl-γ-dimethylaminopropylcarbodimmide; HOBT =1-hydroxy-1,2,3-benzotriazole. 
 
1.2.2 Hybrid POMs: molecules and materials with targeted properties and 
functions 
One of the aims of this Thesis is to explore and broad the use of hybrid POMs towards 
different application fields. For a better contextualization of the results obtained, some 
examples of hybrid POM structures and their applications have been collected and discussed 
within this paragraph.  
In general, the covalent functionalization of the POMs surface with organic residues can be 
exploited to:  
 
(i) stabilize molecular inorganic structures, by preventing structure collapsing;
35
  
(ii) tune the stereo-electronic features of the POMs surface, thus shaping their catalytic 
functions;  
(iii) support organic residues and organometallic catalysts;
19(d),36,37
 
(iv) provide solubilizing tags, suitable for a wide range of media, either aqueous or organic 
solvents, fluorinated phases, and non-conventional solvents, like ionic liquids;  
(v) introduce polyfunctional groups to be used as spacers between polyoxometalates, so to 
obtain dimers, polymers and dendrimers;
20,33 
(vi) provide an efficient tool for the self-organization of POMs in various phases, their 
immobilization on surfaces and their embedding in polymer matrices. 
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In our research group, hybrids POMs obtained by functionalization of [γ-SiW10O36]
8- 
POM 
scaffold with phenylphosphonic acid were used as catalysts in CH3CN or in ionic liquids to 
perform oxidations of alcohols, olefins, sulfides and sulfoxides in the presence of H2O2, even 
under microwave irradiation (scheme 1.6).  
 
 
 
Scheme 1.6 POM-based catalysts for microwave-assisted H2O2 activation. 
 
These hybrid derivatives presented superior performance and stability compared to the total 
inorganic POM precursors.
38
 In addition, (i) functionalization of the vacant site prevents the 
thermal rearrangement of the POM structure, so to allow the use of harsher conditions, 
including microwave (MW) irradiation (Scheme 1.6); (ii) the catalyst activity is strongly 
dependent on the nature of the organic moieties decorating the POM surface.
19,39 
The 
functionalization with chiral phosphonyl groups was also achieved, with the aim of 
performing enantioselective oxygen transfer.
34,39
 
Furthermore, in our research group, a fullerene-based hybrid POM found application in 
photocatalytic oxygenations. The reactivity of the hybrid photocatalyst toward hydrosoluble 
organic substrates has been assessed in water at 25°C, irradiating with λ >375 nm, in the 
presence of dioxygen (1 atm) (Scheme 1.7).  
Combining photoactive groups with POMs is a key strategy to access innovative 
photosensitized processes, with application in the field of photocatalysis and solar energy 
conversion.
19(d),40 
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Scheme 1.7 Schematic representation of the structure of a photoactive fullerene-based hybrid POM, able to 
perform the photo-oxidation of organic substrates, as phenol and L-methionine, in water. 
 
In particular, considering POMs ability to store several electrons with only minor structural 
reorganization, the association of organic sensitizers, as fullerene derivatives or different 
residues: pirene
41
 and perilene
42
, on the polyanionic scaffolds can be used to promote electron 
transfer phenomena between the two domains. 
This behavior is of interest to access new systems capable of combining the three functions 
necessary to photosynthetic activity: (i) collection of light; (ii) charge separation; (iii) 
accumulation of charge.  
As an example, a multi-porphyrin cluster has been covalently attached to a polyoxometalate 
catalyst in order to form an advanced model for the photosynthetic reaction complex. This 
bio-inspired mimic system, reported in Figure 1.9, displays efficient energy transfer from the 
peripheral zinc porphyrins (ZnP) to the central free-base porphyrin (FbP). The latter species 
participate in a light-induced electron transfer with the POM.
43
 
 
Chapter 1 
16 
 
 
 
Figure 1.9 Schematic representation of the structure and of the light-induced electron transfer for the POM-
based multi-porphyrin cluster. 
 
Unprecedented functionalization strategies of lacunary POMs with different luminescent 
probes, as well as their optical and sensing properties will be presented in Chapter 2: 
paragraph 2.2.3. In addition, they have been delivered into model human cells (see Chapter 
3: paragraph 3.2.1). 
 
Polyanionic inorganic scaffolds were also functionalized with organometallic complexes, 
examples include metallo-salen,
36(a) 
Wilkinson-type rhodium ligands
36(b)
. These hybrids were, 
generally, described as being more active and/or selective than the related organometallic 
precursor complexes. The main role of the POM scaffold is to tune the steric and electronic 
properties of the catalyst. Another expected role of the POM is to enhance the robustness to 
the whole hybrid (see also Chapter 4, paragraph 4.1.1). In our research group, POM-appended 
N-heterocyclic carbene (NHC) palladium complexes, capable to promote C-C cross coupling 
reactions were also synthesized.
37
  
 
In Chapter 4, the design of a novel POM-appended N-heterocyclic carbene (NHC) iridium 
organometallic complex and its catalytic activity in hydrogen transfer reactions will be 
discussed. 
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Finally, POMs serve also as building blocks for the bottom-up assembly of organic–inorganic 
hybrid 3D structures with applications in materials science, surface chemistry, 
electrochemistry and photochemistry.
19c),29,44,45
 
In this research group, Strandberg-type polyoxomolybdates[(R*PO3)2Mo5O15]
4-
 where R* is a 
chiral amino-phosphonate, were prepared. Due to the formation of a hydrogen bonded 
network, these hybrid units self-assembleand evolve to a hierarchical architecture of 
entangled fibers, showing solvent gelation capability, and amplification of chirality (Figure 
1.10).
27(b) 
 
 
 
Figure 1.10 Left: TEM analysis of Na-(R,R)-[(R*PO3)2Mo5O15]
2-
. Right: crystal packing diagram for Rb-(R,R)-
[(R*PO3)2Mo5O15]
2-
. MoO6 octahedra orange, O red, P magenta, C gray, N blue, H white, Rb azure.
 
 
 
Moreover, considering the redox activity of POMs, numerous electronic devices based on the 
interaction between POMs and electrically active materials (eg carbon nanotubes, graphene, 
semiconductors, etc..) have been developed (Figure 1.11). In these devices, POMs play the 
role of mediators for electron transfers. Indeed, they can act as electron reservoirs after 
photochemical or electrochemical reduction, to their corresponding colored mixed-valence 
species with no significant structural changes.
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Figure 1.11 Hybrids based on POMs and electrically active materials. 
 
 
In the field of Li-ion battery, for example, different electrodes based on POMs hybridized 
with polyaniline,
46
 carbon
47
 or single-wall nanotubes (SWNTs)
48
 were built; the resulting 
batteries show an increased capacity, due to the high storage electronic ability of POMs, 
based on reversible multi-step reduction processes.  
 
1.3 Polyoxometalates in medicine 
An increasing number of potential applications for polyoxometalates in human medicine have 
been reported in the literature. Several papers deal with their bioactivity as antibacterial, 
antiviral, antitumoral agents.
28
 
The main advantageous feature of POMs is that nearly every molecular property that impacts 
the recognition and reactivity of POMs with target biological macromolecules can be 
controlled. These include polarity, redox potentials, surface charge distribution, shape, and 
acidity. As already introduced above, another attractive feature is that rational and 
reproducible synthetic methods are now available (i) for the replacement of one or more of the 
skeletal d
0 
early transition metal cations in POMs with d- or p-block ions and also (ii) for the 
covalent attachment of organic groups to POMs via linkages that are compatible with 
physiological conditions (long half-lives in H2O or buffers at pH~7). Both metal substitution 
and organic derivatization extend considerably the number of POMs that are potentially 
bioactive. In particular, organic/biological pendant groups could be used to improve 
bioavailability and drug formulation, or to introduce recognition functions of target 
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biomacromolecules. To date, there are only few papers involving the biological behavior of 
POMs derivatized with organic groups, so this is a largely uncharted technical territory. 
The main disadvantage of POMs medicine is that they are not organic species. Low molecular 
weight, organic species dominate in the pharmaceutical industry (drug discovery, synthesis 
and development). An intrinsic counterpoint is that POM-based pharmaceuticals are much 
less expensive and more amenable to scale-ujp than the great majority of organic 
pharmaceuticals, so their successful application might positively impact large and growing 
markets in the emerging world.  
Two types of POM activity, antiviral and antitumoral, have dominated the medicinal 
chemistry of these compounds to date. Moreover, the antibiotic activity of some POMs has 
been demonstrated recently. These topics will be presented in the next paragraphs. 
 
1.3.1 Bioactivity of POMs 
1.3.1.1 Antiviral activities 
In 1970, Chermann and coworkers noticed an inhibitory effect of "silicotungstic acid 
supernatants (STAS)", a cell culture supernatant obtained in a procedure where silicotungstic 
acid was employed.
49
 They subsequently recognized that the inhibitor was the silicotungstate 
ion,
50
 and this led to a systematic study of the antiviral activities of this and other 
polyanions.
51 
Prior to 1990, in vitro studies conducted by various groups showed the efficacy 
of these POMs against several viruses: murine leukemia sarcoma (MLSV), vesicular 
stomatitis (VSV), polio, rubella, Rauscher leukemia (RLV), Rabies (RV), Rhabdovirus, and 
Epstein-Barr (EBV). Most of these POMs showed good inhibitory activity with low 
cytotoxicity, in a variety of cell lines. A particular effective compound was the 
tungstoantimonate (NH4)19[Sb9W21O86] (HPA-23). This POM was shown to be an effective 
antiviral agent against MLSV, RV, rhabdovirus and EBV, at nontoxic doses for the cells.
52
 
The advent of AIDS has increased the search for antiviral agents, and encouraged many 
studies that included polyoxometalates. In particular the groups of Hill and Yamase were very 
active in this area.
28(a) 
More recently, many different POMs have been shown to selectively inhibit in vitro the 
replication of retro-, toga-, paramyxo-, flavi-, and several herpes viruses and cytomegalovirus 
(CMV). Of significance was the finding that most POMs are highly effective against HIV-1, 
HIV-2, and simian immunodeficiency virus (SIV) in culture. Their activity is primarily 
antiviral and not virucidal (i.e., they do not interact directly with the virus in cell-free 
systems).  
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Table 1.2 Anti-HIV-1 activity and toxicity of organosilyl functionalized polytungstosilicate complexes (1-4_R) in 
Human PBM cells. 
a
EC50 = median effective (antiviral) concentration in µM. 
b
IC50 = median inhibitory (toxicity) concentration in µM.
  
 
As for instance, the activities of cesium and tetramethylammonium (TMA) salts of 
polyoxotungstate anions with covalently attached organosilyl groups against human 
immunodeficiency virus in primary human lymphocytes were evaluated (Figure 1.12).
53
 
 
 
Figure 1.12 Structure of the hybrid POM [(RSi)2O(γ-SiW11O39)]
4–
. 1-3_R: cesium (Cs) salts, 4_R: 
tetramethylammonium (TMA) salt. 
 
Table 1.2 lists the median effective concentration (EC50), and the median inhibitory 
concentration (IC50) of compounds 1-4_R compared to phosphonoformate (PFA), an antiviral 
agent used as a positive control, tested on human peripheral blood mononuclear cells 
(PBMC).  
 
 
 
 
 
The activities (EC50) of these compounds against human immunodeficiency virus in primary 
human lymphocytes range from 3.3 µM to 39.0 µM. Their IC50 values are all greater than 100 
 
# R 
HIV-1 in  
PBMC: 
EC50
a
 
toxicity in  
PBMC: 
IC50
b
 
1_R CH2CH2COOCH3 3.3 >100 
2_R CH2CH2CH2CN 19.8 >100 
3_R CH=CH2 35.3 >100 
4_R TMA CH2CH2COOCH3 39.0 >100 
 Phosphonoformate 21.0 >100 
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µM. Compound 1_R, was the most potent in the series with an EC50 of 3.3 µM and no 
toxicity to the uninfected host human lymphocytes when tested up to 100 µM.
53 
 
While the inhibition of viruses by POMs has been well documented, the primary mechanism 
for antiviral action has remained elusive. Both data and physical properties of POMs outlined 
in literature are consistent with multiple modes of action. The most likely of these are 
inhibition of viral enzymes (reverse transcriptase, RT, and/or protease in retroviruses).
53
 The 
polyanionic POM was proposed to bind electrostatically to the viral enzymes. Consequently, 
the charge and size of the POM was postulated to be a factor in viral inhibition. Nearly all the 
early experimental work on POM antiviral activity addressed inhibition of RT.
28(b) 
Another possible antiviral mechanism is the inhibition of surface viral proteins (such as gp120 
for HIV).
54
 Indeed, a strong interaction between a chemotherapeutic agent and viral surface 
proteins can lead to inhibition of virus-cell recognition and viral penetration into the cell (viral 
infectivity).  
POM antiviral activity varies considerably, not only with the structural class, composition, 
size, and charge of the POM, but also with the virus and viral strain and the cell line at parity 
of virus strain. Moreover, countercations of the polyanion and the organic functions of the 
POM play a significant role in biological activity and selectivity.  
As a final remark, while the antiviral effectiveness of over 200 POMs has been documented in 
vitro, the efficacy of fewer than 20 POMs has been documented in vivo. 
 
1.3.1.2 Antitumoral activities 
Antitumor activities of a variety of polyoxotungstates are mentioned in the scientific literature 
or in patents. In the last few years, Liu, Pope and their co-workers have investigated the 
cytotoxic properties of many heteropolyoxotungstates against cancer cell lines in vitro.
55
  
The authors focused mainly on hybrid derivatives of heteropolyoxotungstates containing RSn 
or CpTi (Cp = cyclopentadienyl) groups. Attempts have been made to correlate the 
cytotoxicity of the compounds with the potential of the first reduction process. Within several 
series of closely related compounds, it was found that the sequence of IC50 values is 
consistent with the order of the reduction potential: the higher the reduction potential, the 
higher their cytotoxicity.
56
 However, this correlation cannot be generalized: structure and 
composition clearly also play an important role in determining the activity.  
The IC50 values of some hybrid heteropolyoxotungstates derivatives are reported in μM in 
Table 1.3.
28(b)
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Table 1.3 IC50 values in µM for different heteropolyoxotungstates on tumor cells in vitro.  
 
 
Furthermore, the encapsulation of [CoW11TiO40]
8–
 in starch nanoparticles increases the cell 
penetration of [CoW11TiO40]
8–
: the higher efficiency observed for this system is likely due to 
a higher concentration of the heteropolytungstate inside the cell (see also paragraph 1.3.3.1). 
Organic substituents on the polyoxometalate core might have the same effect (see paragraph 
1.3.3.2) but this hypothesis still needs to be verified. Obviously, further investigations are 
necessary to elucidate the mechanism of the cytotoxicity of polyoxotungstates in vitro, and to 
establish a structure-activity relationship.  
Few data are available on the antitumor activity of polyoxotungstates in vivo. Yamase 
reported, in his patent applications, the growth inhibition of Meth A tumors in mice by rare 
earth-containing decatungstates.
28 
Yamase and his coworkers also recognized the antitumor 
Compound Cancer Cell Line 
 SSMC-7721 HeLa 
α-[(CpTi)3Si3W9O37]
7–
 7.8 14.0 
α-[(CpTi)3Ge3W9O37]
7–
 4.0 7.6 
-[(CpTi)3Si3W9O37]
7–
 6.7 12.1 
   
γ-[(CH3OOCCH2CH2Sn)2SiW10O38]
6–
 20.2 24.5 
γ-[(CH3OOCCH(CH3)CH2Sn)2SiW10O38]
6–
 19.0 23.2 
γ-[(C5H5Ti)2SiW10O38]
6–
 4.4 8.8 
   
[(CH3OOCCH2CH2Sn)2PW10O38]
5–
 17.2 21.7 
[(CH3OOCCH(CH3)CH2Sn)2PW10O38]
5–
 16.7 21.1 
   
[(CH3OOCCH2CH2Sn)3(PW9O34)2]
9–
 8.7 9.1 
[(CH3OOCCH(CH3)CH2Sn)P2W17O61]
7–
 16.7 18.3 
   
α-[(CH3OOCCH2CH2Sn)3SiW9O37]
7–
 28.1 28.8 
-[(CH3OOCCH2CH2Sn)3SiW9O37]
7–
 19.1 24.9 
α-[(CH3OOCCH2CH2Sn)3(SiW9O34)2]
11–
 10.8 15.6 
   
[(C5H5Ti)CoW11O39]
7–
 3.2 11.5 
[(C5H5Ti)BW11O39]
6–
 12.9 14.6 
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activities of Anderson-type polyoxomolybdates and of heptamolybdates in vivo.
28(a)
 They 
found, in particular, that the compound (NH3iPr)6[Mo7O24] significantly suppressed the tumor 
growth in mice bearing subcutaneously or intraperitoneally implanted methylcholanthrene-
induced tumor (Meth A sarcoma) or MM-46 adenocarcinoma. Promising antitumor activity of 
(NH3iPr)6[Mo7O24] was also reported against CO-4 human colon cancer and OAT human 
lung cancer xenografts. The antitumoral activity of POMs was found to compare favorably 
with that of commercial drugs. Based on the strong toxic effect of reduced heptamolybdate, 
the authors have proposed a mechanism for the antitumor action of (NH3iPr)6[Mo7O24]: the 
[Mo7O24]
6–
 species would be reduced to [HxMo7O24]
6–
 after thermal activation of a oxygen-to-
molybdenum-charge-transfer. The reduced species would then be reoxidized by reduction of 
the tumor cell, causing cell lysis.  
 
1.3.1.3 Antibacterial activities 
In 1993, Tajima reported that the lacunary Keggin polyoxotungstate [PW11O39]
7–
, when used 
in combination with β-lactam antibiotics, greatly enhanced antibiotic effectiveness against 
otherwise resistant strains of bacteria.
28(b)
 Thus, an extended investigation on the synergistic 
effect of more than 70 polyoxometalates in combination with -lactam antibiotics followed 
the initial studies.
28(b)
 However, there are too few studies of isostructural polyoxometalates to 
draw conclusions about the relationship between composition and activity.  
 
1.3.1.4 Cellular penetration of POMs 
POMs are large (in the nanometer size range) and highly negatively charged species. These 
two factors certainly do not facilitate their penetration into cells. One might therefore 
conclude that the observed activities result from the interaction of the POMs with the cell 
surface. Some studies however indicate that, under certain circumstances, POMs can cross the 
barrier and penetrate inside a cell.
28
 In particular, some polyoxotungstates have been found 
into the cells by means of high energy techniques, such as X-fluorescence microscopy, raman 
laser microscopy or scanning electron microscopy (see also Chapter 3, paragraph 3.1.1). 
Since these techniques are destructive for the cells, they cannot be used for imaging and cell 
tracking modalities.  
In this respect, in this Thesis hybrid POMs containing chromophores on their surface have 
been designed and exploited to study specific interactions of POMs with the cells. All this 
topics will be presented in the Chapter 3 of this Thesis. 
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On the other hand, as wjue have previously described (see paragraph 1.3.1.1), most of the 
biological, in vivo effects of POMs may be explained by interactions with target proteins 
accessible from the extracellular site. For this reason, the next paragraph will be focused on 
the POM-biomolecules interactions. 
 
1.3.2 Interaction of POMs with biological macromolecules 
Their promising biological activities make POMs attractive candidates for novel, innovative 
and cheap therapeutic strategies for various human diseases. However, the mechanisms of 
these phenomena at a molecular level remain unclear. As a consequence, preliminary studies 
of interactions, in a broad sense, between POMs and several target proteins, are one of the 
necessary steps toward an understanding their bio-functions. Furthermore, research on the 
interaction between POMs and proteins may open new paths for finding novel bio-function 
compounds. 
First, investigations of POMs in the presence of viral enzymes (e.g., HIV-1 reverse 
transcriptase -HIV-1 RT- and HIV-1 protease -HIV-1 P-) and proteins (e.g., gp120 and CD4) 
have indeed provided additional information into their mode of action.  
Initially, the structural and electronic complexity of POMs interacting with biological 
macromolecules has limited the collective efforts to probe these interactions theoretically. In 
this respect, as for instance, Hill and co-workers conducted theoretical studies on 
interaction(s) of different POMs (α1-K7[P2W17(NbO2)O61] and α2-K7[P2W17(NbO2)O61]; α1-
K7[P2W17NbO62] and α2-K7[P2W17NbO62]) with HIV-1 P. These computational studies 
strongly suggest that the POMs bind to a cationic pocket on the “hinge” region of the flaps 
covering the active site and not to the active site directly (the mode of inhibition of all other 
HIV-1 P protease inhibitors). The kinetics and binding studies, conducted after the molecular 
modelling, were in remarkable agreement with the modeling results.
57
 
Furthermore, several classic POMs (such as the Keggin K6SiNiW11O39, the Wells–Dawson α-
K8P2NiW17O61, and the trivacant Keggin-derived sandwich K10P2Zn4(H2O)2W18O68 bind to 
the cationic pocket of basic fibroblast growth factor (bFGF).
58
 The inhibition of angiogenesis-
promoting factors such as fibroblast growth factor is considered to be a potential treatment for 
cancers. 
More recently, the molecular interaction between HSA and two different polyoxometalates 
with Keggin [H2W12O40]
6-
 (H2W12) and wheel-shaped [NaP5W30O110]
14-
 (P5W30) structures 
were studied by isothermal titration calorimetry  (ITC), complemented by fluorescence and 
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circular dichroism (CD) experiments.
59
 Both polyoxometalates H2W12 and P5W30 strongly 
bind to the protein, mainly by electrostatic interactions.  
 
 
Figure 1.13 Left: POM structures: A the Keggin structure [H2W12O40]
6-
 (H2W12), B the wheel-shaped structure 
[NaP5W30O110]
14-
 (P5W30); Right: surface potential of HSA calculated with the GRASP software. The protein is 
in its N conformation. The two views are related by a 180° rotation about the vertical axis of the sheet. The 
region in the green circle is the most likely the unique (for H2W12) or initial (for P5W30) binding site for POMs 
(blue for positively and red for negatively charged areas). 
 
It was suggested that both size and charges of the polyoxometalates play key roles in the 
molecular interaction process. The surface map of the protein is shown in Figure 1.13: upon 
close examination, it appears that a cavity with a positively charged inner wall is located 
roughly in the center of the protein. The width of this cavity is about 1 nm length, which 
would fit to the diameter of H2W12. In particular, the results have suggested that the POM 
H2W12 specifically binds on this cavity of the protein and forms a 1:1 protein-POM complex, 
whereas the wheel shaped P5W30 binds to more than five sites and forms a complicated 
complex with the protein. The binding of H2W12 has almost no effect on the protein structure, 
in contrast with the binding of P5W30, which destabilizes the protein structure.  
Furthermore, the binding with HSA of three POMs with the Wells-Dawson structure, α2-
[P2W17O61]
10-
 and two of its metal-substituted derivatives, α2-[NiP2W17O61]
8-
 and α2-
[CuP2W17O61]
8-
 suggested the importance of the atomic composition in the interaction event.
60
 
The interaction between lanthanide containing decatungstate [EuW10O36]
9-
 (EuW10) and HSA 
was also studied. Fluorescence analysis showed the existence of a strong 1:1 interaction 
between the POM and HSA (Scheme 1.8).  
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Scheme 1.8 Interaction between EuW10 and HSA. 
 
 
This interaction has key effects both on luminescence of the POM and on the behaviour of 
HSA: an enhancement of the POM luminescence is observed upon interaction, while an 
increasing concentrations of the POM results in the progressive quenching of the fluorescence 
of the single tryptophan of HSA. Circular dichroism evidenced that the binding of EuW10 did 
not significantly alter the secondary structure of the protein
61
 (see also Chapter 3, paragraph 
3.1.2). 
Finally, four POMs capable of inhibiting amyloid β-peptides (Aβ) aggregation have been 
identified. The polymerization of Aβ into amyloid fibrils is crucial for the Alzheimer’s 
disease (AD). Therefore, the development of Aβ inhibitors has received much attention. The 
highest inhibition was observed for K8[P2CoW17O61], a phosphotungstate with a Wells 
Dawson structure. POMs with a Keggin structure showed moderate to high inhibition of Aβ 
aggregation. Smaller POMs, such as Na5[IMo6O24] with an Anderson structure were inactive. 
Indeed, the size of POMs might play a key role in Aβ recognition. In particular, an 
electrostatic effect is the main factor in the interactions between POMs and Aβ. Experiments 
based on enzyme digestion, competitive binding, fluorescence quenching, and the use of a 
different Aβ fragment indicated that POMs bind to the positively charged His13–Lys16 
cluster region of Aβ.62  
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1.3.3 Strategies for the biofunctionalization of POMs 
Since the main part of POMs derivatives present little or no hydrolytic stability at 
physiologically relevant pH values and some of them exhibit toxicity, many efforts have been 
made to modify POMs through altering their structure, polarity, charge, and composition in 
order to obtain compounds featuring low toxicity, high stability, and high activity.
57,63
 In this 
respect, a number of new POMs with hydrolytic stability at physiologically relevant pH 
values have been synthesized recently, and the toxicity problems exhibited by some POMs are 
considerably smaller or nonexistent in the second generation of POM-based chemotherapeutic 
agents.  
Moreover, an organic modification of POMs can be used to achieve higher stability under 
physiological conditions, together with a lower toxicity and a tunable biodistribution. In 
particular, two strategies for the biofunctionalization of POMs can be individuated: 
 
(i) non-covalent encapsulation of POMs by biopolymers, dendritic ligands and surfactants; 
(ii) covalent grafting of organic ligand or biomolecule on POMs. 
 
in the next sections these two strategies will be examined. 
 
1.3.3.1 Encapsulation of bioactive POMs into macromolecular matrices 
Different studies investigated the possibility of using nanocarriers for POM delivery, showing 
that the preparation of hybrid composite materials, through encapsulation of bioactive POMs 
into no toxic macromolecular matrices is a flexible and straightforward approach that should 
provide direct access to a wide spectrum of POM composites, improving their cellular uptake. 
The same strategy may be also useful to enhance hydrolytic stability of POMs and to decrease 
their toxicity.  
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Figure 1.14 Strategies for the non-covalent bio-functionalization of POMs. (a) encapsulation using dendrons, (b) 
encapsulation in dendrimers, (c) encapsulation in liposomes and (d) encapsulation in biopolymers (starch, 
chitosan). 
 
For instance, sugar-capped poly(propylene amine) (POPAM) dendrimers (Figure 1.14 (b)) are 
well suited for encapsulating and slowly releasing polyanions such as [Re6S8(OH)6]
4–
. The 
loading capacity of nanosized dendritic hosts with anionic guests and the pharmacokinetic 
properties of the host–guest complexes can be tuned by variation of the generation, the type of 
branching unit and the moieties grafted on to the periphery of the dendrimers.
64
 
Moreover, the synthesis of liposome-encapsulated polyoxometalate (LEP) nanoparticles of 
size 15-60 nm containing K6[SiW11TiO40]∙16H2O (SiW11Ti) is reported in the literature 
(Figure 1.14 (c)). Based on in vitro measurements with KB and HeLa cancer cells, the 
liposome encapsulation enhances cell-membrane penetration, the stability and antitumoral 
activity of the POM. The toxicity of the POM was also reduced when LEPs were employed 
against HL-60 tumors in vivo.
65 
 
The combination of chitosan and its derivatives with different drug types into core-shell 
nanoparticles (preferably in the 100 nm size range) offers manifold therapeutic advantages, 
such as reductions of side effects, prolonged drug circulation times or passive drug 
targeting.
66
 In the case of POMs, the mechanism of interaction with chitosan (Figure 1.14 (d)) 
is likely to be electrostatic. It is expected that the terminal/bridging oxygen on the surface of 
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POM interacts with the NH3
+
 protonated groups of chitosan to form intermolecular cross-
linking which thereby results in the formation of the nanocomposite (Figure 1.15). 
 
Figure 1.15 Representation of the interaction mechanism between POM and chitosan. 
 
 
As an example, the potential of a novel europium containing the polytungstoarsenate  
([CsEu6As6W63O218(H2O)14(OH)4]
25−
)
67
 (EuWAs) trapped whitin biopolymer chitosan, was 
evaluated as a cancer nanomedicine. Highly stable, monodispersed nanoparticles of size about 
200 nm, encapsulating EuWAs were prepared by ionotropic gelation technique. The aggregate 
showed a slow and sustained drug release profile when tested in vitro under physiological 
conditions. Its anticancer activity was found to be enhanced at lower doses. Flow cytometry 
studies revealed that reactive oxygen species (ROS) generation can be the plausible 
mechanism for the apoptosis induced by this material.
68
  
Moreover, the disadvantage of chitosan only being soluble in acidic media, can be overcome 
by transforming it into the water-soluble carboxymethyl chitosan (CMC) through 
carboxymethylation of the primary alcohol group and the amino group.
69
 The 
carboxymethylated chitosan has the ability to serve as a drug carrier for polyoxometalates.
 
In 
this respect, the synthesis, characterization and cytotoxicities of POM/CMC-based composites 
has been investigated. Since [Co4(PW9O34)2]
10-
 is well known for its manifold properties, such 
as antiviral activity, it was selected as a model POM. The resulting composites were 
characterized with a wide range of analytical methods, such as UV-Vis, FT-IR spectroscopy, 
as well as solid-state 
31
P NMR and EDX measurements, which pointed to quantitative 
encapsulation of intact POMs within the CMC matrix. The nanocomposites display a narrow 
size distribution ranging from 50–160 nm, which makes them ideal for cellular uptake. Thus 
the biocompatibility of the POM/CMC nanocomposites on HeLa cells was also evaluated 
through MTT and proliferation assays. Even after prolonged incubation times at high 
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concentrations, the composites did not display cytotoxicity, thereby drastically reducing the 
side effects of POMs.
70  
Finally, the use of fluorescein-tagged CMC as POMs carrier was applied to get insights about 
their localization, by means of confocal fluorescence microscopy.
71
 Thus POM/CMC 
nanocomposites with an average diameter of 130 nm were synthesized and labeled with 
fluorescein isothiocyanate (FITC) for a combined drug-carrier and cellular-monitoring 
approach. In particular, cellular uptake of fluorescently labeled {EuSiW11O39}/FITC-CMC 
nanoparticles were monitored with confocal laser scanning microscopy. Nanoparticle uptake 
occurs after incubation times of about 1 h and no cyctotoxic effect was observed upon 
prolonged treatment. The preferential location of these nanocomposites in the perinuclear 
region was furthermore verified with transmission electron microscopy investigations on 
unlabeled nanopart,icles. Therefore, this approach is a promising dual strategy for the safe 
cellular transfer and monitoring of bioactive POMs.  
 
1.3.3.2 Decoration of POMs with biological macromolecules 
The presence of organic substituents anchored on the POM surface also offers the possibility 
to modulate essential features, such as stability, bioavailability, recognition and affinity 
towards suitable carriers, that need to be mastered for pharmaceutical purposes.
63(c),72,73 
In 
particular, the introduction of chiral molecules on POMs surface is highly desirable for 
biomedical applications.
74
 
In this respect, numerous different synthetic approaches have permitted the grafting of 
biomolecules like amino acids,
75
 peptides
76
 and carbohydrates
77
 onto the polyoxometalate 
framework.  
For instance, in the literature are known complexes of polyoxomolybdates with peptides or 
aminoacids. γ-Type octamolybdates with formula, Na4[Mo8O26(alaO)2]∙18H2O, 
Na4[Mo8O26(glyglyO)2]∙15H2O and Na4[Mo8O26(glyglyO)2]∙12H2O have been prepared from 
sodium molybdate in aqueous solution by adding DL-alanine or glycylglycine. Their crystal 
structures have been determined by X-ray structural analysis. DL-alanine and glycylglycine 
coordinate molybdenum atom in γ-octamolybdate [Mo8O26]
4-
 anions via monodentate 
carboxylate-oxygen atom. These prepared octamolybdates were screened for the possible 
antiproliferative activity on a panel of five tumor cell lines and on a normal cell line. All 
tested compounds showed a differential cell-growth inhibition, in a dose-dependent manner, 
selectively on hepatocellular carcinoma cell line (HepG2) and breast cancer cell line.
78
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Moreover, hybrid organic-inorganic Wells-Dawson polyoxotungstates were prepared through 
addition of functionalized tricholorostannanes to lacunary α2- and α1-[P2W17O61]
10-
. The 
resulting products α2- and α1-[P2W17O61{SnR}]
7-
 with R = CH2COOH, CH2COOEt, 
CH2CHO, CH=CH2 were further functionalized with various molecules. Thus, coupling the 
polyoxotungstate platforms with amines and alcohols led to new structures in good yields.
79
 
In particular, amino acids or chiral amines were covalently linked to the chiral scaffold α1-
[P2W17O61{SnCH2COOH}]
7-
 by means of classic condensation reactions.  
 
 
Figure 1.16 Structure of α1-[P2W17O61(SnCH2CH2CONHR)]
7-
. 
 
In particular, coupling of chiral amines with the previously organotin-substituted α1 
derivatives allowed the isolation of diastereomers, which feature in some cases splitted 
1
H, 
13
C, and 
31
P NMR signals.  
Furthermore, more recently, different kinds of molecules (lipophilic, hydrophilic and 
biologically relevant) were coupled to the platforms α1- and α2-[P2W17O61{SnR}]
7-
 with R = 
CH2CHCH or CH2CH2CH2N3 to generate hybrids by means of the copper-catalyzed 
azide/alkyne cycloaddition (click chemistry).
77
 
Finally, in our research group, lacunary Keggin POMs have been also functionalized with 
enantiopure phosphonates (see also Scheme 1.5). These optically active hybrid complexes 
were characterized by FT-IR, heteronuclear NMR spectroscopy, mass spectrometry, and 
UV/Vis experiments. In such complexes, the merging of the organic and inorganic domains 
induces intense and multiple CD features up to 400 nm.  
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Figure 1.17 Stucture of α2-[P2W17O61(SnCH2CH2CONHR)]
7-
. 
 
 
1.4 Aim of Ph.D Thesis 
The work described in this Thesis mainly deals with the synthesis of functional molecular 
hybrids based on polyoxometalates for sensing, biological and catalytic applications. In 
particular, considering the great potential of hybrid organic-inorganic POMs derivatives, for 
improving recognition capabilities and selectivity towards organic/biological substrates, the 
use of different organic domains grafted on the POMs surface has been explored for imaging, 
targeting and catalytic purposes.  
The work is divided in three parts, involving synthesis, characterization and properties of 
different POMs: 
 
 Chapter 2 describes the functionalization and characterization of lacunary POMs with 
luminescent probes, that exhibit interesting opto-electronic properties and sensing 
applications. Fluorescence experiments have been performed to investigate the chemo-
sensing capabilities of the luminescent hybrid systems towards metal cations and 
hydrophobic molecules.  
 
 Chapter 3 is dedicated to the exploitation of POM-based hybrid systems for biological 
studies.  
In particular, the work has been dedicated to fill the lack of experimental data about POMs 
cellular uptake/ mechanism of action/ localization. In this scenario, the exploitation of 
stable hybrid luminescent complexes is suggested as a method to unravel their cellular 
localization. Furthermore, since the preparation of hybrid derivatives could be a powerful 
strategy for the introduction of molecular recognition sites and the enhancement of 
biocompatibility, studies of interaction between POMs and hybrid POMs with important 
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biological macromolecules (ferritin and avidin) has been explored. For this purpose, a 
hybrid POM containing biotin moieties has been synthesized and its interaction with 
avidin has also been investigated.  
 Chapter 4. In this chapter a strategy for the synthesis of a POM-appended N-
heterocyclic carbene (NHC) iridium complex is presented. To this end, imidazolium 
moieties have been successfully grafted on the defect site of a divacant Keggin polyanion. 
The resulting hybrid POM has been tested for catalyzing hydrogen transfer reactions 
(HT). This last project was developed during a short scientific mission in Dublin, in 
collaboration with the research group of Prof. Martin Albrecht. 
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Chapter 2 
 
Luminescent hybrid polyoxometalates: synthesis, 
characterization, sensing and spectral features 
 
 
 
In this chapter, we report the synthesis of hybrid polyoxometalate (POM) derivatives 
containing luminescent chromophores (dansyl, pyrene and fluorescein), grafted as 
organosilanes or chiral phosphonates, with unique spectroscopic features. The resulting 
hybrids have been characterized at the solid state and in solution by a combination of 
techniques (multinuclear NMR, FT-IR, ESI-MS). The characterization confirmed a bis-
substitution: the inorganic POM framework provides a molecular nanosurface where two 
molecules of the same fluorophore are anchored in a tweezer-type arrangement. Optical and 
chiroptical properties of the hybrid derivatives have been investigated. In particular, the 
fluorescence of the fluorophore-tagged POMs has been exploited for sensing applications 
towards metal ions and organic molecules. A promising potential for applications in many 
different fields such as sensing, catalysis, nanoelectronics, and photochemical conversion of 
solar energy is foreseen for these luminescent systems. 
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2.1 Introduction 
2.1.1 Hybrid polyoxometalates: synthesis and characterization 
Polyoxometalates (POMs) are nano-dimensional molecular, multi-metal oxides, which have 
found applications in catalysis, materials science, and nano-medicine.
1,2,3,4 
Tailored control of 
their properties is readily achieved by tuning the elemental composition, structure, and charge 
density of the inorganic scaffold.
1
 Moreover, the introduction of surface bound organic arms 
is a valuable tool for modifying redox and spectroscopic behavior, as well as their solubility 
and hydrolytic stability in various media.
5,6 
(see Chapter 1 paragraph 1.2: Hybrid POMs: 
synthesis and applications). 
Covalent derivatization of POM surfaces occurs smoothly according to well-established 
synthetic strategies, in analogy to those applied for the functionalization of extended metal 
oxides surfaces. Two basic strategies which rely on direct functionalization of POMs or post 
functionalization of preformed hybrid POM platforms, can be distinguished. 
 
2.1.1.1 Direct functionalization 
As already introduced in Chapter 1 (paragraph 1.1.2), vacant polyanionic complexes feature 
reactive terminal, coordinatively unsaturated, oxygen atoms. Their nucleophilicity can be 
exploited to foster a reaction with electrophilic organic moieties to give O-X-R bonds, where 
X = As, P, Si, Sn, Ge and R = organic residue. In this way organic-inorganic hybrid 
complexes can be obtained.
6,7,8 
In our research group, different procedures have been optimized in order to functionalize the 
POMs vacant site through the covalent grafting of organosilyl derivatives (SiX3, X = Cl, 
OMe) as electrophilic reagents. The covalent functionalization of different vacant POMs has 
been achieved with yields ranging from 65 up to 90%. The use of the bivacant complex [γ-
SiW10O36]
8- 
has shown to be convenient for these reactions, since it is characterized by a 
higher hydrolytic stability than other vacant complexes in the acid environment required for 
these reactions.
 
Thus the divacant complex [γ-SiW10O36]
8-
 has been reacted with organosilyl 
clorides (RSiCl3) and trialkoxysiloxanes (RSi(OR)3), where R = Et, n-Pr, Ph.
 
The general mechanisms for the derivatization of vacant polyanions with organosilanes are 
reported in the following scheme.  
 
Luminescent hybrid polyoxometalates: synthesis, characterization, sensing and spectral features 
41 
 
 
Scheme 2.1 General procedure for the preparation of organosilyl POM derivatives. 
 
The process requires the hydrolysis of the Si-X bonds: although the silanols may give easy 
polymerization (to form RSiOn species), the condensation with oxygen atoms on POM defect 
sites, is preferred. Grafting strategies have been optimized in acetonitrile, where the presence 
of tetrabutylammonium bromide (nBu4NBr) promotes the solubilization of the POM by 
counterion metathesis. Under these conditions, decoration of the vacant POM is known to 
yield hybrids with two surface-anchored organosilyl (RSi-) groups, each one linked to two 
oxygen atoms belonging to two edge-shared WO6 octahedra.
4(a) 
By using a similar protocol, the divacant POM complex reacts with organophosphonyl 
(POX2, X = Cl, OH) compounds in acetonitrile, under phase transfer conditions. In this case, 
the decoration of the divacant [γ-SiW10O36]
8–
 unit provide hybrid POMs with two surface-
anchored organophosphonyl (RPO
2+
) groups facing each other while linked to two oxygen 
atoms of two edge-shared WO6 octahedra. This structural arrangement was shown in the 
literature by solid-state X-ray characterization.
9
 In the scheme below, are reported the 
synthetic strategies for both the functionalizations proposed (organosilyl and 
organophosphonyl derivatives) in the next paragraphs. 
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Scheme 2.2 Functionalization of vacant polyoxometalates with organic moieties to yield hybrid POMs. 
The higher stability of hybrid structures in comparison to lacunary species, can be ascribed to 
the grafted organic functions, acting as protecting groups of the nucleophilic oxygenated sites 
on the POM lacuna. Thus, undesired parallel reactions, such as condensation or isomerisation 
of the vacant POMs, are inhibited, thus increasing their stability in different solvents and at 
higher temperatures. 
 
2.1.1.2 Post-functionalization 
Covalent functionalization of POMs provides – in principle – a robust link between the POM 
and the appended functional group. In this respect, as the complexity of the functional 
compond increases, the post-functionalization strategy is expected to be more attractive. 
Different hybrid POM platforms bearing functional groups have been involved in post 
functionalization reactions. The methodologies used to further derivatize preformed hybrid 
POM platforms can be classified according to the type of covalent bond formed: metal 
coordination, peptide and related bonds, imines as linkers, Huisgen 1,3-dipolar cycloaddition, 
carbon–carbon cross couplings. However, due to purification and stability issues, the number 
of reactions and related platforms are rather limited regarding the tremendous number of 
organic reactions available.
10
 
Compared with direct functionalization of POMs which may involve alkaline salts of parent 
POMs, like in the preparation of silyl or phosphonyl derivatives, the post-functionalization 
reactions reported to date have all been carried out in organic solvents, starting generally with 
tetrabutylammonium salts of the hybrid POM platforms.  
When the anchorage of electroactive groups has been considered, it is worth mentioning that 
the redox properties of both the POMs and the electroactive groups were not altered, thus 
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reflecting limited electronic interactions between the two domains. This is mainly due to the 
poor redox activity of vacant POMs. 
 
2.1.1.3 Characterization  
Different techniques can be combined to obtain information from both the inorganic and 
organic part of the molecule. In particular, the analysis which result most useful for 
monitoring the grafting of organic pendants on POM scaffold are the FT-IR and heteronuclear 
NMR spectroscopies. 
In the FT-IR analysis, a region between 1000 and 600 cm
-1
 (vibrations of the bonds W-O and 
X-O), results particular diagnostic to verify the modification and functionalization of the 
inorganic domain. In particular, narrow and intense bands are consistent with the presence of 
stable and highly symmetrical structures for the complexes of Keggin, while for vacant 
complexes spectra with lower absorption frequencies are observed, in agreement with the 
partial weakening of the vacant polyoxotungstate structure. Furthermore, since in the vacant 
complex the simmetry is reduced from Td to Cs or C2v due to the loss of WO
4+
 units, the 
bands result large and more numerous. The same region is also affected by the covalent 
linkage of the vacancy with organic compounds, with the occurrence of new signals due to 
XO bonds (with X = P, Si) above 1000 cm
-1
. Finally, a partial symmetrization of the complex, 
lead again to a general reduction of the number of signals and to an increase of the absorption 
frequencies. 
Information about the structure of the polyanion can be also derived from 
183
W NMR where 
typical signals patterns demonstrate the symmetry of the complex. The understanding of the 
electronic factors that influence the chemical shifts of the tungsten nuclei in mono and 
polynuclear complexes is still an open and complex topic, discussed in the literature mainly 
on the basis of empirical observations. However, in the case of new structures for which X-
ray diffraction is known, homonuclear 
2
J (W, W) and heteronuclear 
2
J (P, W) scalar couplings 
in 1 and 2-D techniques allowed the peaks assignment. In this way, characteristic patterns of 
signals allow to trace the exact symmetry of the complexes upon comparison with that of 
known structures. 
Finally, 
1
H NMR, 
13
C NMR, 
29
Si or 
31
P NMR spectroscopies and mass spectrometries (ESI-
MS, MALDI), are indispensable tolls to verify the introduction of organic residues. 
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2.1.2 Functionalization of POMs with fluorescent organic probes  
Fluorescence plays a key role in a growing number of disciplines, from molecular biology, to 
analytical chemistry, to optoelectronics and material science. Its high spatial, temporal 
resolution and excellent signal-to-noise ratio make fluorescence an ideal tool for studying the 
structure and dynamics of matter and living systems on a molecular and nanometric scale.  
The organic fluorophores may form covalent or noncovalent linkages with POMs, producing 
the respective conjugates or complexes, that can show fluorescence from short to very long 
wavelengths, depending on the marker used.
11
 
In addition, the interplay of organic fluorophores and POMs by covalent and ionic linkage has 
been recently proposed to promote charge separation states, being instrumental for solar 
energy conversion and storage, as well as for the development of molecular capacitors and 
photosensitized catalytic processes.
12,13 
Indeed the grafting of an organic pendant on POM 
nano-scaffold is a developing field of investigation focusing on the design of new functional 
molecules and materials (see also Chapter 1: paragraph 1.2.2). Furthermore, considering the 
interdisciplinary frontier of inorganic nano-clusters in medicinal chemistry (see Chapter 1 
paragraph 1.3), the introduction of luminescent probes on POMs can be also proposed for bio-
imaging/sensors and could eventually couple the diagnostic potential with innovative therapy 
protocols.
14
 
On these basis and perspectives, to exploit and combine the ability of organic luminescent 
molecules with the use of polyoxometalate scaffolds, fluorescent-tagged hybrids have been 
prepared, starting from vacant Keggin polyoxotungstates. To this aim, the organic reagents 
reported in Figure 2.1. have been selected. 
 
 
 
 
Figure 2.1 Organic reagents selected for the functionalization of POM scaffolds: (a) dansyl chloride (Dans-Cl); 
(b) pyrene sulphonyl chloride (Pyr-SO2Cl); (c) fluorescein isothiocyanate (FITC). 
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In particular, the grafting of the molecules (a), (b), (c) on polyanionic scaffolds has allowed to 
obtain four different luminescent hybrid derivatives:  
 
(a) a dansyl-functionalized POM with emission in the range 500-600 nm, 
(b) a pyrene sulfonyl-functionalized POM with emission up to 500 nm, 
(c) two fluoresceine isothiocyanate-functionalized POMs with emission beyond 500 nm. 
 
The synthesis and the sensing applications of these complexes will be presented in this 
chapter, while the biological properties will be described in depth in the next chapter. 
 
2.2 Results and discussion 
The introductions of fluorescent probes have been achieved following two different synthetic 
strategies: 
 
(i) Synthesis of the lacunary POM. 
(ii) Functionalization of the lacunary POM with an organic spacer containing a 
suitable functional group. 
(iii) Derivatization with the fluorophore in a post-functionalization reaction. 
In a different synthetic strategy, the steps (ii) and (iii) may be replaced by: 
(ii)
*
  Derivatization of the organic fluorophore with an appropriate organic spacer. 
(iii)
* 
 Direct functionalization of the fluorescent organic derivative on the POM. 
 
In the following sections the synthetic procedures developed to prepare new functional hybrid 
derivatives will be described. 
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2.2.1 Preparation and characterization of vacant polyoxotungstate 
precursors 
In this work, two different polyoxotungstates containing structural defects have been prepared 
as convenient precursors for the covalent functionalization with organic residues:  
 
(i) K8[γ-SiW10O36]: divacant decatungstate complex. It presents 4 unsaturated oxygen atoms 
on its surface. Beside the stability under functionalization conditions, it has been chosen 
because it can be produced with high selectivity, with no need to crystallize it;  
(ii) β-A-Na8[HPW9O34]: trivacant nonatungstate complex. It presents 6 unsaturated oxygen 
atoms on the surface. It can be functionalized with two or three organic groups, using, 
respectively, organophosphonates or organosilanes.
15
  
 
183
W NMR has been used to confirm the structure of the POM precursors: the structure and 
the spectra are briefly described below. 
 
(i) K8[γ-SiW10O36] (SiW10) 
The divacant precursor has been synthesized through a two steps procedure. First, the 
monovacant precursor [β2-SiW11O39]
8-
 is obtained as potassium salt, starting from sodium 
silicate and tungstate, then this complex is converted to the divacant derivative in the presence 
of K2CO3 at pH = 9.1.
16
  
The 
183
W NMR spectrum, recorded for the potassium salt of [γ-SiW10O36]
8-
, is reported in 
Figure 2.2: the corresponding spin-system, consisting of three signals with integration ratio 
2:2:1, is in agreement with the anion symmetry (C2v).
16 
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Figure 2.2 Polyhedral (A) and Ball-and-stick representation (B) of the divacant precursor SiW10 and 
183
W- 
NMR spectrum for the potassium salt. A difference in integral ratio is due to spin relaxations. WC (two tungsten 
side atoms), WA (four bottom tungsten atoms), and WB (four vacant tungsten atoms). 
 
(ii) β-A-Na8[HPW9O34] (PW9) 
The trivacant precursor is obtained, according to the the literature,
17
 from the dissolution of 
sodium tungstate in water, followed by addition of orthophosphoric acid, H3PO4 and 
concentrated acetic acid. The purity of the complex isolated was analyzed by 
31
P NMR and 
FT-IR. In particular, FT-IR evidences diagnostic bands at 1056, 1014, 931, 821 and 737 cm
-1
 
are in agreement with a Cs simmetry.
 15,17 
The trivacant structure is reported in Figure 2.3. 
 
 
 
 
Figure 2.3 Polyhedral (A) and Ball-and-stick representation (B) of the trivacant precursor PW9. 
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2.2.2 Synthesis and characterization of a bis-dansylated polyoxotungstate 
Naphthalene-based fluorophores have been extensively investigated, for example, as labels 
for amino acids, peptides, and proteins. The 5-dimethylamino-1 naphthalenesulfonyl label 
(generally indicated as dansyl; see Figure 2.1) carries some key optical properties, such as: (i) 
intense fluorescence in the visible region; (ii) relatively long emission wavelength; (iii) high 
Stokes shift behavior preventing self quenching; (iii) solvatochromism, by effect of a twisted 
intramolecular charge-transfer (TICT) excited state, and (iv) antenna-effects of 
polydansylated arrays.
18,19 
These unique features have been successfully exploited for the 
momolecular design of fluorescent chemosensors in which the dansyl chromophore is used in 
combination with receptor domains, including multi-dentate ligands, supramolecular hosts 
such as calix[4]arenes, cyclodextrins, crown ethers, and also silica surfaces.
20,21,22,23,24 
Depending on the dansyl environment, selective fluoroionophores have been obtained with 
interesting sensitivity towards ions such as Pb
2+
,
25
 Hg
2+
,
20,26
 and Cu
2+
.
21,27
 Moreover, a strong 
signal amplification results from multi-cooperative fluorescence quenching involving a 
dansylated surface-array attached to tailored nanosens hors.
19,28
 
 
2.2.2.1 Synthesis of (nBu4N)4[{((CH3)2N)C10H6SO2NH(CH2)3Si}2O(γ-SiW10O36)] (Dans-
SiW10)  
Selective dansylation of the divacant polyoxotungstate [γ-SiW10O36]
8–
 has been achieved after 
introduction of an aminopropyl trialkoxysilane spacer (step 1). 
The synthetic strategy is reported in scheme 2.3. The reaction entails a double 
functionalization of the POM precursor at the tetra-oxygenated nucleophilic site, which 
occurs readily in acetonitrile under phase-transfer conditions, by addition of nBu4NBr (step 
1).
6(a),29 
The resulting intermediate [{NH2(CH2)3Si}2O(γ SiW10O36)]
4–
 (APTES-SiW10)
12(a)
, 
reacts in a post-functionalization (step 2) with dansyl chloride (3.5 equiv.) in the presence of 
triethylamine (TEA, 3.5 equiv.), in acetonitrile at 50 °C for 2.5 h. The final product 
(nBu4N)4[{((CH3)2N)C10H6SO2NH(CH2)3Si}2O(γ-SiW10O36)] (1) was isolated in 69% yield, 
after precipitation with water and purification by extensive washing/extraction cycles with 
diethyl ether and acetone. 
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Scheme 2.3 Synthetic routes to a Keggin-type decatungstate functionalized with the dansyl chromophore. Step 
1: grafting of NH2(CH2)3SiCl3; Step 2: grafting of the dansyl chromophore.  
 
2.2.2.2 Characterization  
Grafting of NH2(CH2)3SiCl3 (Step 1) 
The hybrid POM APTES-SiW10 isolated in the first step (Scheme 2.3) display spectroscopic 
data (
1
H, 
13
C, 
29
Si and 
183
W NMR, FT-IR) that are in agreement with the expected bis-
functionalized structure.
6(a)
 In particular, as already introduced, among the characterization 
techniques, the spin-systems observed by mean of 
183
W NMR spectrum, is particularly 
diagnostic because it allow to recognize the expected signal patterns, in agreement with the 
structural hypothesis, and with different chemical shifts with respect to the corresponding 
POM precursors SiW10 (see paragraph 2.2.1). In particular, the 
183
W NMR spectrum of 
APTES-SiW10 shows three resonances at -107.8, -135.3 and -141.9 ppm in 2:1:2 ratio, 
confirming the retention of the C2v symmetry of the vacant precursor (Figure 2.4). In 
comparison with the inorganic precursor, a major downfield shift is observed for the signals 
corresponding to Wc (two side W atoms), whereas the atoms WB (four vacant W atoms) in 
proximity of the vacancy are now the most shielded.
30
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Figure 2.4 
183
W NMR spectrum of APTES-SiW10. 
 
The identification of a new signal 
29
Si NMR (at - 62.45 ppm) for the POM hybrid derivative, 
in addition to that observed at - 88.36 ppm for the silicon atom inside the polyanion 
(integration ratio of 2:1), is a further evidence of the introduction of two RSiO-equivalent 
groups (Figure 2.5). 
 
 
 
Figure 2.5 
29
Si NMR spectrum of APTES-SiW10. 
 
The FT-IR spectrum differs from that of the precursor POM SiW10 and shows intense 
absorption bands due to the organic counterion (2960-2874 cm
-1
) and to the hybrid polyanion; 
the intense band at 1100 cm
-1
 is assignable to the stretching of the group Si-O-Si linked to the 
polyoxometalate scaffold and consistent with the bis-functionalization (Figure 2.6). 
As expected, the bands are narrower and shifted to higher frequencies than those of the 
divacant precursor (see paragraph 2.1.1.3). 
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Figure 2.6 FT-IR (KBr) spectrum of APTES-SiW10 (up) in comparison with FT-IR (KBr) spectrum of K8[γ-
SiW10O36] (bottom). 
 
Finally 
1
H NMR and 
13
C NMR analysis confirm the presence of the aminopropyl group 
(Appendix, A1 and A2). 
 
Grafting of the dansyl chromophore (Step 2) 
The novel hybrid POM Dans-SiW10 (1) exhibits 
29
Si and 
183
W NMR spectral patterns 
confirming, respectively, the maintenance of the bis-organosilane anchoring (
29
Si NMR: δ = –
62.5 ppm, 2Si), in addition to the central tetrahedral SiO4 group (
29
Si NMR: δ = – 88.4 ppm, 
1Si), and the overall C2v symmetry of the POM structure with a 2:1:2 intensity ratio of the 
three expected 
183
W NMR signals (
183
W NMR: δ = –107.9, –136.2, –142.1) (Appendix, A4 
and A5). 
The FT-IR spectrum features diagnostic bands between 982 and 737 cm
–1
 (W–O bonds) and 
weak absorptions at 1101 and 1045 cm
–1
 (Si–O); furthermore, comparison with the spectrum 
of APTES-SiW10 confirms the integrity of the hybrid POM network upon dansylation. The 
new absorption bands observed at 1318 and 1143 cm
–1
 result from the sulfonamidic 
substituents (Appendix, A3). 
The ESI-MS spectrum of (1), recorded in the negative mode, shows a dominant cluster 
centered at m/z = 773.9 that can be ascribed to [{((CH3)2N)C10H6SO2NH(CH2)3Si}2O(γ-
SiW10O36)]
4–
, confirming the introduction of two dansyl units through a bis-sulfonamide 
linkage involving both amino pendants on the POM surface (Figure 2.7). 
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Figure 2.7 ESI-MS ((-),CH3CN) spectrum of (1). 
 
Finally, the 
1
H and 
13
C NMR spectra are also consistent with a covalent conjugation and, in 
particular, the signals of the aromatic carbons of (1) are sensibly deshielded (115–153 ppm), 
with respect to the dansyl chloride precursor (115–135 ppm) (Figure 2.9), the α methylene 
protons resonate at δ = 2.84 ppm (Δδ = –0.7 ppm with respect to the dansyl-free APTES-
SiW10), and the amidic (SO2NH) proton resonates at δ = 5.95 ppm (Figure 2.8). 
 
 
Figure 2.8 
1
H NMR spectrum of (1) in CD3CN. 
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Figure 2.9 
13
C NMR spectrum of (1) in CD3CN. 
 
2.2.2.3 Study of optical and sensing properties 
The UV-Vis spectrum of (1) (>200 nm) displays a shoulder at 218 and a maximum at 250 nm, 
together with a broad absorbance tail extending up to 450 nm. This spectral behavior is the 
result of the POM oxygen-to-tungsten charge transfer bands, overlapping with the typical 
absorption features of the fluorophore moiety, as can be seen from the superimposed spectra 
of dansyl-free APTES-SiW10 and of 3-(dansylamido)propyl(triethoxy)silane (reference 
dansylated silane). In particular, the three absorption bands at 218, 252, and 338 nm can be 
ascribed to the appended dansyl tweezer (Figure 2.10). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10. Left: structure of the reference dansylated silane
31
; Right: UV-Vis spectra of the dansyl reference 
(20 μM, dashed line), APTES-SiW10 (10 μM, gray solid line), and Dans-SiW10 (1) (10 μM, black solid line) in 
CH3CN.. 
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The fluorescence spectra of (1) (Figure 2.11) retain the typical pattern expected for the dansyl 
fluorophore with one emission band centered at 449 nm (λexc = 324 nm), albeit somewhat 
blue-shifted and with diminished intensity (20-fold) when compared to the emission observed 
for the singlet n,π* excited state of the dansylated silane, upon excitation at 336 nm. As 
verified for APTES-SiW10, the polyoxotungstate component shows only negligible 
fluorescence so that the excitation spectrum of (1) (λem = 450 nm) is dominated by the dansyl 
contribution, exhibiting well-resolved bands at 223, 245, and 329 nm. 
 
  
The quenching effect can be due to the electron acceptor properties of the POM network: a 
charge transfer state dansyl
+
-POM
- 
is
 
likely occurring at lower energy in comparison to the 
dansyl emission state, so to provide an inactivation route by means of an electron-transfer 
mechanism. Moreover, the blue-shift phenomenon is probably due to destabilization of the 
dansyl emission state by inter-electronic repulsions with electrons on the POM network, 
inducing an increase of its energy.  
 
Protonation equilibria  
Hybrid (1) (10 μM) undergoes protonation equilibria in acetonitrile/water (97.5:2.5 v/v) upon 
addition of acid (HCl, 1.6x10
–3 
M). The spectrophotometric titration shows major 
modifications in the spectral range 210–410 nm, whereby a gradual decrease of the bands at 
342 and 250 nm is accompanied by a progressive increase of a new absorption at 293 nm, 
giving rise to four isosbestic points at 222, 236, 274, and 308 nm (Figure 2.12 a). 
A parallel modification is registered in the emission and excitation spectra (Figure 2.12, b), 
where a progressive decrease of the dansyl-centered bands is observed respectively at 450 
(λexc = 324 nm) and at 247 and 330 nm (λem = 450 nm). This behavior is consistent with the 
protonation of both dansyl amino groups, and is responsible for a gradual disappearance of the 
Figure 2.11 Fluorescence spectra of the 
reference dansylated silane [20 μM, 
dashed lines: excitation (λem = 551 nm) 
and emission (λexc = 336 nm)] and Dans-
SiW10 (1) [10 μM, solid lines: excitation 
(λem = 450 nm) and emission (λexc = 324 
nm)], in CH3CN. 
Luminescent hybrid polyoxometalates: synthesis, characterization, sensing and spectral features 
55 
 
electronic transition bands involving the nitrogen lone-pair, as experimentally observed in 
both the absorption and fluorescence spectra.
19
 
 
Figure 2.12 Titration of Dans-SiW10 (1) (10 μM in CH3CN) with aqueous HCl (1.6x10
–3
 M). (a) UV/Vis 
spectra; (b) Excitation (λem = 450 nm) and emission (λexc = 324 nm) spectra. Inset: relative emission intensity at 
450 nm upon excitation at 236 nm (one of the isosobestic points). 
 
The spectrophotometric titrations determined either in absorption, emission, or excitation 
modes, display similar profiles, as a function of the added acid equivalents, and highlight the 
independent behavior of the dansyl units (Figure 2.13). 
 
 
 
 
Figure 2.13 Spectrophotometric titration of Dans-SiW10 (1) (10 μM in CH3CN) by stepwise addition of aqueous 
HCl (1.6 mM). Normalized values of absorbance (A) and fluorescence intensity (I) variations monitored at 
different wavelengths. 
 
In all cases, the observed spectral variations can mainly be ascribed to the dansyl probe, and 
they follow a sigmoidal behavior, with an initial “silent” phase, which was clearly determined 
in the fluorescence titration, followed by a linear behavior to a plateau value reached at two 
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equivalents. This is likely explained by an initial buffering effect of the inorganic polyanion, 
which acts as a competing proton scavenger in the system.
32
 
This hypothesis has been addressed by DFT calculations by using the ZORA-BP86 functional 
with the TZ2P basis set, including solvent and relativistic effects. Due to the large size of the 
molecules and to the high number of heavy metals, the internal or core electrons were kept 
frozen (see Chapter 5; paragraph: 5.3.2). These methods provide the optimized geometry for 
(1), together with the molecular electrostatic potential (MEP), and frontier molecular orbital 
(FMO) analysis (Figure 2.14). MEP analysis allowed the relative basicity of the different sites 
in the molecular hybrid to be estimated and indicated that a significant and extended electron 
density was localized at the oxygen centers of the polyoxometalate framework (Figure 2.14 
A). Moreover, inspection of the calculated FMO distribution showed that the filled orbitals 
were delocalized on the oxygen POM centers (oxo band) with energy levels close to the 
dansyl HOMO and HOMO
–1
, mostly identified by the π orbitals of the naphthalenic units with 
approximately 30% contribution of the p orbital of the nitrogen atoms of the dimethylamino 
functions (Figure 2.14 B). These findings support the involvement of the POM scaffold in 
protonation equilibria. 
 
 
Figure 2.14 A Map of the electrostatic potential and B representation of the HOMO and HOMO
–1
 orbitals of 
Dans-SiW10 (1), delocalized in the dansyl moieties. 
 
Fluoroionophore properties  
To evaluate the optical response of hybrid DansSiW10 (1) towards other cationic analytes and 
its potential as a fluorescent chemosensor for metal ions, emission quenching experiments 
were performed in the presence of Cu
2+
 Fe
2+
, Ni
2+
, Hg
2+
, Co
2+
, Cd
2+
, Zn
2+
, and Pb
2+
 by 
addition of an aqueous analyte solution (1.6 mM) to (1) (10 μM in CH3CN). The bar-graph in 
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Figure 2.15 highlights the dependence of the fluorescence intensity ratio I/I0 determined at λem 
= 457 (λexc = 324 nm) as a function of the metal ion added in the system.  
 
 
Figure 2.15 Optical sensing screening determined as the ratio between the fluorescence intensity observed for 
Dans-SiW10 (1) (10 μM in CH3CN with 2.5% v/v H2O) in the absence of any metal ion (I0) and in the presence 
of 40 μM metal ions (I) (λexc = 324 nm; λem = 457 nm, for Pb
2+
 λem = 525). 
 
In most cases, no appreciable change in the emission intensity occurred (I/I0 ≈ 1), with the 
remarkable exceptions of Cu
2+
 and Pb
2+
, which are two ions that are typically recognized as 
hazardous contaminants for drinking water.
33
 The optical sensing by (1) clearly entails diverse 
recognition mechanisms, because opposite effects are induced in the fluorescence emission 
upon addition of either Cu
2+
 or Pb
2+
 analyte. 
In particular, sensing of aqueous PbSO4 (40 μM), was determined by a red shift (68 nm) of 
the maximum emission wavelength (λ = 525 nm), together with a progressive tenfold increase 
of luminescence at that wavelength (Appendix, A6). Fluorescence enhancement has been 
previously reported for dansyl-based Pb
2+
 ionophores, and it was ascribed to metal ligation 
upon deprotonation of the NH amide function.
27 
In this specific case, however, Pb
2+
 ions may 
trigger a change either in the electronic structure or in the interactions between the 
chromophoric units, such as a decreased stacking of paired naphthalenic moieties. The similar 
emission of the Pb
2+
 adduct and of reference dansylated silane may also suggest a reduced 
interaction between the dansyl units and the polyanionic domain. 
On the other hand, stepwise addition of CuSO4 (1.6x10
–3
 M, ca. 4 μL aliquots) induced a 
progressive quenching of the emission band, monitored at 457 and at 525 nm (λexc = 324 nm), 
down to a plateau value of about 5–14% with respect to the initial conditions (Figure 2.16). 
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Figure 2.16 A Normalized values of fluorescence intensity (I) obtained for the titration of hybrid DansSiW10 (1) 
(10 μM in CH3CN) with an aqueous CuSO4 solution (0–20 μM), in the presence and in the absence of 40 μM 
CoSO4. B Emission (λexc = 324 nm) spectra. 
 
The Cu
2+
 titration profile resembles the protonation curve, determined for (1) with a similar 
procedure, again showing a sigmoidal shape, with a turning point at about 1:1 equiv. ratio. 
Moreover, the UV/Vis spectrum registered for (1) in the presence of the cuprous salt retains 
isosbestic points (albeit with a lower absolute ΔAbs) similar to those ascribed to the 
protonation equilibria (Figure 2.12 and 2.13). Accordingly, a plausible trigger for the Cu
2+
-
induced emission quenching could originate from its binding at the electron rich amine sites 
of the luminophore moiety. For comparison, the fluorescence response of reference compound 
was evaluated with respect to Cu
2+
, which showed negligible activity. This observation 
highlights the interplay between the two domains in the sensing mechanisms. 
Indeed, at variance with the majority of previously reported Cu-chemosensors, (1) does not 
contain any additional binding site tailored for a specific transition metal.
34
 Selective sensing 
by (1) and the tuning of its optical response stems from its multi-functional molecular nature 
integrating a dansyl-based optical transducer with the tungsten-oxide polyanionic surface. 
These latter features are instrumental for the geometrical constrains/spacing of the bis-
fluorophore tweezer, and the occurrence of competing cation scavenging equilibria that can be 
exploited in the analysis of complex mixtures. Indeed, the selective recognition of Cu
2+
 by (1) 
has also been validated in the presence of potentially interfering bivalent metal ions such as 
Fe
2+
, Ni
2+
, Co
2+
, and Zn
2+
. The presence of these latter ions did not result in any detrimental 
effects in the system, even when added in large excess (40 μM). On the other hand, the 
combined presence of “dansyl silent” metal cations, for instance Co2+, turns out to improve 
the optical signaling of Cu
2+
, resulting in a linearization of the sigmoidal fluorescence titration 
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curve (Figure 2.16). This can be explained by a preferential electrostatic interaction between 
Co
2+
 and the POM surface, thus overriding the initial lag-response of the dansyl 
fluorophore.
35
 Under such optimized conditions, a linear correlation is obtained, featuring a 
micromolar detection limit with maximum quenching at [Cu
2+
] above 12 μM, pointing to a 
1:1 interaction with (1). 
 
2.2.3 Synthesis and characterization of a pyrene-functionalized 
polyoxotungstate 
Pyrene is a rigid polyaromatic hydrocarbon fluorophore. It is a good probe as it presents a 
strong absorption and luminescence in the visible region (350-450 nm). One important 
application of the pyrene fluorescence stems from its ability to probe the polarity of the local 
microenvironment, either in a hydrophobic or hydrophilic media, from the change of specific 
emission spectrum.  
The extended π-system of the pyrene derivatives can be also exploited to bind hydrophobic 
molecules, such as [60]fullerene.
36
 Furthermore, the use of pyrene molecules as donors has 
been reported for a range of molecular systems exhibiting photo-induced electron transfer 
(PET). In this respect, many POMs are able to store several electrons with only minor 
structural reorganization and their reduced forms display efficient electrocatalytic 
properties,
37
 notably for the hydrogen evolution reaction.
38
 As a consequence, POMs are 
attractive candidates for the development of functional artificial photosynthetic devices and, 
in particular, their association to a light-harvesting antenna, such as pyrene derivatives, is yet 
necessary, since POMs themselves are only photoactive in the UV part of the solar 
spectrum.
39
 
Moreover, amphiphilic hybrid POM clusters with pendent pyrene fluorescent probes are of 
potential interest for the construction of smart supramolecular assemblies.
40
  
Finally, planar aromatic moiety, as pyrene, can intercalate into neighboring base pairs of 
double-stranded DNA.
41
 This intercalation can results from collective interactions of different 
forces depending on the structure of intercalators, including π-π interactions, the van der 
Waals force, hydrophobic interactions, and so forth. Considering the potential applications of 
POMs in medicine, the grafting of an intercalator containing aromatic rings on POMs surface, 
could be a focus of interest to researchers in different fields, referring to molecular 
recognition and nanomedicine. 
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2.2.3.1 Synthesis of (nBu4N)4[{C16H9SO2NH(CH2)3Si}2O(γ-SiW10O36)] (Pyr-SiW10)  
Synthesis of the reactive ligand: pyrene sulfonyl chloride 
First, in order to obtain a chromophore reactive in the reaction with the hybrid APTES-SiW10 
(see previous paragraph), we have functionalized the pyrene with the sulfonyl chloride group. 
The synthetic scheme reaction is reported below. 
 
1. ClSO3H
CH2Cl2
2. NaOH
SO3
-Na+
PCl5
CH2Cl2
40°C
SO2Cl
 
 
Scheme 2.4 Synthetic routes to 1-pyrensulfonyl chloride. 
The first synthetic step (Scheme 2.4), chlorosulfonation of pyrene, proceeded smoothly. The 
isolated intermediate, sodium l-pyrenesulfonate contains hydration water and NaOH, but it 
can be used without further purification. Transformation to pyrenesulfonyl chloride was 
performed in CH2Cl2 at 40°C in the presence of phosphorus pentachloride. Pyrene sulfonyl 
chloride was purified by silica gel column chromatography using CH2Cl2:hexane (2:3) as 
eluent. The yield of the orange product was 92.7%.
42
 
 
Grafting of the ligand on the POM scaffold 
 
 
 
Scheme 2.5 Synthetic routes to a Keggin-type decatungstate functionalized with the pyrene chromophore. 
 
Selective introduction of pyrene on the divacant polyoxotungstate [γ-SiW10O36]
8–
 was 
achieved after introduction of an aminopropyl silane spacer, as reported for the bis-dansylated 
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polyoxotungstate (nBu4N)4[{((CH3)2N)C10H6SO2NH(CH2)3Si}2O(γ-SiW10O36)] (1). The first 
intermediate [{NH2(CH2)3Si}2O(γ-SiW10O36)]
4–
 reacts in a post-functionalization reaction in 
acetonitrile at 50°C, in the presence of 1-pyrensulfonyl chloride (Pyr-SO2Cl) (2.5 equiv.) and 
triethylamine (TEA, 2.5 equiv.) for 3 h. Finally, the mixture was centrifuged to remove 
insoluble reagents and byproducts. The volume of the solution was reduced to 1 mL, upon 
evaporation under vacuum, than diethylether was added to precipitate the product. 
(nBu4N)4[{C16H9SO2NH(CH2)3Si}2O(γ-SiW10O36)] Pyr-SiW10 (2) was isolated in 71% after 
washing/extraction with water, diethyl ether, and a small amount of CH2Cl2 on a fritted funnel 
and drying several hours under vacuum.  
The solution characterization of the resulting hybrid POM was performed by the following 
techniques: 
183
W, 
29
Si, 
13
C, 
1
H NMR spectroscopy and ESI-MS. 
The hybrid (2) exhibits a 
183
W NMR spectral pattern in agreement with the expected bis-
functionalized, C2v-symmetric structure, with three multiple resonances at -107.51, -136.03, -
141.52 ppm in relative ratio 2:1:2 respectively, corresponding to WA (four bottom W atoms), 
WC (two side W atoms), and WB (four vacant W atoms).  
 
 
 
Figure 2.17 
183
W NMR of (2) in CD3CN/CH3CN. 
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Figure 2.18 
29
Si NMR of (2) in CD3CN/CH3CN. 
The 
29
Si NMR spectrum reveals two signals at - 62.61 and - 88.34 ppm with integration ratio 
2:1 respectively. These results are consistent with a double functionalization. 
FT-IR evidences diagnostic bands at 964, 950, 903, 886, 840, 821 cm
–1 
for νas(W–O–W),  
weak bands at 1050 cm
-1
 for νas(Si–O-Si) and 1102 cm
-1
 for νas(Si–C), confirming the 
maintenance of the POM structure (Appendix, A7). 
1
H NMR and 
13
C NMR spectroscopies confirm the introduction of the pyrene groups, since 
expected resonances for the aromatic pyrene protons and carbons are observed between 8.86 - 
8.02 and 135.21–124.66 ppm respectively (Figure 2.19 and Appendix, A8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.19 
1
H-NMR of (2) in CD3CN. 
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The ESI-MS of hybrid (2), registered in negative mode, show cluster signals centered at m/z = 
789.5; 1053.1 attributed, respectively, to the ions [C38H32N2O41S2Si3W10]
4- 
= 789.9 and 
[C38H33N2O41S2Si3W10]
3- 
= 1053.5 (Appendix, A9). 
 
2.2.3.2 Study of optical, sensing and interaction properties 
The UV-Vis spectrum of (2) (>200 nm) display seven absorption bands at 233, 242, 269, 279, 
336, 351 and 358 nm that can be ascribed to the appended pyrene tweezer.  
This spectral behavior is the result of the POM oxygen-to-tungsten charge transfer bands 
overlapping with the typical absorption features of the pyrene moiety, as can be seen from the 
comparison with the spectrum of the pyrene (Figure 2.20).  
 
 
Figure 2.20 UV-Vis spectra of Pyr-SiW10 (2) (10 μM, black solid line) and APTES-SiW10 (10 μM, dashed line) 
in CH3CN; Inset: UV/Vis spectrum of pyrene (20 μM) in CH3CN. 
 
The fluorescence spectrum of (2) (Figure 2.21) maintains the typical pattern expected for the 
pyrene fluorophore with two emission bands centered at 379 and 397 nm (λexc = 338 nm), 
albeit somewhat red-shifted in excitation and with diminished intensity (~ 3-fold) when 
compared to the reference compound fluorescence (pyrene). 
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Figure 2.21 Fluorescence spectra of (2) [10 μM, solid lines: excitation (λem = 380 nm) and emission (λexc = 338 
nm)] and pyrene [20 μM, dashed lines: excitation (λem = 389 nm) and emission (λexc = 338 nm)], in CH3CN. 
 
To evaluate the molecular interaction capability of the pyrene-functionalized 
decatungstosilicate towards hydrophobic molecules we have performed luminescence 
quenching experiments in the presence of different neutral molecules. To promote π-π 
stacking interactions, we included derivatives with extended π-system: 1,4-dinitrobenzene 
(DNB),
43
 adenin (ADN), adenosin (ADS), caffeine
44
 and fullerene (C60)
45
.  
The bar-graph in Figure 2.22 highlights the dependence of the fluorescence intensity ratio as a 
function of the molecules added in the system.  
 
Figure 2.22 Optical sensing screening determined as the ratio between the fluorescence intensity observed for 
(2) (1 μM in DMF) in the absence of any molecules (I0) and in the presence of 100 equivalents of aromatic 
molecules (I). 
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In most cases, no appreciable change in the emission intensity occurred (I/I0 ≈ 1), with the 
remarkable exceptions of C60.  
The nature of the interaction between the hybrid system containing pyrene moieties and 
fullerene molecules was further investigated. Stepwise addition of C60 in ortho-
dichlorobenzene (o-DCB) (5x10
–3
 M, 4μL aliquots) induced a progressive quenching of the 
emission band, detected at 379 and at 397 nm (λexc = 330 nm) of the hybrid (2) dissolved in 
DMF. 
The luminescence quenching (Figure 2.23 A) has highlighted the interaction of the POM with 
fullerene molecules in the micromolar range. The fluorescence intensity ratio, (I
0
/I)-1, of 
POM (2) at 400 nm was measured as a function of the C60 concentration at room temperature. 
As shown in Figure 2.23 B, the slope of the Stern-Volmer (S-V) plot is higher in the presence 
of a little percentage of H2O, confirming the π-π stacking contribute in the interaction. 
 
 
 
The Stern-Volmer plot show a linear profile up to 1 equivalent of C60 added (10 µM of C60 in 
solution). After 1 equivalent the plot became highly curved, upward, and non linearly 
proportional to the fullerene concentration. In particular, the competition for light absorption 
Figure 2.23 A Titration of (2) (10 μM in 
DMF) with a solution of C60 in o-DCB (0-
70 μM); λex = 330 nm; B Stern-Volmer plot 
of the quenching of (2) fluorescence by C60 
in DMF (orange circles) and DMF + 1% 
H2O (blue circles). C Stern-Volmer plot of 
the quenching of (2) fluorescence by C60 in 
DMF for lower concentrations of C60 (0-30 
µM); λex = 350 nm.  
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by C60 can explain the observed upward deviation. To minimize this effect, a further titration 
was performed at low C60 concentration region (0-30 µM), choosing an excitation wavelength 
(λex = 350 nm) where the light absorption of the quencher is weaker in comparison to the 
absorption of pyrene groups. In such conditions, a linear S-V behavior can be observed 
(Figure 2.23 C). The data were thus corrected for the inner filter absorption effects of the C60 
(see Chapter 5: paragraph 5.3.1) and the Stem Volmer constant results Ksv = (9.40 ± 0.22) 
x10
3
 M
-1
. Such weak binding constant is likely ascribed to the non-planar structure of C60.
46
  
Hence, experiments with nanotubes (SWNTs) have been performed to yield an enhanced 
bonding. In particular, SWNTs contain a vast mixture of diameters and chiralities defining 
their electronic structure as being metallic or semiconducting. Among the efforts to increase 
the processability of this unique materials, noncovalent functionalization of these systems 
represents a corner stone, as it is nondestructive and does not alter the intrinsic properties of 
nanotubes. In this respect, a strong and specific interaction with the SWNTs can be ensured 
through π–π stacking.  
Thus, 3 mg of carbon nanotubes (CNTs) were added to 3 mg of Pyr-SiW10 dispersed in 3 mL 
of a DMF/MeOH 1:1 solution. Fluorescence experiments show a quenching of the Pyr-SiW10 
luminescence upon addition of CNTs (3 mg/7.27x10
-7
 mol POM) (peaks at 379 nm and 398 
nm), confirming that the pyrene units are involved in an electron transfer with the carbon 
nanostructures. Furthermore, upon the interaction of Pyr-SiW10 with different kind of CNTs, 
changes in the NIR-semiconducting region can be observed: red shift and reduction of 
absorption intensity for HiPCO (SWNTs diameter distribution 0.8–1.4 nm; Figure 2.24 C), 
blue shift for CoMoCAT (SWNTs diameter distribution 0.7–0.9 nm; Figure 2.24 D) 
respectively. This suggest the capability of Pyr-SiW10 to interact and recognize carbon 
nanotubes according to their helicity and diameter. This behaviour will be studied in detail in 
collaboration with the group of Prof. M. Prato (University of Trieste).  
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Figure 2.24 A Representation of interaction of (2) with a nanotube. B Fluorescence spectra of (2) (λexc=335 nm) 
in the absence (blue line) and in the presence of CNTs (HiPCO: red line, CoMoCAT: black line). C UV/Vis/NIR 
spectra of HiPCO nanotubes in the absence (black line) and in the presence of (2) (red line). D UV/Vis/NIR 
spectra of CoMoCAT nanotubes in the absence (black line) and in the presence of (2) (red line). (3 mg/ 7.27x10
-7
 
mol POM); SDS: sodium dodecyl sulfate.u 
 
2.2.4 Synthesis and characterization of two fluoresceine-appended 
polyoxotungstates  
Fluorescein is a synthetic organic compound soluble in water and alcohol. It is widely used as 
a fluorescent tracer for many applications. In particular, in cellular biology, 
the isothiocyanate derivative of fluorescein is often used to label and track labeled compounds 
within cells by fluorescence microscopy. The fluorescence of this molecule is very intense at 
521 nm, and excitation occurs at 494 nm. Fluorescein has a pKa of 6.4, and its ionization 
equilibrium leads to pH-dependent absorption and emission over the pH range from 5 to 9.  
In this paragraph, the introduction of fluoresceine on two different POM scaffolds (K8[γ-
SiW10O36] and β-A-Na8[HPW9O34]) will be described. 
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2.2.4.1 Synthesis of (nBu4N)4[{(C20H11O5)NHCSNH(CH2)3Si}2O(γ-SiW10O36)] (FITC-
SiW10)  
The introduction of fluoresceine probe on the polyanionic scaffold [γ-SiW10O36]
8– 
was 
achieved by a synthetic procedure that also involves the amino-functionalized POM (APTES-
SiW10), and its reaction with fluoresceine isothiocyanate (FITC), to obtain a thioureido group. 
The scheme of reaction is reported below. 
 
Si Si
H2N NH2
(nBu4N)4[(NH2(CH2)3Si)2O (-SiW10O36)]
4-
O
O
O
H
N
HN
S
O
O
O
H
N
NH
S
OHHO Si Si
O
OHHO
O
4-
O
O
O
OH
HO
S
C
N
TEA, CH3CN
    50°C, 3h
(nBu4N)4[(C20H11O5)NHCSNH(CH2)3Si)2O (-SiW10O36)] 
Scheme 2.6 Synthetic routes to a Keggin-type decatungstate functionalized with the fluoresceine chromophore. 
 
The hybrid POM [{NH2(CH2)3Si}2O(γ-SiW10O36)]
4–
 reacts with 2.5 equivalents of FITC in 
the presence of 2.5 equivalents of triethylamine (TEA). As in the previous cases, the product 
(nBu4N)4[{(C20H11O5)NHCSNH(CH2)3Si}2O(γ-SiW10O36)] (FITC-SiW10) (3) was isolated by 
precipitation with water and then washed with water and various organic solvents (diethyl 
ether, methanol), obtaining a yield of 56%. 
The bis-decorated molecular hybrid was characterized by FT-IR, multinuclear NMR, ESI-MS, 
UV-Vis and luminescence spectroscopy. The complete characterization has highlighted 
several features shared with the previously described POMs.  
1
H NMR and 
13
C NMR spectroscopies confirm the introduction of the fluoresceine groups, 
since the expected resonances for the aromatic fluoresceine protons and carbons are observed 
between 9.14 -6.56 ppm and 181.78 and 84.25 ppm respectively. 
Finally, relevant spectral features, in agreement with the bis-substitution, are reported in Table 
2.1 (see also Chapter 5 and Appendix, A10 - A15): 
 
 
 
 
 
Luminescent hybrid polyoxometalates: synthesis, characterization, sensing and spectral features 
69 
 
 
 
 
 
2.2.4.2 Study of optical properties 
Generally, the absorption and the luminescence analysis of free fluorescein are conducted in 
aqueous solution at buffered pH. In our case, since the hybrids are not water-soluble, the 
optical measures were performed in EtOH with added DMSO (1.8 % v/v). EtOH does not 
affect fluoresceine luminescence, whereas the small percentage of DMSO, required to 
dissolve the hybrid POM in solution, is responsible for a minor emission quenching.  
 
 
Figure 2.25 UV-Vis spectrum of FITC-SiW10 (3) (10 μM) in EtOH with added DMSO (1.8 % v/v); Inset: 
UV/Vis spectrum of FITC (20 μM) in EtOH with added DMSO (1.8 % v/v) . 
 
The UV-Vis spectrum of (3) display a shoulder at 275 nm and three absorption bands at 428, 
454 and 482 nm. These can be ascribed to the appended fluoresceine moieties. Upon 
Solvent m/z 
29
Si NMR 
(ppm) 
183
W NMR 
(ppm) 
CH3CN 
852.5
a
 
1217.5
b
  
-61.34 (2Si), 
-88.26 (1Si) 
- 108.32 (4W) 
- 132.87 (2W) 
- 143.32 (4W) 
Table 2.1 Relevant spectral features of FITC-SiW10 (3). 
(a)
 
expected for [C48H38N4O47S2Si3W10]
4- 
= 852.4, (b)
 
expected for [C64H74N5O47S2Si3W10]
3- 
= 1217.3; polyanion 
without (a) and with (b) a single nBu4N
+
 countercation. 
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introduction of the fluoresceine groups on the polyanion, a hypochromic effect, in comparison 
with FITC, can be observed for the UV-Vis absorption (Figure 2.25).  
The fluorescence spectrum of (3) (Figure 2.26 A) maintains the typical pattern of the 
fluoresceine fluorophore, with a large emission band centered at 528 nm (λexc = 480 nm), 
albeit somewhat blue-shifted and with diminished intensity (~ 10-folds) when compared to 
the reference emission (FITC) (Figure 2.26 B). 
 
 
Figure 2.26 A Fluorescence spectra of (3) [10 μM, excitation (λem = 528 nm) and emission (λexc = 480 nm)] B 
Comparison between emission spectrum of FITC (20 μM, dashed lines) with (3) (10 μM, solid lines) (λem = 528 
nm) in DMSO/EtOH (2% v/v). 
To evaluate the effect of POM scaffold on fluoresceine luminescence, the same probe was 
also introduced on β-A-Na8[HPW9O34] (see Figure 2.3). The synthetic strategy is described in 
the next paragraph. 
 
2.2.4.3 Synthesis of (nBu4N)3Na2[{(C20H11O5)NHCSNHCH(CH3)PO}2(α-A-PW9O34)] 
(FITC-PW9)  
The fluorescein probe has been also introduced on the trivacant β-A-Na8[HPW9O34] (PW9) 
scaffold with a different synthetic strategy, exploiting phosphonic acid units. 
 
Synthesis of the reactive ligand: (C20H11O5)NHCSNHCH(CH3)PO(OH)2 (FITC-AEPA) 
In this case, the fluorescein isothiocyanate (FITC) has been first functionalized with a chiral 
residue: 1-aminoethyl phosphonic acid (AEPA), by means of a reaction carried out in water 
and DMSO (9:1) at pH 9. 
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Scheme 2.7 Synthetic route to FITC-AEPA.  
The synthetic procedure and the characterization are reported in the Chapter 5 (Appendix, 
A28-A33).  
Grafting of the ligand on the POM scaffold 
The trivacant POM PW9 was reacted with two equivalents of 1-aminoethyl phosphonic acid 
derivatized with fluorescein in CH3CN, in the presence of four equivalents of hydrochloric 
acid, using a tetrabutylammonium salt (nBu4NBr). The final product 
(nBu4N)3Na2[(C20H11O5)NHCSNHCH(CH3)PO)2(α-A-PW9O34)] (FITC-PW9) (4) was 
isolated with 50% yield, upon precipitation with water and purification by extensive 
washing/extraction cycles with ethanol and Et2O/MeOH (5:1). 
 
 
Scheme 2.8 Synthetic routes to a Keggin-type nonaoxotungstate functionalized with fluoresceine chromophore. 
The spectroscopic characterization confirms an bis-functionalization, in agreement with the 
data in literature.
15
  
In the FT-IR the low-wavenumber part (ν< 1000 cm-1) is characteristic of the polyoxometalate 
framework.
47
 The stretching vibrational bands [νasym (W-Ob-W) and νasym (W=Oter)] are 
shifted to higher frequency, compared to those of the starting trivacant [PW9O34]
9-
 anion 
(Figure 2.27 and Table 2.2). This effect, previously observed for organosilyl derivatives of 
trivacant polyoxotungstates, is attributed to a partial saturation of the polyoxometallic moiety. 
The stretching vibration bands of the PO4 and RPO3 groups are observed between 1000 and 
H 2 O - D M S O 
N H 2 C H ( C H 3 ) P O ( O H ) 2 
C O 3 
2 - / H C O 3 
- 
F IT C 
O 
O 
H 
N 
S 
O H H O 
O 
H N C H 3 
P O 
H O 
O H 
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1100 cm
-1
.  Finally, vibrational bands relative to the counterion (2850-3000 cm
-1
) and minor 
bands attributable to fluorescein (1100-1650 cm
-1
) can be observed.  
 
 
 
 
 
Figure 2.27 FT-IR (KBr) spectrum of (4) (red) in comparison with FT-IR (KBr) spectrum of PW9 (blue). 
 
 
The 
31
P NMR spectrum presents two lines with a relative intensity of 2:1 (Figure 2.28). 
Integration was carried out on proton coupled spectra: the high-frequency resonance (19.32 
ppm) is attributed to the RPO group. The low-frequency singlet of relative intensity 1 (-12.59 
ppm) is assigned to the central PO4 unit of the polyoxotungstate. The value of literature for 
compounds bis-functionalized is δ = - 11.46 ± 0.217.  
 
Assignment
47
 FIPW9 β-PW9 
ν(P-C) 1179m  
νasym(P-O)
 
(PO4) 1090s; 1036m 1056s; 1014w 
νasym(P-O)
 
(PO) 998m  
νasym(W=Oter) 959vs 931vs 
νasym(W-Ob-W) 879vs; 850vs; 782vs; 752vs 821vs; 737vs 
Table 2.2 Infrared data (cm
-1
) for (4) and -A-Na8H[PW9O34]*24H2O 
m: medium; s: strong; vs: very strong 
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Figure 2.28 
31
P NMR ([D6]DMSO, 28 °C) of (4). 
 
Studies of 
1
H NMR and 
31
P NMR, performed at different temperatures, have shown the 
presence of different equilibria in solution: a splitting of the signals that still maintain an 
integration ratio 2:1 is observed at temperature under 18° C (Appendix, A16) . This is 
probably due to the fact that the fluorescein has several forms in equilibrium in solution 
(cationic, neutral, anionic and dianionic) dependent on the pH and temperature.
48
 These forms 
probably affect the electron density of the polyanion in different ways. 
 
2.2.4.4 Study of optical and chiroptical properties 
Since, the conjugation with AEPA does not affect the spectral properties of FITC, we used 
this latter as reference. Optical features were studied by using solutions of EtOH with a little 
percentage of DMSO. 
 
Figure 2.29 A UV-Vis spectrum of (4) (10 μM) in EtOH with added DMSO (1.8 % v/v) B Fluorescence spectra 
of (4) [10 μM, excitation (λem = 528 nm) and emission (λexc = 480 nm)]. 
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Also in this case, we observed a depletion of fluorophore absorption and fluorescence when 
the FITC is grafted on the polyanion, as reported for the hybrid polyoxotungstate FITC-
SiW10 (3). 
In particular, a comparison of fluorescence spectra (reported in Figure 2.30), shows that the 
divacant polyanion [γ-SiW10O36]
8-
 induces a stronger quenching of the fluoresceine 
luminescence with respect to the trivacant [A-β-PW9O34]
9-
, suggesting that the interaction 
with the divacant POM is stronger. This can be explained by the fact that the divacant POM 
(SiW10) does not show equilibria involving the ligand, as in the case for the trivacant one 
(PW9).  
 
 
Figure 2.30 A Fluorescence spectra of (3) [10 μM, dashed line: excitation (λem = 528 nm) and emission (λexc = 
480 nm)] and fluorescence spectra of (4) [10 μM, solid line: excitation (λem = 528 nm) and emission (λexc = 480 
nm)]. B Comparison between emission spectra of (3) (black solid line) and (4) (gray solid line) with emission 
spectra of fluoresceine isothiocyanate (dashed line). (λexc = 480 nm); solvent: DMSO/EtOH (2% v/v). 
 
Finally, both (R,R) and (S,S) enantiomers of (4) were prepared upon functionalization of PW9 
with the two enantiomers of the aminoethylphosphonic acid, functionalized with fluoresceine 
isothiocyanate. As expected, the two enantiomers of hybrid (4) show mirror-symmetric CD 
spectra (θmax = 8.3×10
4
 deg cm
2
 dmol
-1
 at 274 nm) (Figure 2.31). In addition, the lower 
optical activity observed for the FITC-AEPA (a single positive Cotton effect at 253 nm with 
θmax = 7.30×10
3
deg cm
2
 dmol
-1
) in the spectral region where the characteristic oxygen-to-
tungsten charge-transfer bands of the polyanion absorbs (Appendix, A33) suggests that the 
optical activity is induced through chirality transfer.
49
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Figure 2.31 Circular dichroic spectra of (R, R) and (S,S)-(4) in CH3CN (10 µM). 
 
2.3 Conclusions and future perspectives 
In conclusion, we have presented a family of novel POMs featuring different luminescent 
behaviour. In particular, an innovative polyoxometalate-based molecular chemosensor 
displaying recognition and luminescent signalling functions has been described. The POM-
based bis-dansyl tweezer (1) acts as selective fluorescence sensor for Cu
2+
 and Pb
2+
 ions, in 
quenching and enhancing mode, respectively, with tunable intensity depending on the 
emission wavelength, POM-aided scavenging of potentially interfering cations, detection 
limit in the micromolar range. In addition, a remarkable benefit, with respect to previously 
known nano-colloid analogs, is that the tweezer arrangement does not require the integrating 
of a multi-dentate ligand fragment for the Cu
2+
/Pb
2+
 capture. 
Moreover, the present study reports the synthesis of a pyrene-functionalized POM (2), and its 
interaction with C60 and SWCNTs in DMF and DMF/MeOH 1:1 medium respectively. The 
bidimensional ordering of [60]fullerene and its derivatives with organic counterparts, self-
assembled on suitable metal or semiconductor single-crystal surfaces, is a interesting 
perspective to develop photoactive materials. A promising potential for applications in many 
different fields such as sensing, catalysis, nanoelectronics, and photochemical conversion of 
solar energy is foreseen. 
Finally, considering the medical applications of POMs (see Chapter 1 paragraph 1.3) 
compounds (1)-(4) can be exploited for the cellular tracking by means of fluorescence 
microscopy. In the next Chapter, the biological properties and the exploitation of the organic 
domain for imaging or targeting purposes will be described. In particular, POM (3) and (4) are 
specifically designed for cellular trafficking studies, and their behavoir will be presented in 
the next chapter. 
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Chapter 3 
 
Interaction of polyoxometalates  
with biological targets 
 
 
 
 
 
 
 
 
Due to the potential applications of polyoxometalates (POMs) in medicine (many POMs 
exhibit antiviral, antitumoral and antibiotic activity), their association with organic domains 
and ligands is of interest to improve targeting and delivery strategies.
 
In particular, the 
fluorescence of POMs functionalized with luminescent probes is maintained under 
physiological conditions and, due to the overall low toxicity of POMs, they can be exploited 
for in vitro cellular imaging, whereby the luminescent moieties is useful to track POMs 
towards different regions of the cells. Furthermore, since the preparation of hybrid derivatives 
could be a powerful strategy for the introduction of molecular recognition sites and the 
enhancement of biocompatibility, studies on the interaction between POM and hybrid POMs 
with important biological macromolecules (ferritin and avidin) has been explored. 
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3.1 Introduction 
Among small inorganic systems, polyoxometalates (POMs) are multi metallic and 
polyanionic oxides which have shown interesting potential applications in nanomedicine (see 
Chapter 1 paragraph 1.3). Several papers deal with their bioactivity as antibacterial,
1
 
antiviral,
2
 antitumoral
3
 agents, suggesting their possible use as drugs. Such activity mainly 
stems from their redox behaviour and their capability to interact with biological 
macromolecules through electrostatic bonds. Some paper, indeed, focuses on their interactions 
with cation pockets of proteins and enzymes.
4
 In this respect, systematic studies, performed 
particularly by the groups of Yamase, Hill and Pope, indicated that the biological activities of 
polyoxometalates, in many cases, are closely associated with enzyme inhibition. However, 
fundamental questions concerning the mechanisms responsible for many of the observed 
biological effects remain essentially unanswered. In particular, although most of the in vivo 
effects of POMs may be explained by interactions with extracellular target proteins, different 
POMs, despite their size and charge density, can cross cell membranes and interact with 
intracellular targets. The interaction capability of POMs with intracellular and biological 
targets will be presented in the next paragraphs. 
 
3.1.1 Interactions of POMs with intracellular targets 
Few details are known about POMs cellular localization. In this regard, POMs can be used as 
electron-dense imaging agents when exposed to high energy radiations. Different electronic 
microscopies may give information on the molecular shape, orientation and assembly of the 
cluster compounds.
5
 Thus, the distribution of POMs in cells can be determined with high 
spatial resolution. 
For example, an increased number of vacuoles was observed by fluorescence into 
macrophages cell line J774 incubated with different POMs: [P2W12O48]
14–
, 
[P2W18Zn4(H2O)2O68]
10–
 , [Si2W18Nb6O77]
8-
. In particular, exploiting transmission electron 
microscopy (TEM) and scanning electron X-ray -wavelength dispersive spectroscopy (SEM-
WDS), it was possible to detected the tungsten.
6
 The results confirmed that the POMs were 
taken up by the macrophages and concentrated in the cytoplasma. Furthermore, X-ray 
fluorescence microscopy and raman laser microscopy were used to detect a POM into a  
cytoplasmic precipitate obtained after incubation of C3HBi fibroblasts with the 
tugstoantimonate [NaSb9W21O86]
18–
.
7
 By using electron probe microanalysis, this 
tungstoantimonate was localized in the lysosomes of different macrophages after intravenous 
administration in rats. Moreover, a scanning proton microprobe was used to analyse the metal 
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content of individual peripheral blood mononuclear cells treated with the cobalt substituted 
polyoxotungstate [Co4(H2O)2(PW9O34)2]
10–
,
8
 showing its subcellular distribution: this 
trivacant Keggin-derived sandwich structure was found on the surface of the cell nucleus in 
peripheral blood lymphocytes. 
The studies reported above have allowed to establish that POMs are able to penetrate into 
scavenger cells such as macrophages. However, they were carried out by means of invasive 
techniques, that cause the destruction of cells. To avoid damage at cellular level, luminescent 
lanthanide-substituted POMs were also used as model probes, but their emission is readily 
quenched by water oscillators, thus hampering imaging studies under physiological 
conditions, unless they are completely encapsulated and protected from the aqueous 
environment.
9
  
A promising alternative to study POMs cellular tracking, could stem from decoration of the 
POM scaffolds with resident luminophores (see Chapter 2), whereby covalent bonds 
guarantee long-term performance under physiological conditions. In particular, in this chapter 
we will see the utilization of the luminescent hybrid POMs described in the Chapter 2, to 
investigate the interactions of POMs with cells by means of fluorescence microscopy. 
 
3.1.2 Interactions of POMs with extracellular targets 
The pharmacological POMs effects observed in vivo could be mainly due to the interaction 
between POMs with extracellular target proteins as well as proteins integrated into the cell 
membrane. In particular, enzyme inhibition has been demonstrated for several different 
enzyme families (e.g., ecto-nucleotidases, ecto-kinases, sulfo- and sialyltransferases) and for a 
variety of POMs with inhibitory potencies from micro- to nanomolar concentrations.  
As for instance, inactivation of reverse transcriptases and DNA polymerases by POMs may 
contribute to the protection against viral infection.
10
 The synergistic effect of POMs with β-
lactam antibiotics against the pathogenic Gram-positive bacteria Staphylococcus aureus 
appears to be due to the reduced expression of the penicillin binding protein and β-lactamase, 
but additional, yet unknown, mechanisms of actions are likely involved.3,11 The activity of the 
decavanadate against leishmania (a genus of Trypanosomatid protozoa, parasite responsible 
for the disease leishmaniasis) may be due to the inhibition of phosphoglycerate mutase and 
various phosphatases.
12
 It has been speculated that the antidiabetic activities of oxometalates 
might be a result of the inhibition of regulatory protein phosphates or glucose-6- 
phosphatase.
13
 Recently, ecto-nucleotidase and protein kinase inhibition by POMs have been 
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identified as possible modes of actions contributing to their antibiotic and/or anticancer 
activities.
4e),14
 
However, systematic structure–activity relationship studies of POMs using various enzymes 
are still difficult because of the very limited number of compounds, often with large structural 
variations and different stabilities.  
In this scenario, the research on POM–protein interactions (structural and energetic aspects) is 
an active field of interest due to the perspective of understanding POM action mechanisms 
and the possibility of designing novel drugs (see also Chapter 1, paragraph 1.3.2). In 
particular molecular recognition and binding of POMs by the target proteins constitute the 
first step in the complex mechanism of their biological action. In this respect, the interaction 
capability of different classes of POMs with various proteins was investigated in the 
literature.  
For example, the direct interaction between human serum albumin (HSA)
4a),15
 or basic 
fibroblast growth factor (bFGF)
16
 and POMs was demonstrated by the combination of several 
techniques: fluorescence, ultraviolet absorption, circular dichroism and isothermal titration 
measurements. In the case of HSA a complex forms upon selective binding of POM in a site 
containing positively charged residues. In figure 3.1, HSA intrinsic fluorescence quenching 
by a selected polyoxometalate [EuW10O36]
9- 
is reported.
17
 
The fluorescence of HSA, which is due to the single tryptophan residue in the protein, 
Trp214, can efficiently be quenched by POM. A Stern–Volmer analysis was applied to the 
fluorescence quenching data and the Stern–Volmer plot shows a linear relationship (Figure 
3.1 B). The quenching stopped when the molar ratio between EuW10 and HSA reached 1, 
indicating the stoichiometry of the interaction between EuW10 and HSA.
15,17 
Furthermore, as shown in Figure 3.1 C, binding of EuW10 has no significant effect on the 
secondary structure content of the protein, which is characterized by a high helical 
proportion.
15,17 
In this chapter, preliminary interaction studies of POMs and hybrid POMs with different 
proteins (ferritine and avidin) will be described.  
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3.1.3 Bioactive POMs: strategies for imaging, delivery and targeting 
Despite the great potential of hybrid organic-inorganic POMs derivatives,
18
 for improving 
recognition capabilities and selectivity, no report deal with the exploitation of the organic 
domain for imaging or targeting purposes.  
New POM based systems have thus been designed to overcome the main obstacles to POMs 
medical exploitation. In particular we will present: 
 
(i) The use of POM luminescent derivatives for cellular imaging. The introduction of 
organic probes on the polyanionic scaffolds can help to study the POMs cellular uptake 
and to reveal their specific interactions with intracellular portions, by means of 
fluorescence microscopy. The utilization of organic probes on the polyanionic scaffolds 
can allow to investigate POM cellular tracking, without inducing any cellular change or 
damage. 
 
(ii) The study of interaction between an hollow protein (apoferritin) with totally inorganic 
POMs. Interaction studies between POMs and macromolecules can be useful to clarify 
POM biological effects (paragraph 3.1.2) as well as to design novel drug delivery 
Figure 3.1 A Emission spectrum (λexc = 295 nm)  of 
HSA in the presence of increasing concentrations of 
EuW10 ([HSA] = 1.0x10
-5 M, in pure water). (from top 
to bottom, the concentration of POM increases from 0 to 
1.0x10-5 M; increments of 1.0x10-6 M); B Plot of Stern-
Volmer quenching of the fluorescence of HSA in pure 
water (λem = 350 nm); C CD spectrum of HSA (1.0x10
-6 
M) in the absence and presence of different 
concentrations of EuW10 (in pure water, 20 °C). 
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systems, capable to limit the toxicity of POMs. In this respect, different literature studies 
investigated the possibility of using nanocarriers for POM delivery, showing that the 
encapsulation of POMs by dendritic ligands, surfactants and biopolymers leads to an 
increase in both the stability and cellular uptake of POMs (see Chapter 1 paragraph 
1.3.3).
19
 
 
(iii) The design of a hybrid POM containing a bioactive molecule (biotin) capable of 
biomolecular recognition for targeting purposes. The goal of a selective POM-based 
bioconjugate is to increase its concentration in the vicinity of the cells responsible for 
disease thus decreasing unwanted side effects on healthy cells.  
 
3.2 Results and discussion 
3.2.1 Interaction studies of luminescent POMs with cells  
In this chapter, we describe the biological activity and the use of the organic chromophore-
appended POMs described in Chapter 2 to unravel their cellular localization by means of 
fluorescence microscopy. The following POMs were prepared (see Chapter 2, paragraph 2.2): 
three derivatives of the divacant decatungstosilicate [γ-SiW10O36]
8-
:  
 
(i) a dansyl-tagged POM (nBu4N)4[{((CH3)2N)C10H6SO2NH(CH2)3Si}2O(γ-SiW10O36)] 
(Dans-SiW10) (1),  
(ii) a pyrene-tagged POM (nBu4N)4[{(C16H9)SO2NH(CH2)3Si}2O(γ-SiW10O36)] (Pyr-
SiW10) (2),  
(iii) a fluorescein-tagged  (nBu4N)4[{(C20H11O5)NHCSNH(CH2)3Si}2O(γ-SiW10O36)] 
(FITC-SiW10) (3).  
In addition, a fluoresceine-tagged chiral derivative of the trivacant nonatungstophosphate β-
A-Na8[HPW9O34] was also prepared, to explore the effect of a different inorganic scaffold:   
(iv) a fluorescein-tagged (R,R) and (S,S)-(nBu4N)4[{(C20H11O5)NHCSNHCH(CH3)PO}2(α-
A-PW9O34)] (FITC-PW9) (4).  
 
a
)  
b
)  
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They were characterized by several techniques (see Chapter 2) and delivered into HEK293 
cells, showing their different localization, which depends on both the chromophore and on the 
inorganic scaffold. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.1. Chemical structures of luminescent polyoxotungstate derivatives: (1): Dans-SiW10; (2): Pyr-SiW10; 
(3): FITC-SiW10 ; (4): FITC-PW9. 
 
The emission of the luminescent POMs cover different spectral regions, as shown in Figure 
3.2. 
 
 
Figure 3.2 Fluorescence spectra of Dans-SiW10 (10 µM), Pyr-SiW10 (10 µM) in CH3CN and of FITC-SiW10 (5 
µM) in EtOH with added DMSO (2% v/v).  
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3.2.1.1 Structural investigation of luminescent hybrid POMs in aqueous and 
physiological conditions 
The hybrid POMs (1-4) are very soluble in polar organic solvents (acetonitrile, 
dimethylformamide (DMF), dimethylsulfoxide (DMSO). To test their behaviour in water, 
spectroscopic and structural features of POMs have been monitored in aqueous and 
physiological conditions. A first attempt to obtain a water soluble hybrid POM, involving the 
exchange of tetrabutylammonium (nBu4N
+
) with sodium countercations, has also been 
performed (see Chapter 5: paragraph 5.2.2). 
The resulting hybrid POM Nax(nBu4N)4-x[{(N(CH3)2)C10H6SO2NH(CH2)3Si}2O(γ-SiW10O36)] 
(Na
+
_Dans-SiW10)  has been isolated and characterized by FT-IR, UV-VIS and fluorescence 
analysis. 
The FT-IR spectrum is consistent with the exchange of the countercation; whereby 
particularly diagnostic regions are: 
(i) 3000-2875 cm
-1
: the C-H stretching of nBu4N
+
 are significantly reduced; 
(ii) 1700 cm
-1
: appearance of a strong band relative to coordinated H2O (H-O-H bending); 
(iii) 1000-600 cm
-1
: the variation of the characteristic stretching of the inorganic 
framework (vibrations of the bonds W-O and Si-O) suggests a variation of the electron 
density of the structure due to the introduction of sodium as countercation. 
 
 
Figure 3.3 FT-IR spectrum of Nax(nBu4N)4-x[{(N(CH3)2)C10H6SO2N(CH2)3Si}2O(γ-SiW10O36)] (below) 
compared with the FT-IR spectrum of (nBu4N)4[{(N(CH3)2) C10H6SO2NH(CH2)3Si}2O (γ-SiW10O36)] (above). 
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The UV-Vis spectral features of the water soluble hybrid Na
+
_Dans-SiW10 are kept in H2O: 
the shoulder at 250 nm can be attributed to the dansyl fluorophore (Figure 3.4 A). The 
fluorescence spectrum presents an emission band centered at 495 nm (λexc = 330 nm) and an 
excitation band centered at 332 nm (λem = 510 nm). The emission band of the water soluble 
POM exhibits a red-shift (Δλ = 46 nm) and a reduced intensity (about 20 times less) in 
comparison with the corresponding emission band observed for the acetonitrile soluble- 
hybrid derivative Dans-SiW10 (Figure 3.4 B). 
 
Figure 3.4 A UV-Vis spectrum of  Na
+
_Dans-SiW10 (2.4x10
-5
 M), B Emission (λexc = 330 nm) and excitation 
(λem = 510 nm) spectra of Na
+
_Dans-SiW10 (solid line, 2.4x10
-5
 M) in H2O in comparison with emission (λexc = 
336 nm) and excitation (λem = 551 nm) spectra of Dans-SiW10 (dashed line, 2.4x10
-5
 M) in CH3CN. 
 
Despite partial water-induced fluorescence quenching, POM (1) still maintains its 
luminescence features into aqueous conditions even after countercation exchange. 
However, the solubility of hybrid POMs (1-4) in H2O is strongly affected by the apolar 
organic compound grafted on the surface of the polyanion. In particular the POM Na
+
_Pyr-
SiW10 (2) only gives an emulsion in water. 
Due to the generally low metathesis yield, we found more convenient to dissolve hybrid 
POMs (1-4) in water (or in physiological conditions) at low concentration, upon dilution of a 
concentrated DMSO solution.  
Dynamic Light Scattering (DLS) measurements show the formation of nanoparticles 
characterized by a large polydispersion, with minor peaks around 150-250 nm and higher 
peaks between 500 nm-1.05 µm for Dans-SiW10, 400-900 nm for Pyr-SiW10, 300-800 nm for 
FITC-SiW10. FITC-PW9 forms smaller aggregates, with 25-105 nm diameter. (Appendix, 
A37). ζpotential investigations highlighted the polyanionic nature of the assemblies: SiW10 
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derivatives are more negatively charged, with potentials between -25 and -30 mV, whereas 
FITC-PW9 displays a less negative potential (-17 mV) (Appendix, A36). 
Transmission electronic microscopy (TEM) confirms the formation of spherical aggregates 
with a broad size distribution. Coalescence of the nanoparticles towards the formation of 
worm-like aggregates has been frequently observed. The formation of such aggregates is 
expected to be driven by the hindered organic chromophores, bearing aromatic residues, 
whereas the tetrabutylammonium cations may assist the assembly, avoiding repulsion 
between adjacent inorganic polyanions.
20
 
 
 
 
Figure 3.5 Transmission electronic microscopy (TEM) images of POMs in H2O/0.05 % DMSO. 
 
 
Scheme 3.2 Assembly of the hybrid POMs in H2O/0.05 % DMSO; (circular sector representing a portion of a 
spherical vesicle with exposed anionic scaffolds). 
 
To evaluate the use of the POMs (1-4) under physiological conditions, we have performed 
further investigations in a extra cellular-mimicking solution. DLS and ζ-potential 
measurements were not reproducible, thus suggesting that the aggregates are less stable. 
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Indeed, different inorganic cations may efficiently neutralize the surface charges. However, 
the formation of nanoparticles has been confirmed by SEM and TEM measures, which show 
the formation of vesicles with diameter of 80-100 nm (Dans-SiW10; Figure 3.6), 150 nm 
(Pyr-SiW10; appendix A38) or 200-220 nm (FTIC-PW9; appendix A39). 
 
 
 
 
 
 
 
 
 
Figure 3.6 Left: transmission electronic microscopy (TEM) images of POM Dans-SiW10 (1) in physiological-
like solution containing 0.05% v/v of DMSO. Right: scanning electronic microscopy (SEM) images of POM  
Dans-SiW10 (1) in physiological-like solution containing 0.05% v/v of DMSO. 
Partially coalesced aggregates can be observed also in these conditions. In particular, TEM 
analysis show nanoparticles consisting in an denser inner part, surrounded by a shell featuring 
lower contrast, likely rich in solvent.
21
 This kind of assembly is expected to reduce repulsion 
with the negatively charged cellular membrane, while increasing the affinity toward lipid 
bilayers.  
3.2.1.2 Biological activity of luminescent hybrids POMs  
Cytotoxic tests were carried out with MTT
22
 assays based on the quantification of cell 
mitochondrial metabolism of (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. 
Viability MTT test were performed after an exposure of 24 h with different POM 
concentrations (up to 500 µM), upon comparison of the metabolic activity of the treated cell 
with the control ones (Figure 3.7).  
Chapter 3 
92 
 
 
Figure 3.7 Cells viability studies of HEK cells incubated with different concentrations of POMs (1-4) and 
FITC-AEPA at 37°C for 24 h. 
 
After 24 h, very low toxicity was observed for all compounds. In addition, a even larger MTT 
metabolic activity was found in cells exposed to 62-250 µm of FITC-PW9.  
IC50 (median inhibitory (toxicity) concentration in µM) assessed at ca. 0.5 mM. This value 
has been extrapolated from the MTT test at 48 h, in correspondence of 500 µM (Appendix, 
A42). 
This value is 1-2 orders of magnitude higher in comparison with other polyoxotungstates.
23
 
To test if 24 h exposure with POMs (1-4) altered cell basic functions, cell proliferation was 
tested using a dedicated assay (Cell proliferation WST-1 assay, Roche)
24
 at different 
concentrations (18 µM and 250 µM).  
After removing the medium containing the POMs, the proliferation curve was monitored up 
to 6 hours (Figure 3.8). The data show that at higher concentration all POMs except Pyr-
SiW10 have a significant delay in the proliferation rate with respect to control (Figure 3.8 B). 
This effect is less important at lower concentrations (18 µM), although SiW10-based samples 
show a higher toxicity (Figure 3.8 A). Proliferation rate of samples exposed with FITC-
AEPA was comparable with that of the control. 
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Figure 3.8 Proliferation assay in HEK cells treated for 24 h with POMs (1-4) at 18 µM (A) and 250 µM (B). 
The analyses were performed at time 0.5, 1.5, 3 and 6 h after removal of the POM containing medium. 
Proliferation of non-treated cells (control) is also shown. 
 
Considering the minor alteration of cell viability at low POM concentrations, we performed 
cell uptake and distribution studies on HEK293 culture cells at 18 µM.  
 
3.2.1.3 Cell tracking of luminescent hybrids POMs  
Thank to their intrinsic emission properties, luminescent hybrid POMs (1-4) can be observed 
by fluorescence microscopy. In particular Dans-SiW10 and Pyr-SiW10 were observed with a 
selective 305 nm filter (EX G 365, BS FT 395, EM BP 445/50), while fluorescein-based 
compounds were observed with a selective 488 nm filter (EX BP 470/40, BS FT 495, EM BP 
a
)  
b
)  
Chapter 3 
94 
 
525/50). Despite a very fast quenching of the luminescence (Δt = 20-30 sec), the POMs can 
be easily observed in specific subcellular regions, showing a strong dependence with the 
organic domain itself. Their uptake was more efficient after a prolonged time (>12 h). 
Transmitted light microscopy allowed to monitor cell morphology after the uptake, and 
showed that POMs do not induces major morphology changes or damages (Figure 3.9). 
 
 
Figure 3.9 Effect on cell survival and proliferation. Representative microscopy images of cells in control 
conditions and after exposure with different POMs (18 µM, 15 h, 37
o
C), visualized with transmitted light. Note 
limited effects of exposed compounds on cell morphology, limited overall toxicity. Bar = 50 µm. 
 
Compounds Dans-SiW10 (1) and Pyr-SiW10 (2) were mainly detected as spots in the 
cytoplasmatic and in the perinuclear regions. To identify the cellular localization of POMs (1) 
and (2),  colocalization experiments using mitochondria and nuclei-selective staining reagents 
were also performed.   
The cells have been also incubated with carbocyanine-based MitoTracker
 
Red FM Probe: both 
POMs show a signal in spots, and a partial co-localisation with mitocondria. 
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Figure 3.10 Subcellular localization of Dans-SiW10 and Pyr-SiW10  compounds. In vitro fluorescence imaging 
of HEK cells treated with POMs (18 µM, 16h at 37°C) and counterstained with mitochondrial probe 
(Mitotracker, red)
 25
 suggesting preferential mitochondrial localization of the compounds.  
Fluorescein-based compounds FITC-SiW10 and FITC-PW9 were able to penetrate the 
nuclear membrane and to accumulate into the nuclei. Furthermore, a different fluorescence 
efficiency, depending on the inorganic domain was observed. FITC-PW9 shows a better 
uptake, with preferential nuclear localization (Figure 3.11). The brillant aggregates seems to 
be co-localised with inner nuclear structures. FITC-SiW10, was scarcely and not evenly 
uptaken, with bright aggregates on cell surface. The POM-free FITC-AEPA was also 
detected in the nuclear regions, even if only at low intensity, highlighting a major role of the 
organic tag (Appendix, A41).  
A 
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Figure 3.11 Subcellular localization of FITC-POMs. Fluorescent microscopy imaging of HEK cells treated 
with FITC-PW9 and FITC-SiW10 (18 µM, 16h at 37°C) and counterstained with nuclear dye (Hoechst blue)
26
 
confirm nuclear localization of these compounds. Scale bar: 10 µm. 
Cell fixation with 2% paraformaldehyde in phosphate buffer increased consistently membrane 
permeability of POMs, that retained the subcellular preferential colocalisation, towards the 
cytoplasmatic region (Dans-SiW10 and Pyr-SiW10) or nuclei (FITC-based compounds). 
 
3.2.1.4 Conclusions and future perspectives 
In conclusion, we have shown that the luminescent hybrid POMs(1-4) are hydrophobic and 
self-assemble into nanoparticles: in such form, they can be delivered into HEK cells without 
any carrier, likely using the intrinsic surface membrane recycling activity of the cells.
27
 We 
have indeed proven that the these luminescent POMs can be tracked in the cells, showing 
their localization in different subcellular regions. An unprecedented uptake into nuclei and 
mitochondria has been highlighted. Biological effects and biocompatibility of hybrid POMs 
have been determined, showing a reduced toxicity at low doses. These results are expected to 
pave the way to the use of suitable POMs both as drugs and as nanodimensional scaffolds.  
In the next paragraphs we will consider the design and the possible delivery of POMs 
functionalized with small biochemical molecules
28
 and POM-based bioconjugates. 
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3.2.2  Interaction studies between POMs and apoferritin protein (aFtn) 
As we have mentioned in the Introduction of this chapter (paragraph 3.1), the mechanisms of 
POMs biological activity at a molecular level remain unclear. As a consequence, preliminary 
studies on the interactions, in a broad sense, between POMs and several proteins is an 
important field of interest with the aim of unravel biological effects and the possibility of 
designing novel POMs-based drugs. 
Furthermore, such kind of interaction studies between POMs and macromolecules can be also 
useful to design drug delivery systems, capable to carry, protect and confine POMs, while 
decreasing their toxicity. In particular, the encapsulation of POMs within an organized 
protective protein environment represents a promising approach to overcome stability issues 
and can be used to generate functional nanodevices with potential medical applications. In 
this respect, in the literature, some types of nanocarriers have already been investigated to 
gather information about the stabilization, biocompatibility, cell permeability and interaction 
of these systems with healthy and tumour cells (see Chapter 1, paragraph 1.3.3).  
Within this context, due to their well defined size and morphology, proteins can act as soluble 
templating agents with enhanced recognition capabilities, useful to increment the 
biocompatibilty of POMs into physiological conditions. In particular, POM polyanionic 
nature can be indeed exploited to drive electrostatic interactions with the cationic residues on 
the surface or into the pockets of the proteins.
15,17,29  
In this paragraph, a preliminary investigation to explore the use of apoferritin (aFtn) as a nano 
cage/scaffold for polyoxometalate complexes will be presented. Apoferritin is an hollow 
protein containing 24 subunits, with approximately 12 and 8 nm external and internal 
diameter (Figure 3.12). The protein, present in the intestinal mucosa, it is able to bind  and 
store iron. Inside the apoferritin shell, Fe
III 
ions are incorporated in mineral ferrihydrite 
[FeO(OH)]8[FeO(H2PO4)], together with phosphate and hydroxide ions and form ferritin. To 
release iron when the body needs it, the iron must be changed from the Fe
III 
to the Fe
II 
oxidation state. Then, the iron leaves through channels in the spherical structure. In this way, 
Ftn molecules result ubiquitous proteins which are used by several organisms to temporarily 
store up to 4500 iron ions as hydrated Fe
III
 oxide, so to prevent the formation of free radicals 
that can be generated by an excess of Fe
II
 ions, through Haber-Weiss reaction mechanism.
30
 
 
a
)  
b
)  
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Figure 3.12 Drawing of aFtn: subunit(left), exterior (middle) and internal cavity (right). 
 
Fe can be completely removed by dialysis against a reducing agent and aFtn can be used as a 
bio-template, to host inorganic nanoparticles and organometallic complexes with catalytic 
properties. In addition, aFtn is able to disassemble into subunits at pH<3.0 and reassemble as 
an almost intact sphere at pH>5.
31
 This property has allowed the introduction of different 
molecules including drugs
32
 and quantum dots
33
 within the Ftn, to be used as delivery agents. 
In this work, in particular, the POMs reported in Figure 3.13 have been chosen for the 
interaction studies with apoferritin: 
 
 
 
 
 
 
 
 
 
Figure 3.13 Polyhedral/ball and stick representations of the two POMs used for the experiments. Red polyhedra 
contain tungsten atoms. EuPOM: green sphere is europium heteroatom (Eu
III
); RuPOM: red spheres are oxygen 
atoms, blue spheres are ruthenium heteroatoms (Ru
IV
). 
 
(i) [EuW10O36]
9-
 (EuPOM) is a fluorescent POM and it can be used as a fluorescent probe. 
Its emission spectrum exhibits three main emissions: 593 nm (
5
D0  
7
F1), 619 nm (
5
D0  
7
F2), and 700 nm (
5
D0  
7
F4), which are very sensitive to the environment.
34
  
(ii) [Ru
IV
4(µ-OH)2(µ-O)4(H2O)4(γ-SiW10O36)2]
10- 
(RuPOM) has been selected for its 
outstanding activity in mimicking the activity of photosystem II and of catalase enzymes.
35
  
[RuIV4(m-OH)2(m-O)4(H2O)4(g-SiW10O36)2]
10-
RuPOM
[EuW10O36]
9-
EuPOM
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In particular, two strategies have thus been explored for the development of a novel 
nanocomposite material featuring noncovalent interactions between the POMs and the proteic 
scaffold: 
 
(i) Electrostatic interaction between POMs and Ftn at pH 3.5, to reduce the overall 
negative charges on the Ftn surface upon protonation of acidic residues (Glu, Asp) and of 
amino groups (His, Arg, Lys). 
 
(ii) Opening of the Ftn at pH 2.5, to exploit the internal sites of Ftn for POM binding, 
followed by reassembly at neutral pH. 
 
3.2.2.1 Association through electrostatic interactions 
 
 
Scheme 3.3 
 
Study of fluorescence, ζ-potential and DLS were performed to study the interaction of aFtn 
with EuPOM and RuPOM. Since the buffers may give a strong contribution to ζ-potential 
measurements, analyses were carried out in non buffered media.  
As stated above, to favour the association with the polyanionic POM, the pH was decreased to 
3.5 (with diluted HCl or in a 20 mM AcONa/AcOH buffer). At these values ζ-potential 
increases towards less negative values (from -21.3 to -9.8 mV). Addition of RuPOM resulted 
in a shift at -17.8 mV, suggesting an interaction with the polyanion (Appendix, A43). 
Binding of the POM was thus followed by fluorescence spectroscopy in such pH conditions. 
The Trp residues present in the three-fold channels can be irradiated at 290 nm, while the 
emission can be monitored at 327 nm. 
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Figure 3.14 Schematic representation of a three fold channel of Ftn. 
 
 
The RuPOM was dissolved in a buffered media (20 mM AcONa/AcOH) and added stepwise 
to a Ftn solution in the same buffer. 
A complete quenching of the Trp fluorescence was observed when > 30 eqs of the RuPOM 
were added (Figure 3.15). Each subunit seems able to coordinate with a POM unit, without 
yielding a complete saturation of other accessible binding sites. 
 
 
 
Figure 3.15 A Fluorescence quenching observed upon addition of RuPOM to a 0.5 µM Ftn solution in acetate 
buffer 20 mM, pH 3,5. B Monitoring of the emission at 327 nm (λexc = 290 nm). 
 
At pH 3.5, quenching of the Trp fluorescence was also observed upon addition of 0-35 eqs of 
[EuW10O36]
9-
 (EuPOM) (Figure 3.16). Since the luminescence of this POM is also 
completely quenched, we can state that the POM is not protected from the aqueous 
enviroment.
17 
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Figure 3.16 Fluorescence quenching observed during the addition of EuPOM to a solution of Ftn 0.5 µM in 20 
mM AcONa/AcOH (pH 3.5); monitoring of the emission at 327 nm (λexc = 290 nm). 
 
The minor differences in charge (-9 vs -10) and dimensions of this last POM (ca 1.6 vs 1.8 
nm), in comparison with RuPOM does not strongly affect the binding process. This suggests 
that the binding could be readily obtained with different POMs featuring similar charge 
density. 
Even if at pH 3.5, aFtn may start to loose some subunit, so to expose a fraction of Trp 
residues, the quenching is not expected to result from a direct interaction between these 
aminoacids and the POM. Indeed, the channels are too small to allow the introduction of the 
polyanion; moreover, Trp residues are close to Glu aminoacids, and no cationic side chain is 
present to favour the interaction (see Figure 3.14). As reported in the literature, for Eu-based 
POMs with HSA, a dynamic quenching, involving long range energy transfer may be 
considered.
15
 As a further remark, the addition of POM do not seem to alter the tridimensional 
secondary structure of the protein, since the CD signal is only slightly decreased (Figure 
3.17). 
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Figure 3.17 CD of a 0.5 µM aFtn solution in acetate buffer 2mM (pH 3,5), in the absence and in the presence of 
RuPOM (25µM). 
 
Finally, the isothermal titration calorimetry (ITC) analyses show a saturation behaviour after 
addition of 20 (EuPOM) or 25 (RuPOM) eqs. The binding is an exothermic process with 
reaction enthalpies of about -15 (RuPOM) and -17 kcal/mol (EuPOM). This results are in 
agreement with an enthalpy driven electrostatic assembly. 
 
 
Figure 3.18 Isotherms recorded during the titration of aFtn (2.25 µM) with A EuPOM and B RuPOM (2 µl 
aliquots of a 0.315 mM solution) at pH 3.5 (20 mM AcONa/AcOH). 
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3.2.2.2 Opening the aFtn at pH 2.5  
As already introduced, the aFtn can partially disassemble upon release of some subunits at 
pH<3.0, to be reassembled at neutral pH. Ftn has been opened at pH 2.5 by using a glycine-
HCl buffer or diluted HCl, and POMs have been added (Scheme 3.4).  
 
 
 Scheme 3.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At this pH, the ζ-potential exhibits a less negative value. A trend can thus be observed while 
going from pH 7.8 (-21.3 mV), pH 3.5 (-9.8 mV) and pH 2.5 (-7.0 mV), in non buffered 
media. The decreased stability of the particles featuring less negative potential is confirmed 
by the broader dispersion of the potential. 
The addition of RuPOM decreases the negative charge to -20 mV. This values is, as 
expected, lower than those observed at pH 3.5 (-17.8 mV), confirming the possibility to host 
more POM complexes. 
# Compound pH Peak 1 (mV)
* 
Peak 2 (mV) 
1 Ftn 2.5 HCl -7.0 - 
2 Ftn Back to 7,8 with NaOH -26.8  
3 RuPOM@Ftn 2,5 (HCl) -19.0 ÷ -15.4  
4 RuPOM@Ftn Back to 7,8 with NaOH -33.0 -14.6 
5 RuPOM@Ftn Back to 7.4 with tris/acetate -21.6 -5.19 
6 EuPOM@Ftn Back to 7.4 with tris/acetate -28.1 (1.72) 
Table 3.1: ζ-potential measurements of POMs (5.88 µM) and Ftn (0.245 µM) in 
different aqueous conditions. 
*Main peak. 
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The fluorimetric analysis has been repeated in such conditions. A very similar behavior has 
been observed, even if with a decreased quenching efficiency. 
 
 
Figure 3.19 Fluorescence quenching observed during the addition of RuPOM to a 0.5 µM Ftn solution. A 
Comparison of titrations at pH 3.5 and 2.5 (20 mM Gly/HCl); B Ster-Volmer graphs.  
 
A Stern-Volmer analysis was applied to the fluorescence quenching data in a range of POM 
concentrations where the plot remains linear (up to 10-15 eqs of quencher). The quenching 
constant calculated from the Stern-Volmer plot at 293 K are KSV = 2.78 x 10
5
 M
-1
 at pH 3.5 
and KSV = 1.59 x 10
5
 M
-1
 at pH 2.5, respectively.
15(a)
 The saturation occurs after the addition 
of > 35 eqs of POM. In such conditions, however, there is an extensive precipitation of the 
adduct. To avoid separation of the adducts from the solution, further experiments have been 
carried out in the presence of 24 eqs of POMs. 
The addition of TRIS to restore the neutral pH resulted in a partial recovery of fluorescence 
(Figure 3.20 A). Closure of the Ftn and release of non trapped POM is indeed expected. This 
speaks in favour of a stable interaction.  
The CD spectrum, recorded at pH 2.5, is slighty affected after addition of RuPOM (partial 
unfolding) but the spectral features can be recoverd at pH 7.8 (Figure 3.20 B). In addition, the 
CD spectrum show that at this pH apoferritin has a high proportion of ordered structures. 
Indeed protein undergo changes attributed to pH-dependent conformational transitions in the 
range 200-240 nm.
36
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Figure 3.20 Ftn (0.5 µM) at pH 2.5 (blue), Ftn with RuPOM (12 µM) at pH 2.5 (red) and after addition of TRIS 
(green), up to pH 7.8. 
Upon pH increase with NaOH, ζ-potential of aFtn get close to its initial value (-26.8 mV Vs -
21.3 mV), whereas in the presence of RuPOM, the ζ-potential is still more negative, even if 
with an irregular distribution (Table 3.1, # 2 and 4; Appendix, A44). 
The procedure has also been carried out in different conditions (Table 1, #5 and #6) with 
0.245 µM aFtn and 50 eqs of POMs. The Ftn has been placed in the presence of a glycine 
buffer (pH 2.5), followed by addition of the POM and further modification of the pH by 
dialysis against a TRIS buffer (pH 7.8). The size of the particles containing POMs, after 
opening/closure is 10.8 nm, whereas a -28.1 mV of ζ-potential has been observed (with 
EuPOM), suggesting that there could still be POM on the spherical aFtn surface (Appendix, 
A45). 
Interestingly, transmission electronic microscopy (TEM) images had shown further possible 
evidences relative the inner confinement of the RuPOM (Figure 3.21). 
The darker regions into the ferritin core can be attributed to the POM: indeed, the reference 
aFtn does not display the same contrast.   
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Figure 3.21 Transmission electron microscopy (TEM) image of aFtn containing RuPOM, upon opening with 
Gly/HCl buffer (pH = 2.5) and closing with NaOH (pH=7.5). Inset: aFtn in the same conditions and without 
RuPOM. Both images were obtained in the presence of uranyl acetate (5%) to provide a negative staining of the 
proteic structures. 
 
Dialysis procedures were also used to remove non encapsulated POM, but the POMs do not 
cross the membrane (100KDa cut off). PAGE (Polyacrylamide gel electrophoresis) seems to 
be more promising for the separation of the Ftn and the free POMs and will be carefully 
investigated. 
 
3.2.2.3 Conclusions and future perspectives 
The bio-template approach has been studied by a combined investigation, involving DLS 
(dynamic light scattering), ζ-potential measurements, ITC (isothermal titration calorimetry), 
fluorimetry, CD (circular dichroism) and TEM (trasmission elctronic microscopy). The results 
have shown that the POM can be successfully attached to the Ftn by means of ionic 
interactions. The binding of the POMs ( [Ru
IV
4(µ-OH)2(µ-O)4(H2O)4(µ-SiW10O36)2]
10-  
and
 
 
[EuW10O36]
9-
 on Ftn has been indeed higlighted by: 
(i) the shift of Ftn ζ-potential towards more negative potentials (by 8-13 mV), in the 
presence of the POM; 
(ii) complete quenching of the Trp luminescence (λexc = 290 nm, λem = 327 nm), upon 
addition of >24 eqs of POM, likely due to energy transfer between the two domains;  
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(iii) hexothermal heat tranfer during the titration of Ftn with POM.  
In addition, the integrity of the Ftn has been estabilished by DLS and CD analysis showing, 
respectively, retention of the cage size (10 nm) as well as of its secondary structure (positive 
Cotton effect of -sheets).  
 
3.2.3 Synthesis of a biotin-conjugated POM and study of its interaction with 
avidin protein 
In this paragraph the synthesis of a hybrid POM containing a bioactive molecule and a 
preliminary study of its capability to interact with a protein will be presented. This study 
allows to investigate the possibility to confine hybrid POMs in correspondence of specific 
protein binding sites and to design bio-conjugated systems with molecular recognition 
properties, to be exploited in targeted cancer therapy. 
To this purpose, the polyanion [γ-SiW10O36]
8-
 have been bis-functionalized with biotin 
molecule. In particular, biotin is able to bind avidin, a protein isolated from chicken eggs, and 
its bacterial analogue, streptavidin, (from Streptomyces avidinii) with an extremely high 
affinity, fast on-rate, and high specificity.  
The biotin-avidin interaction system is extensively used in biotechnology and, more recently, 
in biomedical field in order to (i) isolate proteins, (ii) perform biochemical assays and, in 
particular, (iii) implement drug therapies. 
 
 
Figure 3.22 avidin containing 4 molecules of biotin 
 
In detail, avidin consist of 4 subunits, each capable of binding a molecule of biotin, with 
dissociation constants of the order of 10
-15 
M (Figure 3.22). 
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The specific characteristics of avidin have been shown to be of great advantage for selective 
drug design: the high positive charge of avidin augments the efficiency of cellular uptake of 
biotin-coated particles, whereas incubation of bio-conjugated avidin with biotinylated cells 
lines results in rapid surface attachment and endocytosis, with efficiencies approaching 100%. 
In addition, avidin has been demonstrated to accumulate in specific tissues, especially in 
tumors in vivo. Indeed the strong avidin-biotin interaction can be used to develop targeted 
therapies by the biotinylation of ligands or tissues in vivo.
37
 
In the next paragraph the synthesis of a biotinylated POM and its interaction with avidin 
protein is described. 
 
3.2.3.1 Synthesis of (nBu4N)4[{(C5H7N2OS)(CH2)4CONH(CH2)3Si}2O(γ-SiW10O36)] (Biot-
SiW10)  
 
 
 
 
Scheme 3.5 Synthetic routes to a Keggin-type polyoxotungstate functionalized with biotin biomolecules. 
 
The complex Biot-SiW10, containing two molecules of biotin, was prepared by means of a 
classical coupling reaction in solution between the carboxylic acid function of the biotin and 
the amine function of the hybrid POM intermediate APTES-SiW10 (see Chapter 2, paragraph 
2.2.2) in the presence of TEA (triethylamine). 
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In a first step (Scheme 3.5), the carboxyl group of biotin was activated with DCC 
(dicyclohexyl-carbodiimide, 2.5 eq) and NHS (N-hydroxy-succinimide, 2.5 eq) in 
CH3CN/DMF for one night at 50°C. The resulting activated biotin was reacted, in a molar 
ratio 2:1, with the hybrid precursor APTES-SiW10 in CH3CN, in the presence of TEA for 24 
h, at room temperature.  
Finally, the product, (nBu4N)4[{(C5H7N2OS)(CH2)4CONH(CH2)3Si}2O(γ-SiW10O36)] (Biot-
SiW10) (5) was isolated by precipitation with diethyl ether and extensively washed with water, 
obtaining a yield of 64%. 
The bis-decorated molecular hybrid was characterized by FT-IR, multinuclear NMR, ESI-MS, 
UV-Vis and circular dichroism. The complete characterization has highlighted several 
features shared with the previously hybrid POMs (1-4) described in Chapter 2. In particular, 
relevant spectral features, reported in Table 3.2, are in agreement with a bis-substitution.  
 
 
 
After the introduction of the biotin chiral centers, a C2 symmetric complex is obtained. 
However, since the distance between the asymmetric centers and the POM is too long, 
29
Si 
and 
183
W NMR resonance values are very close to those of the precursor APTES-SiW10 and 
do not display any splitting (see Chapter 2, paragraph 2.2.2).
38
 
Finally, the 
1
H NMR spectrum is also consistent with the biotinylation, since resonances due 
to protons of the condensed rings of biotin can be recognized. 
In this case, the signals of the biotin protons are not significantly shifted with respect to the 
free molecule, suggesting that also the organic moiety is not altered after attachment to the 
POM. 
Solvent m/z 
29
Si NMR (ppm) 
183
W NMR (ppm) 
CH3CN 
 
768.0* 
 
-62.01 (2Si), 
-88.43 (1Si) 
- 107.55 (4W) 
- 136.09 (2W) 
- 142.08 (4W) 
Table 3.2 Relevant spectral features of Biot-SiW10 (5) 
* expected for [C26H44N6O41S2Si3W10]
4- -
= 770.5. 
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Figure 3.23 
1
H NMR (CD3CN) of Biot-SiW10. 
 
3.2.3.2 Preliminary interaction studies of Biot-SiW10 with avidin 
Once synthesized the hybrid POM containing two molecules of biotin, we have evaluated its 
capability to bind avidin (see the introduction of the paragraph). To this aim, a known 
amounts of Biot-SiW10 has been added to a solution containing avidin and the 4'-
hydroxyazobenzene-2-carboxylic acid (HABA). The HABA is a dye capable to weakly bind 
avidin and produce a yellow-orange colored complex. The interaction between biotin and 
avidin causes the release of HABA, with a consequent increase of its absorbance (monitored 
at 348 nm) in aqueous solution. The binding event can thus be followed by UV-Vis 
spectroscopy. 
The UV-Vis titration show a saturation behaviour after addition of 1.28 equivalents of Biot-
SiW10, leading to a 64% saturation of the binding sites available in the protein. This important 
result suggests that biotin maintains its ability to bind avidin even when anchored to the 
polyanionic scaffold. 
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Figure 3.25 A UV-Vis titration of Avidin/HABA system (0.68 µM in H2O) with Biot-SiW10 (0-3 eqs); B 
binding monitored at 348 nm; in y-axes is reported the absorption of HABA. 
 
In figure 3.26 are reported the different binding models proposed for the Biot-SiW10/avidin 
interaction. 
 
 
 
Figure 3.26 Possible binding models between Biot-SiW10 and avidin. 
 
Figure 3.24 Structure of HABA.  
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Considering the structural features of the hybrid complex, since the distance between the two 
biotin molecules on the polyanionic scaffold is not sufficient, a single Biotin-SiW10 molecule 
is not able to bind with both biotin units to a single avidin molecule (Figure 3.26, C).
39
 
Indeed, it is much more probable that the Biotin-SiW10 binds the protein according to the 
cases A and B illustrated in figure 3.26. The possibility that the POM may bridge two 
different molecules of avidin to yield a cross-linked polymeric structure, is suggested by the 
decreased solubility of the resulting adduct. 
 
3.2.2.3 Conclusions and future perspectives 
A POM-based bio-conjugate has been successfully prepared by the bis-functionalization of 
the [γ-SiW10O36]
8-
 scaffold with biotin molecules. Furthermore, its interaction capability with 
avidin has been investigated by means of UV-Vis titration. The results suggested that the 
Biot-SiW10 is proximal to the biotin binding site of the protein. Such kind of interaction could 
be useful to protect and deliver POMs towards biological targets, increasing the bio-stability. 
The final goal is to obtain bio-conjugated systems that integrate POMs with molecular 
recognition properties. Although these are preliminary studies, these data demonstrate the 
potential of POM hybrid for targeting and delivery applications. 
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Chapter 4 
 
Hybrid polyoxometalate  
as ligand for an iridium catalyst 
with hydrogen transfer activity 
 
 
 
 
 
 
 
* This work has been developed during a short scientific mission in Dublin, in collaboration 
with the research group of Prof. Martin Albrecht.
In this chapter, we report a strategy for the synthesis of a POM-appended N-heterocyclic 
carbene (NHC) iridium complex. To this end, imidazolium moieties have been successfully 
grafted on the defect site of a divacant Keggin polyanion. The hybrid POM synthesized has 
been tested for catalyzing hydrogen transfer reactions. The reduction of benzophenone to 
diphenyl methanol in iPrOH as solvent and hydrogen donor has been used as a model reaction 
for probing the catalytic activity of the iridium(I) complex. In particular, full conversion after 
120 min has been obtained using tBuOK as base.* 
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4.1 Introduction 
4.1.1 Organometallic catalysts tethered to POMs 
The anchorage of an organometallic catalyst on a nanodimensional and molecular scaffold is a 
valuable tool to implement the catalytic strategy. This allows to introduce a bulky molecule 
which can be useful to tune the solubility, so to easily exploit removal by precipitation, or for 
the successful recovery through nanofiltration and dialysis techniques. Between the suitable 
molecular species, we can find dendrimers, POSS (polyhedral oligomeric silsesquioxane), 
fullerenes, polyoxometalates (POMs) and metallic clusters.  
POMs, in particular, represent molecular models of extended oxide-based solid supports, with 
the advantage of a tuneable solubility, that mainly depend on the counterions. In this respect, 
polydentate salen-type ligands, thiols, phosphines, and N-heterocycles carbene ligands have 
already been immobilized on the POM surface to bind Mn, Pd or Rh ions, respectively.
1,2,3
 
The resulting hybrid POMs may display a remarkable stability under harsh catalytic 
conditions, enabling a multi-turnover performance under both oxidative and reductive 
conditions.
2,4
  
In particular, Neumann and co-workers, developed new catalytic systems based on the 
covalent linkage of well-established organometallic catalysts to POM scaffolds: examples 
include tethering of metallo-salen (SiW11–Msalen, M = Mn, Co, Ni, Pd)
1
 and Wilkinson-type 
rhodium (SiW11–Rh)
2
. 
 
 
 
Figure. 4.1 Representation of the SiW11–Msalen (left), and SiW11–Rh (right) hybrids. Blue octahedra, {WO6}; 
green tetrahedral, {SiO4}. 
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At first, [SiW11O39]
8-
 scaffolds were functionalized with silyl groups, than the metalation was 
achieved in a post-functionalization reaction.  
These hybrids have been described as being more active and/or selective than the related 
organometallic precursor complexes. The main role of the POM is to tune the steric and 
electronic properties of the catalyst. In the case of the SiW11–Msalen complexes, a charge 
transfer between the metallo-salen donor and the POM acceptor has been observed, with 
stabilization of unusual oxidation state of the appended metal M and/or oxidation of the salen 
ligand. Interestingly, this is an intramolecular phenomenon, not observed for mechanical 
mixtures of the parent POM and metallo-salen complexes. This underlines the beneficial 
effect of covalent tethering, compared to an electrostatic association. Improved stabilization 
of an intermediate Rh(III) was also proposed to account for the increased reactivity of the 
SiW11–Rh hybrid. 
 
4.1.2 Polyoxometalate-based N-heterocyclic carbene (NHC) complexes 
N-heterocyclic carbenes (NHC) behave like typical σ-donor ligands able to form robust 
metal-carbene bonds with a variety of transition metals M, leading to M-NHC metal 
complexes with extraordinary stability toward temperature, oxidation and hydrolysis.
5,6 
 
 
 
 
Figure 4.2 Singlet state of a carbene (A) and structure of an imidazol-2-ylidene (B) (the most widely used NHC 
in catalysis). 
Electronic features of the NHC ligands may be optimized in order to improve the catalytic 
performance of the resulting M-NHC complexes, which are often reported to overcome the 
activity of phosphine analogues, in different catalytic reactions (e.g. cross-coupling reactions, 
metathesis).
6(a),7,8
 Thus, several NHCs incorporating bulky substituents, donor groups, rigid 
systems and chiral functionalities have been developed. Recently, a series of homo- and 
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hetero-dimetallic complexes of 9
th
 and 10
th
 group metal ions have been obtained using Y-
shaped tris-NHC ligands, to perform tandem process including a transfer hydrogenation (TH) 
step.
9
 
In our research group, a hybrid POM containing Pd-NHC units has been prepared. In this 
case, the organometallic hybrid derivative (SiW10–Pd(NHC)) results from the direct 
functionalization of the [-SiW10O36]
8-
 scaffold with the preformed organometallic silane.
3
 
 
 
 
Figure 4.3 Representation of SiW10–Pd(NHC). Blue octahedra, {WO6}; green tetrahedral, {SiO4}. 
 
In particular, the complex SiW10–Pd(NHC) displays outstanding catalytic activity in Suzuki 
Miyaura C–C cross coupling in harsh catalytic conditions, i.e. under microwave (MW) 
irradiation. In this case, the polyanionic domain represent an efficient MW-absorber, and 
provides for repulsive interactions between the catalytic units, so to prevent formation of 
inactive Pd-black upon aggregation of Pd
0
 centers during catalytic turnover. Furthermore, the 
POM, due to its charge, presents high affinity towards ionic liquid media.
4
 The POM-based 
system was also effective in coupling aryl chlorides. The particular role of the POM in these 
catalytic systems is to bring robustness to the whole hybrid and thus to increase its stability 
and performance.
4
 
In this chapter, we present the synthesis of a hybrid POM, with anchored Ir-NHC moieties. 
This kind of complex has been tested as catalysts for the transfer hydrogenation of ketones.  
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4.1.3 Metal-catalyzed hydrogen transfer reactions 
During transfer hydrogenation (TH), a hydrogen is transferred from an alcohol to an 
unsaturated bond. With respect to hydrogenation reaction using the hydrogen, TH is a safer 
and environmentally benign method, in which the alcohol acts as both the reaction solvent and 
the source of hydrogen. There is a continuous demand in developing new active catalysts that 
can perform such reactions under mild conditions and by simple methodologies. Many recent 
reports have also focused on the mechanistic aspects of the reaction. A common feature of 
these reactions is that they involve metal hydride (monohydride or dihydride) intermediates, 
and a base is generally required in order to promote their formation.  
Two general reaction pathways can thus be envisaged for hydrogen transfer: a step-wise 
process, called “hydridic route”, and a concert process, called “direct hydrogen transfer” 
(Scheme 4.1). 
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ML H
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C
R1
R2
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- A
ML H
A
ML
A H
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ML
O
C
R2R1
H
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O
C
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O
C
R1
R2
H
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- A
(a) (b)  
 
Scheme 4.1 Possible paths for the hydrogen-transfer reactions. M = metal; L = ligand; A = hydrogen-donor. 
 
The “hydridic route” involves the formation of a metal hydride intermediate by interaction of 
the catalyst with the hydrogen donor, followed by hydride transfer from the metal to the 
substrate (Scheme 4.1 (a)).
10
 The “direct hydrogen transfer” implies that hydrogen is 
transferred to the substrate in a concerted process where both the H-donor and the H-acceptor 
are held together in close proximity by the catalyst (Scheme 4.1 (b)). 
In particular, the hydrogen transfer activity of Ir complexes is well established.
11
 Moreover, 
the introduction of N-heterocyclic carbene ligands (NHC) greatly improves the catalytic 
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performances of different iridium complexes. As, we have previously mentioned, indeed, 
NHCs impart high thermal robustness and stability to the organometallic intermediates during 
multi-turnover catalysis.
12
 An example of a transfer hydrogenation catalysis by an Ir-NHC 
complex is reported in Scheme 4.2. 
 
 
 
 
Scheme 4.2 Catalytic transfer Hydrogenation of acetophenone catalyzed by a chelated Iridium(III) bis-NHC 
complex (R = iPr); conditions: 0.2 M substrate solution, molar ratio catalyst/base 1:5. Product yields determined 
by 
1
H NMR.
11(i)
 
 
A polymer-supported, carbon dioxide protected Ir(I)-NHC complex, was also successfully 
used to promote hydrogen transfer from isopropanol to benzaldehyde.
13
  
Finally, the presence of a strong base and an appropriate activation procedure are required to 
achieve a high catalytic activity; the addition of a base, however, often may hamper the 
hydrogenation of base-sensitive ketones and aldehydes. New catalytic strategies are thus 
expected to address this issue. 
In the following paragraphs, our strategy, based on the synthesis of molecular hybrid POM-
appended NHC iridium complex will be described, together with its application in TH 
catalysis.  
 
4.2 Results and discussion 
As we have seen in the Introduction part of this chapter, the design of novel ligands for 
transition metals is a major goal in catalysis, to obtain better performances in terms of yields, 
selectivities and sustainability of the reaction. Molecular hybrids are of particular interest in 
catalysis, due to the interplay of joint organic-inorganic domains with very diverse functional 
environments. Such hybrid up-grade of the catalytic system can be readily accessed, through 
the covalent functionalization of molecular polyoxometalates.
4,14 
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4.2.1 Synthesis of a POM-appended N-heterocyclic carbene (NHC) iridium 
complex 
We present herein the synthesis, characterization, and catalytic applications of a POM-
appended N-heterocyclic carbene (NHC) iridium complex and its activity in catalyzing 
hydrogen transfer reactions.  
To this end, imidazolium moieties have been successfully grafted on the defect site of the 
divacant Keggin polyanion [γ-SiW10O36]
8-
.  
In particular the synthesis of the complex has been achieved by two steps:  
 
(i) synthesis of an iridium organometallic complex containing an unsaturated heterocycle 
with a trialkoxysilyl substituent on the nitrogen atom in position 3; 
(ii) grafting of the iridium organometallic complex on the polyanionic scaffold [γ-
SiW10O36]
8-
. 
 
The synthetic strategy is described in the next paragraphs. 
 
4.2.1.1 Synthesis of [(1,2,5,6-η)-1,5-cyclooctadiene][1-butyl-3-(3-triethoxysilylpropyl)-
imidazol-2-ylidene]chloroiridium ((NHC)Ir)  
First, a monomeric imidazolium derivative has been prepared following a procedure, 
optimized in our research group, depicted in Scheme 4.3.
4
  
 
 
Scheme 4.3 
 
The trialkoxysilyl-tagged unsaturated heterocycle containing a less hindered n-butyl 
substituent at the nitrogen atom (1), was synthesized under strictly anhydrous conditions, 
from (3-chloropropyl)-triethoxysilane and 1-butylimidazole. The ligand was characterized by 
1
H NMR and ESI-MS analyses. Both techniques gave results in agreement with the expected 
structure.
3
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Afterwards, the intermediate (1) was reacted with Ag2O ("silver-route" ), and the reaction was 
followed by transmetallation with [Ir(COD)Cl]2, to afford the (NHC)Ir complex [(1,2,5,6-η)-
1,5-cyclooctadiene][1-butyl-3-(3-triethoxysilylpropyl)-imidazol-2-ylidene]chloroiridium (2), 
with 78% yield (Scheme 4.4).
15
  
 
 
Scheme 4.4 
 
Complex (2) was characterized by 
1
H NMR and 
13
C NMR analyses. In the 
1
H NMR 
spectrum, the signal of the proton at position 2 of the imidazolium ring (δ = 10.6 ppm) 
disappeared, thus suggesting the formation of the carbene (see Figure 4.4 for a comparison 
between the spectrum of the product (2) and of the starting material (1)). 
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Figure 4.4 
1
H NMR of the complex (2) (A) and of the starting material (1) (B) in CDCl3. 
 
13
C NMR of the complex (2) reveals the presence of a weak signal at 178.70 ppm, as expected 
for  the resonance of C(-Ir), and confirms the formation of the complex (Figure 4.5). 
 
 
 
Figure 4.5 
13
C NMR of the complex (2) in CDCl3. 
Moreover, a single 
29
Si NMR signal at - 48.2 ppm is indicative of a pure product. The ESI-
MS (positive mode) analysis confirms the formation of the desired iridium complex, bearing 
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NHC and cyclooctadiene (COD) as ligands, showing signals centered at m/z = 628.9 and 
670.6, corresponding to [(C8H12){C10H17N2Si(OEt)3}Ir]
+
 and [(C8H12){C10H17N2(OEt)}Ir( 
CH3CN)]
+
, respectively (Appendix; A35). Attempts to crystallize the complex (2) are still in 
progress. 
 
4.2.1.2 Synthesis of (nBu4N)4[{ClIr(C8H12)(C10H17N2Si)}2O(γ-SiW10O36)] ((NHC)Ir-SiW10)  
The synthetic route to obtain the Keggin-type hybrid (NHC)Ir-SiW10 involves the reaction of 
the iridium  organosilane complex (2) with the nucleophilic oxygen atoms that border a defect 
site on the divacant Keggin POM [-SiW10O36]
8-
 (see Chapter 2: paragraph 2.1.1.1). As 
already described for the complex APTES-SiW10 (Chapter 2, paragraph 2.2.2.1), the bis-
substitution of the divacant POM yields hybrids with two surface-anchored organosilyl (RSi-) 
groups, each one linked to two oxygen atoms of two edge-shared WO6 octahedra. Grafting 
occurs in acetonitrile, in which nBu4NBr promotes the solubilization of the POM by 
counterion metathesis (Scheme 4.5), leading to the functionalized hybrid POM 
(nBu4N)4[{ClIr(C8H12)(C10H17N2Si)}2O(γ-SiW10O36)] (3) in 54% yield.  
 
 
 
Scheme 4.5 Synthetic routes to Keggin-type decatungstate functionalized with the (NHC)Ir complex (3). 
 
The product was characterized both in the solid state (by FT-IR spectroscopy and CHN 
elemental analysis) and in solution (
1
H, 
13
C, 
29
Si and 
183
W NMR, ESI-MS and cyclic 
voltammetry).
16
 The 
183
W NMR spectrum shows three resonances at -107.4, -135.8, and -
142.1 ppm in 2:1:2 ratio, in agreement with a C2v symmetry of the product. The 
29
Si NMR 
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spectrum reveals two signals at -62.8 (organosilane resonance) and -88.4 (silicotungstate 
resonance) ppm with integration ratio 2:1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6  
29
Si NMR (79.5 MHz, 25°C) of (3) in CD3CN and of (2) in CHCl3 (inset). 
 
These results are consistent with a double substitution of the POM surface, while a 16.6 ppm 
upfield shift can be observed for the organosilicon signal after grafting (Figure 4.6). 
The FT-IR spectroscopy is also in agreement with the expected bis-functionalization, as 
shown by the RSi-O vibrational band at 1102 cm
-1
 and by the diagnostic spectral pattern due 
to W-O bonds vibrations, observed between 1000 and 700 cm
-1
. 
ESI-MS spectrum of (3), registered in negative mode, shows a dominant cluster centred at m/z 
= 1723, ascribable to [{(C8H12)Ir(C10H17N2Si)}2O(γ-SiW10O36)]
2-
 (Figure 4.7).  
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Figure 4.7 ESI-MS of (3) in CH3CN (negative mode). 
 
Finally, the cyclic voltammetry measurements rule out the occurrence of any undesired 
reduction pathway during the anchoring process; the Ir
(I)
 center show a good stability upon 
attachment on the polyoxometalate, and present an irreversible anodic wave at 0.64 V (vs 
Ag/AgCl). In comparison to the POM-free complex (2), the oxidation of the complex is 
anticipated by 0.07 V. Furthermore, the cathodic scan in CH3CN is dominated by a quasi 
reversible wave at E1/2=0.76 V (vs Ag/AgCl), due to the formation of Ir
(0)
, that occurs at less 
negative potential than the W
(VI) 
reduction (Appendix; A24, A25). 
 
4.2.1.3 Transfer hydrogenation (TH) activity 
A catalytic screening has been performed with the catalyst (3) to test the activity of the 
(NHC)Ir complex in the hydrogen transfer reaction. The reduction of benzophenone to 
diphenyl methanol in iPrOH was used as a model reaction for probing the catalytic activity of 
the Iridium(I) complex (Scheme 4.6 and Table 4.1). 
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Scheme 4.6 Hydrogen transfer reaction of benzophenone. 
Catalyst manipulation does not need particular precautions, and transfer hydrogenations were 
generally performed in air. Product conversion was monitored by 
1
H NMR: the results are 
collected in Table 4.1.  
In a typical reaction, the active catalyst was formed by heating a mixture of catalyst in 
alkaline iPrOH for 10 min prior to substrate addition. The base KOH was added from a 
concentrated aqueous solution. The complex [Ir(COD)Cl(NHC)] (4) has been used as a 
reference.
15
 This is inactive in the absence of a base, while 90% conversion, in 2 h, can be 
achieved in the presence of KOH (entry 1). The parent [γ-SiW10O36]
8-
 (SiW10) is essentially 
inactive (entry 2). Combining the reference complex with the vacant POM did not affect 
catalytic activity of (4) (entry 3). Under analogue conditions, the compound (3) is active, but 
less than (4) (entry 4). (3) is also inactive in the absence of KOH (entry 5). To improve the 
solubility of (3) under the catalytic conditions, we performed a reaction with a minimum 
amount of DMF (entry 6), but the DMF appear to be detrimental for the catalysis.
17
 Identical 
conversions were obtained in a comparative experiment using tBuOK dissolved in iPrOH, to 
avoid the addition of water (entries 7, 8). The use of tBuOK as base gave full conversion after 
120 min (entry 7). This base is also expected to improve POM hydrolytic stability. Lowering 
the Ir-POM concentration from 1 mol% to 0.1 mol% still provided 70% conversion after 5h 
(entry 8). On the contrary, the use of nBu4NOH substantially lowered the activity (entry 9).  
 
 
 
 
 
 
O HO H
i-PrOH
base
Ir complex
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Finally, Figure 4.8 compares the activity over time during hydrogenation of  benzophenone 
with the POM-based catalyst in presence of different bases. 
Entry pre-catalyst Base Conv. 
(10 min) 
Conv. 
(2 h) 
Conv. 
(5 h) 
1 (4) KOH 40 90  
2 SiW10 - 0.1 1.6  
3 (4) + SiW10 KOH 33 87  
4 (3) KOH 16 57  
5 (3) - 0 0  
6
[a] 
(3) KOH 1.7 13  
7 (3) tBuOK 60 (30‘)  99  
8
[b]
 (3) tBuOK  45  70 
9 (3) nBu4NOH  14  23 
Table 4.1 TH reactions obtained with Ir(I) complexes. 
 
[a] with DMF; [b] 0.1% catalyst loading. 
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Figure 4.8 Kinetic behaviour for some of the TH reported in table 4.1. 
 
4.3 Conclusion and future perspectives 
In summary, we have described a novel POM-supported Ir
(I)
 catalyst, capable of TH to 
carbonyls. A preliminary optimization has demonstrated that we can tune the activity of the 
supported catalyst up to the level of the unsupported one. In particular, the interplay of the Ir 
binding domains with the inorganic POM scaffold provides new opportunities to access multi-
turnover catalysis while preserving good performance. Recovery strategies for the catalyst 
will thus be implemented. 
The covalent functionalization of POM vacant sites with other M-NHC complexes will be 
also evaluated (e.g. Ru-NHC)   
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5.1 General remarks 
5.1.1 Solvents and chemicals 
All commercially available reagents and solvents were used as received, without further 
purification.  
MilliQ-deionized water (Millipore) was used as solvent for the reactions and for spectrometric 
measurements. 
Sigma-Aldrich: ethylic ether, hexane, pentane, tetrahydrofuran, methanol, ethanol, 
chloroform, dichloromethane, acetonitile, deuterated chloroform, deuterated acetonitrile, D2O; 
Fluka: anhydrous dichloromethane, anhydrous ethylic ether; Prolabo: acetonitrile, 2-propanol, 
N,N-dimethylformamide, dichloromethane, P2O5; Lab Scan: dimethylsulfoxide. 
Sigma-Aldrich: sodium tungstate dihydrate, KBr, KCl, K2CO3, Na2SiO3, (R)-(−)-1-
aminoethylphosphonic acid, (S)-(+)-1-aminoethylphosphonic, tetrabutylammonium bromide, 
tetramethylammonium bromide, sulfonic acid, pyrene, dansyl chloride, fluorescein 
isothiocyanate, biotin, 1-hydroxy-1,2,3-benzotriazole (HOBt), N,N'-dicyclohexylcarbodiimide 
(DCC), N-hydroxysuccinimide (NHS), acetophenone, silver oxide, HABA/avidin reagent; 
Fluka: 1-methylimidazole; Prolabo: MgSO4, NaOH; Acros Organics: 1-ethyl-3-(3-
dimethylaminopropyl)carbodimmide (EDC); Carlo Erba: HCl 37%, HNO3 65%, Na2CO3, 
KHCO3, triethylamine; Merck: celite. 
K8[γ-SiW10O36],
1
 -A-Na8[HPW9O34]*24H2O,
2
 3-(dansylamido) propyl triethoxysilane,
3
 
pyrene-1-sulfonyl-chloride,
4
 triethoxysilyl-functionalized 4,5-dihydro-imidazolium bromide,
5
 
[Ir(COD)Cl]2 and [Ir(COD)Cl(NHC)]
6 were prepared as described in the literature.  
HEK-293 cell culture was maintained in Dulbecco's modified Eagle' s medium (DMEM, 
Sigma–Aldrich) containing glucose (4500 mgL-1), l-glutamine (5 mM), sodium pyruvate (1 
mM) and sodium bicarbonate (1 mM), supplemented with heat-inactivated FCS (foetal calf 
serum, 10%, Sigma–Aldrich) in a humidified atmosphere (5% CO2) at 37 °C. 
 
5.1.2 Instruments and apparatus 
1
H NMR spectra have been recorded with Bruker AV300 instruments operating at 300.13 
MHz; for protonic spectra, the following symbolism has been used: s: singlet; d: doublet; t: 
triplet; q: quartet; m: multiplet. 
13
C NMR spectra have been recorded with Bruker AV300 
operating at 75.4 MHz; Si(CH3)4 was used as reference. 
183
W NMR and 
29
Si NMR spectra 
have been recorded with a Bruker Avance DRX 400 instrument operating at 16.67 MHz and 
79.50 MHz, respectively, using 2M Na2WO4 in D2O and Si(CH3)4 in CDCl3 as external 
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references; 
31
P NMR spectra were recorded with a Bruker Avance DRX 300 spectrometer 
operating at 121.49 MHz with H3PO4 85% as external reference. FT-IR (KBr) spectra were 
collected on a Thermo Quest Nicolet 5700 instrument. For FT-IR spectra the following 
symbolism has been used: w: weak signal; s: strong signal; b: broad band signal. ESI-MS 
spectra have been obtained with a Agilent LC/MSD Trap SL spectrometer, by using a 
capillary potential of 1500V. UV-Vis spectra were recorded with Lambda 45 Perkin-Elmer 
and Cary 5000 Varian spectrophotometers (the spectra were collected in the range 200-800 
nm using a 1 cm quartz cell). Molar extinction coefficients ε are expressed in M-1 x cm-1. 
Fluorimetric analysis have been performed on a Perkin Elmer LS50B instrument 1 cm quartz 
cell. Circular dichroism (CD) spectra were recorded with a Jasco J-715 polarimeter with 1 cm 
UV quartz cells. Dynamic light scattering (DLS) was performed on a Malvern Zetasizer 
Nano-S instrument. Field emission-scanning electron microscopy (FESEM) measurements 
were carried out at acceleration voltages between 5 and 20 kV by means of a Zeiss SUPRA 
40VP instrument. Transmission Electronic Microscopy (TEM) measurements were obtained 
using a FEI Tecnai G2 transmission electron microscope at Biology Department, University 
of Padova. Cyclic voltammograms were recorded with a BAS (Bio Analytical Systems) 
Epsilon workstation at scan rates of 200 mV s
-1
 in a conventional electrochemical cell 
containing a three-electrode system; experiments were performed in CH3CN (0.1 M 
nBu4ClO4), using a Ag/AgCl reference. Elemental Analysis were performed at Microanalysis 
Laboratory of Chemical Science Department, University of Padova. Thin Layer 
Cromatography (TLC) were performed using DC Fertigplatten-Durasil-25 UV254 sheets 
(Machery-Nagel). Chromatography Column purifications were performed on gravity column 
using Sigma Aldrich silica gel, mesh grade 10184, granulometry 70-230 mesh, 100 Angstrom. 
pH meter: pH lab 827, Metroohm – Swiss.  
The imaging microscopy experiments and biological analysis were performed at Center for 
Biomedical Science and Engineering, University of Nova Gorica: HEK cells were plated in 
glass bottom optical imaging petri dishes and exposed to different compounds for the 
indicated time; samples were analyzed using a Axiovert Zeiss microscope with the following 
filter sets: EX BP 470/40, BS FT 495, EM BP 525/50 for the analysis of POMs: FITC-SiW10, 
FITC-PW9 and of the ligand FITC-AEPA; EX G 365, BS FT 395, EM BP 445/50 for the 
analysis of POMs: Dans-SiW10, Pyr-SiW10 and for the detection of nuclear probe Hoechst 
333423 (Invitrogen). For mitochondrial staining, cells were incubated for 15 min with 
MitoTracker probe (Molecular Probes, 250 nM) and observed with following filter set: EX 
BP 587/25, BS FT 605, EM BP 647/70. Images were acquired simultaneously using a 10x and 
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40x oil-immersion objective in transmitted light and fluorescence mode with the Axiovision 
software (Zeiss). For proliferation tests, after exposure with different compounds, cells were 
washed and incubated with Cell Proliferation Reagent WST-1 (Roche), following 
manufacturer instructions, and absorbance was measured at different time points during an 
interval of 6 h. For citotoxicity, cells were incubated for Thiazolyl Blue Tetrazolium Bromide 
(MTT, 0.025mg/ml Sigma) for 1.5 h at the cell incubator. Reaction was blocked with DMSO 
and absorbance was analysed with a Tecan Infinite Reader at 560 nm. 
 
5.2 Synthesis and characterization  
5.2.1 Synthesis of hybrid POMs 
Synthesis of (nBu4N)4[(NH2(CH2)3Si)2O(γ-SiW10O36)] (APTES-SiW10) 
600 mg (0.20 mmol) of K8[γ-SiW10O36] were suspended in 10 mL of a mixture CH3CN/H2O 
10:1, and 262 mg (0.80 mmol, 4 equiv.) of nBu4NBr, were added. Then 95 µl (0.40 mmol, 2 
equiv.) of 3 amminopropyl triethoxysilane and 293 µL (6 equiv.) of HCl 4M were added in 
rapid sequence. Upon addition of acid, immediate clearing of the solution was observed. The 
mixture was kept under vigorous stirring overnight at r.t., then filtered to remove the insoluble 
material. The mixture was concentrated to about 1 mL volume, and the product was 
precipitated by adding deionized water (20 mL). The product was collected by filtration, in a 
fritted funnel, washed with portions of deionized water and diethyl ether, and dried in vacuo. 
257 mg (76.5 µmol) of 2 were obtained (38% yield).  
FT-IR (KBr): ν= 2964 (m), 2932 (m), 2872 (m), 1626 (m, b), 1485 (m), 1381 (w), 1105 (m), 
1043 (m, b), 965 (m), 904 (s), 874 (s), 823 (s), 792 (s), 740 (s, b) cm
-1
. 
1
 H NMR: δH (300.13 
MHz, CD3CN, 301 K) 0.70 (m, 4H, N(CH2)2CH2Si), 0.99 (t, 48 H, (CH3CH2CH2CH2)4N); 
1.39 (m, 32 H, (CH3CH2CH2CH2)4N), 1.62 (m, 32 H, (CH3CH2CH2CH2)4N), 1.86 (m, 4H, N 
CH2CH2CH2Si), 3.18 (t, 32 H, (CH3CH2CH2CH2)4N), 3.50 (m, 4H, NCH2CH2CH2Si), 7.39 
(m, broad, 4 H, H2N(CH2)3Si). 
13C NMR: δC (75.47 MHz, CD3CN, 301 K) 58.97 (16C, 
(CH2CH2CH2CH2)4N), 38.03 (2C, SiCH2CH2CH2N), 29.02 (2C, SiCH2CH2CH2N), 24.10 
(16C, (CH2CH2CH2CH2)4N), 20.04 (16C, (CH2CH2CH2CH2)4N), 15.13 (SiCH2CH2CH2N), 
13.64 (16C, (CH2CH2CH2CH2)4N). 
29
Si NMR (79.49 MHz, CD3CN/CH3CN, 298 K): δ = –
62.45 (2 Si), –88.36 (1 Si) ppm.183 W NMR (16.67 MHz, CD3CN/CH3CN, 298 K): δ = –107.8 
(4 W), –135.3 (2 W), –142.1 (4 W) ppm.  
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(nBu4N)4[{{(CH3)2N}C10H6SO2NH(CH2)3Si}2O(γ-SiW10O36)] (Dans-SiW10) 
In a round-bottomed flask, APTES-SiW10 (400 mg, 0.12 mmol) was suspended in acetonitrile 
(3 mL). Triethylamine (58 μL, 0.42 mmol) was slowly added under vigorous stirring. After 5 
min, dansyl chloride (112 mg, 0.415 mmol) was dissolved in acetonitrile (4 mL) and added to 
the solution whilst stirring. The mixture was heated at 40 °C under reflux for 2.5 h and then 
centrifuged to remove insoluble reagents and byproducts. The volume of the solution was 
reduced to 1 mL by evaporation under vacuum, then diethyl ether was added to precipitate the 
product. The solid was washed with water and diethyl ether on a fritted funnel and dried for 
several hours under vacuum. Yield: 69% (366 mg, 0.09 mmol). C94H182N8O41S2Si3W10 
(4067.38): calcd. C 27.75, H 4.51, N 2.75, S 1.58; found C 26.87, H 4.45, N 2.82, S 1.06. 
FTIR (KBr): ν = 2961 (m), 2938 (m), 2873 (m), 634 (w,b), 1476 (m), 1394 (w), 1316 (w), 
1146 (m), 1102 (m), 1043 (m,b), 967 (m), 906 (s), 885 (s), 821 (s), 792 (s), 741 (s, m), 684 
(m), 625 (m), 569 (m), 544 (m), 508 (m) cm
–1
. 
1
H NMR (300 MHz, CD3CN, 301 K): δ = 0.24 
(m, 4 H, NCH2CH2CH2Si), 0.97 [t, 
3
J = 8.7 Hz, 48 H, N(CH2CH2CH2CH3)4], 1.31 [m, 36 H, 
N(CH2CH2CH2CH3)4 and SiCH2CH2CH2N], 1.62 [m, 32 H, N(CH2CH2CH2CH3)4], 2.84 [m, 
16 H, N(CH3)2 and SiCH2CH2CH2N], 3.14 [m, 32 H, N(CH2CH2CH2CH3)4], 5.95 (t, 
3
J = 6.0 
Hz, 2 H, NHCH2CH2CH2Si), 7.22 (m, 2 H, Ar-H), 7.58 (m, 4 H, Ar-H), 8.16 (m, 2 H, Ar-H), 
8.30 (d, 
3
J = 8.7 Hz, 2 H, Ar-H), 8.48 (d, 
3
J = 8.4 Hz, 2 H, Ar-H) ppm. 
13
C{1H} NMR (75.47 
MHz, CD3CN, 301 K): δ = 13.01 (2 C, SiCH2CH2CH2N), 14.07 [16 C, N(CH2CH2CH2CH3)4], 
20.47 [16 C, N(CH2CH2CH2CH3)4], 24.51[16 C, N(CH2CH2CH2CH3)4], 24.73 (2 C, 
SiCH2CH2CH2N), 45.83 [4 C, N(CH3)2], 46.83 (2 C, SiCH2CH2CH2N), 59.40 [16 C, 
N(CH2CH2CH2CH3)4], 124.53, 129.27, 129.99, 130.50, 130.70, 136.82, 152.87 (20 C, Ar) 
ppm. 
183 
W NMR (16.67 MHz, CD3CN/CH3CN, 298 K): δ = –107.9 (4 W), –136.2 (2 W), –
142.1 (4 W) ppm. 
29
Si NMR (79.49 MHz, CD3CN/CH3CN, 298 K): δ = –62.5 (2 Si), –88.4 (1 
Si) ppm. ESI-MS (–, CH3CN): calcd. for [C30H36N4O41S2Si3W10]
4– 773.3; found 773.9. UV: λ 
(log ε) = 251 (4.7), 211 (5.1) nm. 
 
Synthesis of (nBu4N)4[{C16H9SO2NH(CH2)3Si}2O(γ-SiW10O36)] (Pyr-SiW10) 
In a round bottomed flask, APTES-SiW10 (450 mg, 0.14 mmol) was suspended in CH3CN (3 
mL). After stirring for 5 min, triethylamine (49 μl, 0.35 mmol) was slowly added under 
vigorous stirring. 1-Pyrensulfonyl chloride (105 mg, 0.35 mmol) was dissolved in CH3CN (6 
ml) and added dropwise in solution whilst stirring. The mixture was heated at 50°C under 
reflux for 3 h and then centrifuged to remove insoluble reagents and byproducts. The volume 
of the solution was reduced to 1 mL, upon evaporation under vacuum, than diethylether was 
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added to precipitate the product. The solid was finally washed with diethyl ether (2 times), 
water (2 times) and a small amount of CH2Cl2 (2 times) on a fritted funnel, and dried several 
hours under vacuum. 410 mg (0.1 mmol) of product were obtained (71% yield). 
Elemental analysis: Calcd. for C102H176N6O41S2Si3W10 C 29.65 H 4.26; N 2.03; S 1.55; 
Found: C 28.87; H 3.57; N 1.94; S 1.03. FTIR (KBr): ν = 2961 (m), 2923 (m), 2873 (m), 1483 
(m, b), 1385 (m), 1318 (w, b), 1159 (w), 1143 (w), 1132 (w), 1100 (m, b), 964 (m), 949 (m), 
902 (s), 885 (s), 839 (s), 819 (s), 742 (s, b), 650 (w) cm
-1
. 
1
H NMR (300 MHz, CD3CN, 301 
K) δ = 0.57 (4H, m, NCH2CH2CH2Si), 0.94 [48H, t, N(CH2CH2CH2CH3)4], 1.27 (4H, m, 
NCH2CH2CH2Si), 1.34 [32H, m, N(CH2CH2CH2CH3)4], 1.59 [32H, m, 
N(CH2CH2CH2CH3)4], 3.09 [32 H, m, N(CH2CH2CH2CH3)4], 3.54 (4H, m, NCH2CH2CH2Si), 
6.14 (2H, t, 
3
J = 5.6 Hz, NHCH2CH2CH2Si), 8.86 - 8.02 (18 H, m, Ar-H), ppm. 
13
C{
1
H}NMR 
(75.47 MHz, CD3CN, 301 K): δ = 12.35 (2C, SiCH2CH2CH2N), 13.86 [16C, 
N(CH2CH2CH2CH3)4], 20.29 [16C, N(CH2CH2CH2CH3)4] 22.99 (2C, SiCH2CH2CH2N), 
24.32 [16C, N(CH2CH2CH2CH3)4], 46.50 (2C, SiCH2CH2CH2N), 59.24 [16C, 
N(CH2CH2CH2CH3)4], 135.25-124.42 (32 C, Ar-C) ppm. 
29
Si NMR (79.5 MHz, CD3CN/d-
DMSO, 25°C): δ = -62.61 (2 Si), -88.34 (1 Si) ppm. 183W NMR (16.7 MHz, CD3CN, 25°C): - 
107.51 (4 W), -136.03 (2W), - 141.52 (4 W) ppm. ESI-MS (–, CH3CN): m/z = 789.5, 1053.1 
expected for [C38H32N2O41S2Si3W10]
4- 
= 789.9; [C38H33N2O41S2Si3W10]
3- 
= 1053.5. 
Synthesis of (nBu4N)4[{(C20H11O5)NHCSNH(CH2)3Si}2O(γ-SiW10O36)] (FITC-SiW10) 
In a round bottomed flask, APTES-SiW10 (400 mg, 0.12 mmol) was suspended in CH3CN (7 
mL). Triethylamine (42 μl, 0.30 mmol) was slowly added under vigorous stirring. After 
stirring for 5 min, fluoresceine isothiocyanate (116 mg, 0.30 mmol) was dissolved in CH3CN 
(5 ml) and added in solution whilst stirring. The mixture was heated at 50°C under reflux for 
3 h and then centrifuged to remove insoluble reagents and byproducts. The volume of the 
solution was reduced to 1 mL, upon evaporation under vacuum, than diethylether was added 
to precipitate the product. The solid was finally washed with water (3 times), diethyl ether (3 
times), and finally Et2O/MeOH (5:1, 5 times) on a fritted funnel and dried several hours under 
vacuum. 276 mg (0.06 mmol) of product were obtained (53% yield). 
Elemental analysis: Calcd. for C112H182N8O47S2Si3W10 C 30.72; H 4.19; N 2.56; S 1.46; 
Found: C 28.80; H 3.94; N 2.09; S 1.04. FT-IR (KBr): ν =  2960 (m), 2927 (m), 2872 (m), 
1751 (m),1616 (m), 1457 (m), 1107 (w), 966 (m), 888 (s), 820 (s), 778 (s,br), 541 (w) cm
-1
. 
1
H NMR (300 MHz, CD3CN, 301 K) δ = 9.14-6.56 (fluoresceine protons), 3.32 (4H, 
SiCH2CH2CH2N), 3.14 [32 H, m, N(CH2CH2CH2CH3)4], 2.14 (4H, SiCH2CH2CH2N), 1.63 
[32H, m, N(CH2CH2CH2CH3)4], 1.38 [32 H, m, N(CH2CH2CH2CH3)4], 0.97 [48 H, m, 
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N(CH2CH2CH2CH3)4], 0.76 (4H, SiCH2CH2CH2N). 
13
C{
1
H} NMR (75.47 MHz, CD3CN, 301 
K): δ = 181.78 (2C, C=S), 169.93 (2C, C=O), 160.24, 153.34, 148.63, 142.79, 137.40, 130.23, 
127.76, 124.73, 113.39, 111.55, 103.42, 84.25 (fluoresceine carbons), 65.48 (2C, 
SiCH2CH2CH2N), 59.23 [16C, N(CH2CH2CH2CH3)4], 47.87 (2C, SiCH2CH2CH2N), 24.35 
[16C, N(CH2CH2CH2CH3)4], 20.32 [16C, N(CH2CH2CH2CH3)4], 13.94 [16C, 
N(CH2CH2CH2CH3)4], 9.54 (2C, SiCH2CH2CH2N). 
29
Si NMR (79.5 MHz, 
CD3CN/[D6]DMSO, 25°C): δ = -61.34 (2 Si), -88.26 (1 Si) ppm. 
183
W NMR (16.7 MHz, 
CD3CN, 25°C): - 108.32 (4 W), -132.87 (2W), - 143.32 (4 W) ppm. ESI-MS (–, CH3CN): m/z 
= 852.5, expected for [C48H38N4O47S2Si3W10]
4- 
= 852.4; m/z = 1217.5, expected for 
[C64H74N5O47S2Si3W10]
4- 
= 1217.3. 
 
Synthesis of (nBu4N)3Na2[((C20H11O5)NHCSNHCH(CH3)PO)2(α-A-PW9O34)] (FITC-
PW9) 
In a round-bottomed flask, β-A-Na8[HPW9O34] (187 mg, 0.06 mmol) was suspended in 
CH3CN (3 mL), with nBu4NBr (99 mg, 0.30 mmol). FITC-AEPA (70 mg, 0.13 mmol) was 
dissolved in DMSO (0.4 mL) and added to the solution, followed by the slow addition of HCl 
(70 µl, 4 M) under vigorous stirring. The mixture was heated at reflux overnight and filtered 
to remove insoluble reagents and byproducts. The volume of the solution was reduced to 1 
mL, upon evaporation under vacuum, than water was added to precipitate the product. The 
solid was washed with water (3 times), diethyl ether (3 times), and finally Et2O/MeOH (5:1, 5 
times) on a fritted funnel. 112 mg (0.03 mmol) of product were obtained (50% yield). 
Elemental analysis: Calcd. for C94H142Na2N7O46P3S2W9 C 28.48; H 3.61; N 2.47; S 1.62; 
Found: C 29.63; H 3.07; N 2.32; S 1.12. FTIR (KBr): ν = 2962 (m), 2934 (m), 2873 (m), 1755 
(m, b), 1620 (m, b), 1461 (w, b), 1383 (w), 1341 (w), 1258 (w), 1182 (m, b), 1086 (m), 1034 
(m), 962 (s), 881 (s), 850 (s), 785 (s), 750 (s), 640 (w) cm
-1
. 
1
H NMR (300 MHz, [D6]DMSO, 
301 K) δ = 10.42 – 6.59 (m, OH and Ar-H), 3.55 (2H, m, CH hidden by the water peak) 3.17 
[m, 24 H, N(CH2CH2CH2CH3)4], 1.57 [m, 24 H, N(CH2CH2CH2CH3)4], 1.33 [m, 30 H, 
N(CH2CH2CH2CH3)4; CH3], 0.93 [m, 36 H, N(CH2CH2CH2CH3)4] ppm. 
13
C{1H} NMR 
(75.47 MHz, [D6]DMSO, 28 °C): δ = 179.76, 168.56, 159.31, 151.81, 148.08, 145.74, 140.92, 
128.95, 126.51, 125.40, 112.51, 110.08, 109.53, 102.14, 83.08 (fluoresceine carbons), 57.52 
[12 C, N(CH2CH2CH2CH3)4], 56.41 (2 C) 23.04 [12 C, N(CH2CH2CH2CH3)4], 19.16 [12 C, 
N(CH2CH2CH2CH3)4], 13.30 [12 C, N(CH2CH2CH2CH3)4], 7.98 (2C, CH3) ppm. 
31
P{1H} 
NMR (121.50 MHz, [D6]DMSO, 28 °C): δ = 20.18 (s, 2 P), - 12.02 (s, 1 P) ppm. 
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Synthesis of (nBu4N)4[{(C5H7N2OS)(CH2)4CONH(CH2)3Si}2O(γ-SiW10O36)] (Biot-SiW10) 
Biotin (37 mg, 151 µmol) was introduced in a well dried Schlenk with magnetic stirring and 
connected to the line of nitrogen. Anhydrous DMF (0.5 mL), anhydrous CH3CN (1 mL), 
N,N'-dicyclohexylcarbodiimide DCC (33 mg, 160 µmol) and N-hydroxysuccinimide NHS (19 
mg, 164 µmol) were then added. The reaction mixture, vigorously stirred, was allowed to 
react for one night at 50 ° C, under nitrogen. After one night, APTES-SiW10 (200 mg, 59.4 
µmol) and TEA (21.3 µL, 149 µmol) were dissolved in 2 ml of anhydrous CH3CN and added 
to the reaction mixture. The mixture was stirred for one day at room temperature. Finally, the 
reaction mixture was centrifuged to remove insoluble reagents and byproducts. The volume of 
the solution was reduced to 1 mL, upon evaporation under vacuum, than water was added to 
precipitate the product. The solid was washed with water (3 times), diethyl ether (3 times) on 
a fritted funnel. 154 mg of product were obtained (64% yield). 
Elemental analysis: Calcd. for C: 23.3; H: 4.0; N: 3.3; S: 1.7. Found: C: 23.1; H: 4.2; N: 2.7; 
S: 0.9. FT-IR (KBr): ν = 2961 (m), 2934 (m), 2873 (m), 1662 (m), 1469 (m), 1387 (w), 1099 
(w), 948 (m), 901 (s), 820 (s), 734 (s), 544 (w) cm
-1
. 
1
H NMR (CD3CN) δ: 0.55 (4 H, m), 0.99 
(48 H, m), 1.39 (32 H, m), 1.64 (32 H, m), 2.63 (2 H, m), 3.15 (32 H, m), 4.33 (2 H, m), 4.49 
(2 H, m), 5.09 (2 H, s, br), 5.85 (2H, s, br), 6.89 (2 H, s, br).
13
C NMR (75.5 MHz, CD3CN, 
301 K) δ: 14.08 (32 C), 20.42 (32 C), 21.96 (2 C), 24.47 (32 C), 25.92 (2 C), 26.67 (2 C), 
29.21 (2 C), 36.77 (2 C), 41.89 (2 C), 42.90 (2 C), 56.56 (2 C), 61.24 (2 C), 62.77 (2 C), 
164.69 (2 C), 174.18 (2 C). 
29
Si NMR (CH3CN\CD3CN, 301 K) δ: - 62.01 (2 Si, s), - 88.43 
(1 Si, s). 
183
W NMR (16.67 MHz, CH3CN/CD3CN, 301 K) δ: - 107.55 (4 W, s), - 136.09 
(2W, s), -142.08 (4 W, s). ESI-MS (–, CH3CN): m/z = 768.0, calc. for 
[C26H44N6O41S2Si3W10]
4-
 = 770.5. 
 
Synthesis of (nBu4N)4[{ClIr(COD)(C10H17N2Si)}2O(γ-SiW10O36)] ((NHC)Ir-SiW10) 
380 mg (0.13 mmol) of K8[γ-SiW10O36] were suspended in 500 µL of H2O under nitrogen. 
206 mg (65 mmol, 5 equiv.) of nBu4NBr, and CH3CN (5 mL) were added and the mixture 
was stirred at room temperature for 20 minutes. The ligand [(1,2,5,6-η)-1,5-
cyclooctadiene][1-butyl-3-(3-triethoxysilylpropyl)-imidazol-2-ylidene]chloroiridium 
((NHC)Ir) (170 mg, 0.26 mmol) was dissolved in 3 mL of solution CH2Cl2/CH3CN 1/2 under 
nitrogen. Then the solution of (NHC)Ir and 190 μl of HCl 4.05 M were added in rapid 
sequence to the reaction mixture. Upon addition of acid, immediate clearing of the solution 
was observed. The mixture was kept under vigorous stirring overnight at r.t., then filtered to 
remove the insoluble material. The mixture was concentrated to about 1 mL volume, and the 
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product was precipitated by adding deionized water (20 mL). The product was collected by 
filtration, in a frittel funnel, washed with portions of deionized water and diethyl ether, and 
dried in vacuo. 298 mg (0.07 mmol) of product were obtained (54% yield). 
Elemental analysis calcd (%) for C100N8Si3Ir2Cl2W10O37: C 26.75, H 4.50, N 2.50; found: C 
25.25, H 4.00, N 2.54. FTIR (KBr): ν= 2960 (m), 2932 (m), 2872 (m), 1660 (m), 1482 (m), 
1463 (m), 1418 (m), 1380 (m), 1105 (m), 964 (s), 902 (s), 886 (s), 820 (s), 733 (s), 544 (m), 
508 (m) cm-1. 
1
H NMR (300 MHz, CD3CN, 301 K) δ = 7.22 (2H, s, CH imidazol-2-ylidene), 
7.04 (2H, s, CH imidazol-2-ylidene), 4.44-4.16 [24H, m, CHCOD, Si(CH2)2CH2N, 
NCH2(CH2)2CH3, CH3CH2O], 3.16 [32H, m, (CH3CH2CH2CH2)4N], 2.79-2.13 (28H, m, 
CHcod, NCH2CH2CH2CH3, SiCH2CH2CH2N, NCH2CH2CH2CH3), 1.65 [32H, m, 
N(CH2CH2CH2CH3)4], 1.40 [50H, N(CH2CH2CH2CH3)4, OCH2CH3], 0.98 [54H, 
N(CH2CH2CH2CH3] N(CH2)3CH3], 0.60 (4H, m, SiCH2) ppm. 
13
C{
1
H} NMR (75.47 MHz, d-
DMF, 301 K): δ = 178.7 (2C, C-Ir), 122.16, 121.40 (4C, C4 and C5, imidazol-2-ylidene), 
82.75 (2C, CHCOD), 82.57 (2C, CHCOD), 59.27 [16C, N(CH2CH2CH2CH3)4], 58.93, 58.54, 
58.17, 50.77 [8C, CH3(CH2)2CH2N, SiCH2CH2CH2N and CHCOD], 34.06, 33.89, 33.48, 30.46, 
26.31 (14C, methylene groups and CHCOD), 24.36 [16C, N(CH2CH2CH2CH3)4], 20.6 (6C, 
OCH2CH3), 20.33 [16C, N(CH2CH2CH2CH3)4], 13.90 [16C, N(CH2CH2CH2CH3)4], 13.16 
[2C, CH3(CH2)2CH2N] 
29
Si NMR (79.5 MHz, CD3CN, 25°C): δ = -62.0 (2 Si), -87.8 (1 Si) 
ppm. 
183
W-NMR (16.7 MHz, CD3CN, 25°C): - 105.8 (4 W), -135.6 (2W), - 141.8 (4 W) ppm. 
ESI-MS (–, CH3CN) m/z = 1723.0, calcd. For {[(C8H12)Ir(C10H17N2Si)]2O(γ-SiW10O36)}
2- 
= 
1723.  
 
5.2.2 General procedure for the cationic exchange 
In around-bottomed flask with magnetic stirring 100.0 mg of Dans-SiW10 (24.8 µmol) were 
dissolved in 3 ml of acetonitrile. Then 26.7 mg of tetramethylammonium (173 µmol) 
dissolved in 2 ml of water were added. The reaction mixture, vigorously stirred, was allowed 
to react at room temperature, for one night. The solution obtained was poured into EtOH (15 
mL). The white precipitate obtained was filtered, dried under vacuum and, finally, eluted in a 
resin (Amberlyst 15) loaded with sodium ions, using a gradient eluent of a mixture water / 
acetonitrile (1:1 to 1:0). Finally, the solution was lyophilized to remove water.  
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5.2.3 Synthesis of organic ligands 
Synthesis of 1-Pyrensulfonyl Chloride (PyrSO2-Cl) 
Sodium 1-Pyrene Sulfonate. To a vigorously stirred solution of pyrene (9.2 g, 47.1 mmol) in 
CH2Cl2 (60 mL) at 0 °C under nitrogen, chlorosulfonic acid (3.2 mL, 48 mmol), previously 
dissolved in CH2Cl2 (10 mL), was added dropwise. This solution was stirred at 0 °C for 3 h, 
then at room temperature for 16 h. The resulting dark green solution was poured onto ice (100 
g), and the CH2Cl2 was removed by rotary evaporation. The remaining solution was filtered 
twice through celite to remove particulates, and washed with water (2 x 30 ml) each time. 
Solid NaOH (2 g) was added, followed by addition of an aqueous solution of 5% NaCl (20 
ml). The resulting yellow solid was filtered off, washed with water and air-dried. Yield 10.2 g 
(71%). 
1-Pyrenesulfonyl Chloride. In CH2Cl2 (95 ml) sodium pyrene sulfonate (1.8 g, 5.9 mmol) and 
phosphorus pentachloride (4 g, 13.9 mmol) were dispersed, and then heated at 40 °C for 1 h. 
The resulting solution was filtered and the filtrate was washed with water (2 x 200 ml), then 
dried (MgSO4) and concentrated by rotary evaporation to give pyrene sulfonyl chloride, that 
was purified by silica gel column chromatography, using CH2Cl2:hexane (2:3) as eluent. The 
yield of the orange product was 1.65 g (92.7%); m.p. 172-173 °C (lit. 172).
 
FT-IR (KBr): ν = 2921 (m, aromatic CH stretch); 1588 (m, S-Cl stretch); 1384 (m), 1373 (m), 
1362 (s, asymmetric S=O), 1172 (s, asymmetric S=O), 1146 (m), 1134 (m), 849 (m) cm
-1
; 
1
H 
NMR δH (300 MHz, d6-DMSO, 301 K) all aromatic resonances; 
13
C-NMR: δC (75.47 MHz, 
d6-DMSO, 301 K) 143.04, 132.82, 132.15, 131.56, 129.13, 128.67, 128.31, 128.11, 127.65, 
126.75, 126.74, 126.24, 125.67, 125.16. 
 
Synthesis of (C20H11O5)NHCSNHCH(CH3)PO(OH)2 (FITC-AEPA) 
In around-bottomed flask, R or S 1-aminoethylphosphonic acid (AEPA) (70 mg, 0.56 mmol) 
was dissolved in H2O (12 mL) buffered with a solution of CO3
2-
/HCO3
-
 (1M) at pH 9. 
Separately, FITC (200 mg, 0.51 mmol) was dissolved in DMSO (1 mL). This latter solution 
was added dropwise to the solution of AEPA, and the resulting mixture was stirred overnight. 
The solution was acidified with aqueous KHSO4 solution (pH 2) to obtain a neutral species. 
Then the product was collected upon centrifugation and washing with acidic water (3 times) 
and finally with AcOEt (5 times). 123 mg (0.24 mmol) of product were obtained (yield 47% ). 
FTIR (KBr): ν= 3090-2850 (w), 1636 (m), 1603 (m), 1539 (m), 1459 (m), 1389 (m), 1318 
(m), 1277 (m), 1209 (m), 1174 (m), 1118 (m), 1024 (m), 950 (m), 850 (m) cm
-1
.
 1
H NMR 
(300 MHz, CD3OH, 28°C): δ = 8.41 – 6.73 (m, 11 H, Ar-H), 3.60 (1H, m, CH hidden by the 
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ethanol peak), 1.44 (m, 3H, CH3). ppm. 
13
C{
1
H} NMR (75.47 MHz, CD3OH, 301 K): δ = 
183.12, 182.99, 182.56, 169.92, 165.66, 156.70, 156.38, 143.26, 142.78, 132.70, 131.88, 
131.68, 130.20, 127.69, 116.45, 114.16, 113.75, 103.49 (fluoresceine carbons), 15.88 (1C, 
CH3) ppm 
31
P{
1
H} NMR (121.50 MHz, [D6]DMSO, 28 °C): δ = 21.05 (s, 1 P) ppm. ESI-MS 
(–, CH3OH): m/z = 513.1, expected for [C23H18N2O8PS]
-
= 513.4. 
 
Synthesis of [(1,2,5,6-η)-1,5-cyclooctadiene][1-butyl-3-(3-triethoxysilylpropyl)-imidazol-
2-ylidene]chloroiridium ((NHC)Ir)  
1-butyl-3-(3-triethoxysilylpropyl)-imidazolium bromide (0.5 g, 1.22 mmol) was introduced in 
a well dried schlenk tube. Anhydrous CH2Cl2 (40 mL) and Ag2O (0.142 g, 0.61 mmol) were 
then added. The reaction mixture, vigorously stirred, was allowed to react at room 
temperature, under nitrogen. After 5 h [Ir(cod)Cl]2 (0.410 g, 0.61 mmol) was added and the 
mixture was stirred for one night, then filtered through celite. Evaporation of the solvent gives 
the desired product as a yellow oil. Yield: 85% (0.69 g ). 
Elemental analysis calcd (%) for C24H44ClIrN2O3Si: C 43.39, H 6.68 N 4.22; found: C 42.39, 
H 5.75 N 4.13; FT-IR (KBr). ν = 3163 (w), 3126 (w), 3103 (w), 2961 (s), 2927 (s), 2876 (s), 
2013 (w, b), 1456 (m), 1420 (m), 1257 (m), 1226 (m), 1201 (m), 1167 (m), 1102 (s), 1077 (s), 
956 (m), 883 (w), 798 (m), 777(m), 703 (m), 690k (m) cm-1. 
29
Si-NMR (79.5 MHz, CD3CN, 
25°C): δ = - 48.2 ppm. 1H NMR (360 MHz, CD2Cl2, 25°C) 6.87 (1H, s, CH imidazol-2-
ylidene), 6.82 (1H, s, CH imidazol-2-ylidene), 4.58 (2H, s, b, CHcod ) 4.36 [4H, m, 
Si(CH2)2CH2N, NCH2(CH2)2CH3], 3.84 (6H, q, CH3CH2O), 2.92 (2H, s, b, CHcod ), 2.20 (4H, 
s, b, CHcod ), 2.06-1.38 (10H, m, CHcod, NCH2CH2CH2CH3, SiCH2CH2CH2N, 
NCH2CH2CH2CH3), 1.24 (9H, t, CH3CH2O), 1.00 [3H, t, N(CH2)3CH3], 0.71 (2H, m, SiCH2) 
ppm. 
13
C{
1
H} NMR (62.5 MHz, CD2Cl2, 25°C): 179.65 (C-Ir), 119.99, 119.68 (C4 and C5, 
imidazol-2-ylidene), 83.83 (1C, CHcod), 83.52 (1C, CHcod), 58.44 (3C, OCH2), 52.79, 51.46, 
51.14, 50.23 (4C, CH3(CH2)2CH2N, SiCH2CH2CH2N and CHcod), 33.73, 33.35, 32.94, 29.69, 
29.33, 24.50, 19.98 (7C, methylene groups and CHcod), 18.27 (3C, OCH2CH3), 13.70 [1C, 
CH3(CH2)2CH2N], 7.77 (1C, SiCH2) ppm. ESI-MS(+, CH3CN) m/z = 628.9 and 670.6, calcd. 
For [(C8H12){C10H17N2Si(OEt)3}Ir]
+
 and [(C8H12){C10H17N2(OEt)3}Ir(CH3CN)]
+
.  
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5.3 Analysis methods 
5.3.1 Spectrophotometric titrations 
Fluorimetric titrations of Dans-SiW10  
CuSO4·5H2O, Zn(NO3)2·6H2O, HgSO4, PbSO4, NiSO4·6H2O, FeSO4, CdSO4·H2O, and 
CoSO4·6H2O were analytical-grade products and were used to prepare 1.6 mM aqueous 
solutions. 2 mL of a 10 μM CH3CN solution of Dans-SiW10 were placed in a fluorescence 
quartz cell. A variable volume of concentrated metal ion solution (up to 40 μL) was added, 
and water was added to provide a fixed 2.5% water content. The resulting solutions were 
allowed to equilibrate until stable emission spectra were obtained (less than 5 min were 
usually required, except for Pb
2+
). 
 
Fluorimetric titrations of Pyr-SiW10  
C60 titration: 3 mg of Pyr-SiW10 were dispersed in 10 mL of DMF (solution A); at the same 
time, 7.2 mg of C60 was dissolved into 2 mL of o-DCB (solution B). Both the solutions were 
stirred for 5 minutes for a complete and homogeneous dispersion of the molecules in solution. 
Afterwards, solution A and B were dilute for having UV signals under Abs value of 1; so, 
0.45 ml of solution A were added to 2.25 mL of DMF (solution C, dilution of 1/6), and 0,4 ml 
of solution B were added to 2 ml of o-DCB (solution D, dilution of 1/6). 
UV-Vis-NIR and fluor. titrations were performed with stepwise addition of 4 μl of solution D 
to solution C, except for the very last add (+ 50 μl). About fluor. experiments, excitation 
wavelength was set at 335 nm. 
The inner filter effect correction was carried out as follows: in our system, C60 shows 
absorption at the excitation wavelength (335 nm) of Pyr-SiW10. As a consequence, with the 
gradual addition of C60, the excitation light is absorbed by both of the entities. This 
phenomenon is called inner filter effect. Thus it is very important to subtract such an effect 
from the raw quenching data. At the position of emission, which is in the half of the cell 
length, the absorption of the excitation light by the C60 can be calculated by the following set 
of equations : 
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where ε295 is the molar absorption coefficient constant of the C60 at 335 nm, F is the real 
fluorescence intensity after deduction of the inner filter effect, and F1 is the original 
fluorescence intensity measured from the spectra.  
 
Carbon nanotubes (CNTs) titration: 3 mg of Pyr-SiW10 were dispersed in 3 ml of 
DMF/MeOH 1:1 solution; after stirring the mixture for 5 minutes for increasing 
solubilisation, 3 mg of CNTs were added. The solution was sonicated for 30 minutes, and 
then was stirred for further 30 minutes. The mixture was centrifugated for 1 h at 3000 rpm, 
and after this the supernatant solution was collected. UV-Vis-NIR and fluor. experiments 
were performed directly on the supernatant solutions without any dilutions; excitation 
wavelength was set at 335 nm. 
 
Binding study between Biot-SiW10 and avidin 
The binding between Biot-SiW10 and avidin has been monitored by means of UV-Vis 
spectrophotometry. The solution avidin/HABA acid was commercially available product 
(Sigma-Aldrich) and suitable for the spectrophotometric determination of biotin levels. The 
commercial reagent was diluted 1/10 (0.68 µM in H2O; solution A). 2 mL of solution A were 
placed in a fluorescence quartz cell. 5 µL of a concentrated Biot-SiW10 solution (70 μM; 
solution B in DMF) were added to the solution A up to 20 µL, and then 5 µL of a 
concentrated Biot-SiW10 solution (140 μM; solution C in DMF) up to 50 µL. 
 
5.3.2 DFT Calculations 
Computational resources and assistance were provided by the Laboratorio Interdipartimentale 
di Chimica Computazionale (LICC) at the Department of Chemical Sciences of the University 
of Padova. DFT calculations were carried out using the Amsterdam density functional (ADF) 
code;
7
 scalar relativistic effects were taken into account by means of the two-component 
zeroorder regular approximation (ZORA) method,
8
 adopting the Becke 88 exchange plus the 
Perdew 86 correlation (BP) functional.
9
 The basis functions for describing the valence 
electrons are triple-zeta quality, doubly polarized (TZ2P), specially optimizedfor ZORA 
calculations. Due to the large size of the molecules under investigation, the internal or core 
electrons (C, N and O: 1s; Si: 1s to 2sp; W: 1s to 4spdf) were kept frozen. Geometries were 
optimized without symmetry constraints. The solvent effect was modeled by means of the 
ADF implementation
10
 of the COSMO method.
11
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5.3.3 Typical procedure for catalytic transfer hydrogenation 
Typically, the transfer hydrogen of benzophenone to diphenyl methanol in iPrOH was 
performed in a glass reactor. Catalyst manipulation does not need particular precautions, and 
transfer hydrogenations were generally performed in air.  
In a typical reaction, the catalyst (0.01 mmol, 1 mol%) was stirred, together with KOH (0.05 
mL of 2 M solution in H2O, 0.1 mmol) and iPrOH (5.0 mL) at reflux for 10 min. Then the 
ketone (1.0 mmol) was added at once. Aliquots (0.2 mL) were taken at fixed times, quenched 
in hexane (2 mL), and filtered through a plug of silica, then the silica was washed with diethyl 
ether or tert-butyl methyl ether. The combined organic filtrates were evaporated and analyzed 
by 
1
H NMR spectroscopy. 
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Acronyms and abbreviations 
 
AcOH: Acetic Acid (CH3COOH) 
AcONa: Sodium Acetate (CH3COONa) 
AEPA: 1-aminoethylphosphonic acid 
ADF: Amsterdam Density Functional code 
aFtn: apoferritin 
Ftn: Ferritin 
APTES-SiW10 = (nBu4N)4[(NH2(CH2)3Si)2O(γ-SiW10O36)] 
Biot-SiW10: (nBu4N)4[{(C5H7N2OS)(CH2)4CONH(CH2)3Si}2O(γ-SiW10O36)] 
COD: Cyclooctadiene 
Dans-SiW10: (nBu4N)4[{{(CH3)2N}C10H6SO2NH(CH2)3Si}2O(γ-SiW10O36)] 
DCC: N.N'-Dicyclohexylcarbodiimide 
DCU: N,N'-Dicyclohexylurea 
DFT: Density Functional Theory 
DLS: Dynamic Light Scattering 
DMF: Dimethylformamide 
DMSO: Dimethylsulfoxide 
EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
ESI-MS: Electrospray Ionsation Mass Spectroscopy 
EtOH: Ethanol 
EuPOM: [EuW10O36]
9-
 
FID: Flame Ionisation Detector  
FITC: Fluorescein Isothiocyanate  
FITC-AEPA: (C20H11O5)NHCSNHCH(CH3)PO(OH)2 
FITC-PW9: (nBu4N)3Na2[((C20H11O5)NHCSNHCH(CH3)PO)2(α-A-PW9O34)] 
FITC-SiW10: (nBu4N)4[{(C20H11O5)NHCSNH(CH2)3Si}2O(γ-SiW10O36)] 
FT-IR: Fourier Transform - Infrared spectroscopy  
Gly: Glycine 
HABA: 4'-hydroxyazobenzene-2-carboxylic acid 
HEK293: Human Embryonic Kidney 293 cells 
HOBt: 1-hydroxy-1,2,3-benzotriazole 
HPAs: Heteropolyacids 
HSA: Human Serum Albumin 
  
IC50: median inhibitory concentration (in µM) 
ITC: Isothiocyanate  
ITC: Isothermal Titration Calorimetry 
LICC: Laboratorio Interdipartimentale di Chimica Computazionale 
LUMO: Lowest Unoccupied Molecular Orbital  
MTT: (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
MW: Microwave radiation 
nBu4N
+
: Tetrabutylammonium cation  
NMR: Nuclear Magnetic Resonance 
NHC: N-Heterocyclic Carbene  
(NHC)Ir: [(1,2,5,6-η)-1,5-cyclooctadiene][1-butyl-3-(3-triethoxysilylpropyl)-imidazol-2 
ylidene]chloroiridium 
(NHC)Ir-SiW10: (nBu4N)4[{ClIr(COD)(C10H17N2Si)}2O(γ-SiW10O36)] 
NHS: N-hydroxysuccinimide 
o-DCB: ortho-dichlorobenzene 
Pyr-SiW10: (nBu4N)4[{C16H9SO2NH(CH2)3Si}2O(γ-SiW10O36)] 
PyrSO2-Cl: 1-Pyrensulfonyl Chloride 
POM: Polyoxometalate 
RuPOM: [Ru
IV
4(µ-OH)2(µ-O)4(H2O)4(γ-SiW10O36)2]
10-
 
SEM: Scansion Electron Microscopy 
TEA: Triethylamine 
TEM: Transmission Electron Microscopy  
TH:  Transfer Hydrogenation 
THF: Tetrahydrofuran 
TLC: Thin Layer Cromatography 
TMA: Tetramethylammonium 
TMSP: Transition Metals Substituted Polyoxometalates 
TOF: Turnover Frequency 
TON: Turnover Number 
TRIS:  tris(hydroxymethyl)aminomethane ((HOCH2)3CNH2) 
TZ2P: Triple-Zeta quality, doubly Polarized 
UV-Vis: Ultraviolet-Visible spectroscopy 
WST-1: Water Soluble Tetrazolium salts 
ZORA: two-component ZeroOrder Regular Approximation 
  
SPECTRA 
 
Hybrid POMs 
 
(nBu4N)4[(NH2(CH2)3Si)2O(γ-SiW10O36)] (APTES-SiW10) 
 
 
A1 
1H NMR (CD3CN) of APTES-SiW10. 
 
 
A2 
13
C NMR (CD3CN) of APTES-SiW10. 
 
 
 
  
(nBu4N)4[{{(CH3)2N}C10H6SO2NH(CH2)3Si}2O(γ-SiW10O36)] (Dans-SiW10) 
 
 
A3 FT-IR of APTES-SiW10. 
 
A4 
29
Si NMR (CD3CN) of Dans-SiW10. 
 
A5 
183
W NMR (CD3CN) of Dans-SiW10. 
  
 
 
A6 Emission of  Dans-SiW10 (1x10
-5
M in CH3CN with 2.5% v/v H2O, λex = 293 nm) after addition of Pb(NO3)2 
(40 M). 
 
 
 
 
(nBu4N)4[{C16H9SO2NH(CH2)3Si}2O(γ-SiW10O36)] (Pyr-SiW10) 
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A7 FT-IR (KBr) of Pyr-SiW10. 
 
 
  
 
A8 
13
C NMR (CD3CN) of Pyr-SiW10. 
 
 
 
A9 ESI-MS ((-),CH3CN) of Pyr-SiW10. 
 
 
 
 
 
 
 
 
  
 (nBu4N)4[{(C20H11O5)NHCSNH(CH2)3Si}2O(γ-SiW10O36)] (FITC-SiW10) 
 
3500 3000 2500 2000 1500 1000 500
60
62
64
66
68
70
72
74
76
78
%
 T
ra
s
m
it
ta
n
c
e
Wavenumbers (cm
-1
)
 
A10 FT-IR (KBr) of FITC-SiW10. 
 
 
A11 
1
H NMR (CD3CN) spectrum of FITC-SiW10. 
 
 
  
102030405060708090100110120130140150160170180190  
A12 
13
C NMR (CD3CN) spectrum of FITC-SiW10.  
 
 
A13 
29
Si NMR (CD3CN) spectrum of FITC-SiW10. 
 
 
A14 
183
W NMR (CD3CN) spectrum of FITC-SiW10. 
 
  
 
A15 ESI-MS ((-),CH3CN) of FITC-SiW10. 
 
 
 
(nBu4N)3Na2[(C20H11O5)NHCSNHCH(CH3)PO)2(α-A-PW9O34)] (FITC-PW9)  
 
 
A16 
31
P NMR (CD3CN/[D]6DMSO) recorded at -32 °C of FITC-PW9. 
 
 
 
 
 
  
(nBu4N)4[(C5H7N2OS(CH2)4CONH(CH2)3Si)2(γOSiW10O36)] (Biot-SiW10) 
 
A17 FT-IR (KBr) of Biot-SiW10. 
 
A18 
29
Si NMR (CD3CN) spectrum of Biot-SiW10. 
 
A19 
183
W NMR (CD3CN) spectrum of Biot-SiW10. 
  
 
 
A20 ESI-MS ((-),CH3CN) of Biot-SiW10. 
 
 
 
(nBu4N)4{[ClIr(COD)(C10H17N2Si)]2O(γ-SiW10O36)} ((NHC)Ir-SiW10)  
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A21 FT-IR (KBr) of (NHC)Ir-SiW10. 
 
  
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5  
A22 1H NMR (CD3CN) of (NHC)Ir-SiW10. 
 
 
 
A23 13C NMR (CD3CN) of (NHC)Ir-SiW10 
 
. 
  
 
  
 
 
A24 Cyclic voltammetry; cathodic scan: 0.5 mM; CH3CN (nBu4ClO4; 0.1M); 200 mV/sec. 
 
 
 
A25 Cyclic voltammetry; anodic scan: 0.05 mM; CH3CN (nBu4ClO4; 0.1M); 200 mV/sec. 
 
 
  
Ligands 
Synthesis of 1-Pyrensulfonyl Chloride (PyrSO2-Cl) 
ppm (f1)
12.5012.6012.7012.8012.9013.0013.1013.2013.3013.4013.5013.6013.7013.8013.9014.0014.1014.2014.3014.40  
A26 1H NMR (CD3CN) of PyrSO2-Cl. 
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A27 13C NMR (CD3CN) of PyrSO2-Cl. 
 
 
 
  
(C20H11O5)NHCSNHCH(CH3)PO(OH)2 (FITC-AEPA) 
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A28 FT-IR (KBr) of FITC-AEPA. 
 
 
 
A29 
13
H NMR spectrum of FITC-AEPA in CD3OH.*Residual peaks (ethanol and water). 
 
  
 
A30 
13
C NMR spectrum of FITC-AEPA in CD3OH. *Residual ethanol peaks. 
 
 
 
A31 
31
P NMR spectrum of FITC-AEPA in [D6]DMSO. 
 
 
 
  
 
A32 ESI-MS ((+),CH3OH) of FITC-AEPA. 
 
 
A33 Circular dichroic spectrum (CH3CO) of FITC-AEPA. 
 
 
 
 
 
 
 
 
  
[(1,2,5,6-η)-1,5-cyclooctadiene][1-butyl-3-(3-triethoxysilylpropyl)-imidazol-2 
ylidene]chloroiridium ((NHC)Ir)  
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A34 FT-IR (KBr) of (NHC)Ir 
 
 
A35 ESI-MS ((+),CH3CN) of (NHC)Ir. 
 
  
ζ-potential measurements of luminescent hybrid POMs 
Dans-SiW10 
 
Pyr-SiW10 
 
FITC-SiW10 
 
 
  
FITC-PW9 
 
A36 ζ-potential of hybrid POMs: Dans-SiW10, Pyr-SiW10, FITC-SiW10, FITC-PW9 in in H2O/0.05 % DMSO. 
 
 
 
Dynamic light Scattering of luminescent hybrid POMs 
 
 
 
Dans-SiW10 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Pyr-SiW10 
 
 
 
 
FITC-SiW10 
 
 
 
FITC-PW9 
 
 
 
A37 Dynamic Light Scattering (DLS) of Dans-SiW10, Pyr-SiW10, FITC-SiW10, FITC-PW9 in H2O/0.05 % 
DMSO. 
 
  
Electronic microscopy imaging of luminescent hybrid POMs 
 
 
 
 
 
 
A38 Left: transmission electronic microscopy (TEM) images of POM Pyr-SiW10 (2) in physiological-like 
solution containing 0.05% v/v of DMSO. Right: scanning electronic microscopy (SEM) images of POM  Pyr-
SiW10 in physiological-like solution containing 0.05% v/v of DMSO 
 
 
 
 
 
 
 
 
 
 
 
A39 Scanning electronic microscopy (SEM) images of POM FITC-PW9 in physiological-like solution 
containing 0.05% v/v of DMSO. 
 
 
 
 
 
 
 
 
 
 
  
Optical microscopy imaging of cells incubated with luminescent 
hybrid POMs 
 
 
 
 
A40 Subcellular localisation In vitro fluorescent large magnification microscopy imaging of HEK cells exposed 
to  FITC-PW9 and Pyr-SiW10 (18 M, at 37oC) for longer time (>15h). Note different preferential localisation 
of the two compounds. Scale bar : 10  m. 
 
  
 
 
A41 Representative images of cells exposed to different POMs (18 µM, 15 h, 37
o
C) and visualised with 
appropriate fluorescence filters and transmitted light to appreciate cell morphology. Note dense cell monolyer 
induced by FITC-PW9. Bar = 50 m. 
 
  
Biological activity of luminescent hybrid POMs 
 
 
 
A42 Cells viability studies of HEK cells incubated with different concentrations of POMs Pyr-SiW10  and 
FITC-PW9 at 37°C for 48 h. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ζ-potential measurements of aFtn/POMs system 
 
 
 
 
A43 ζ-potential of aFtn (0.245 µM) (up) and in the presence of RuPOM (below), at pH 3.5 with HCl. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
A44 Ftn (0.245 µM), in the absence (top) and in the presence (bottom) of RuPOM (24 eqs), after addition of 
NaOH, to solutions at pH 2.5 (final pH 7.8).  
 
 
 
 
 
 
 
  
 
 
 
 
A45 DLS (above) and ζ-potential (below) of aFtn (0.245 µM) and EuPOM (12.25 µM), back to pH 7.8, by 
dialysis against TRIS/AcOH buffer. 
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